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CHAPTER 1 Introduction 
1.1 What is neuroplasticity? 
“Lifelong learning” is a colloquial term often used in academic 
environments or in the workplace to refer to neuroplasticity. Originally 
coined as a term that means learning is not confined within academic 
institutions but in fact, occurs throughout life. Although most parts of 
the developed brain are made of post-mitotic or non-dividing neurons, 
the brain has developed remarkable capacity to “reinvent” function 
through alterations in the connectivity of existing neurons. As new 
environmental conditions exert new demands on the brain, it remodels 
itself to ensure survival. When placed in a new environment, we learn 
new skills and neglect skills that are no longer advantageous for 
performance. 
Many environmental cues manifest themselves as sensory information, 
stimulating the senses. Neurons that respond to a similar type of 
environmental stimuli, such as visual stimuli, form networks and their 
connection become strengthened with each subsequent activation. 
Environmental stimulation that results in learning and memory is 
accompanied by the sprouting of new dendrites, producing a new 
circuit or connection that represents the new experience. On the other 
hand, in less frequently activated circuits, dendrites are pruned. While 
genetic programs and prenatal factors influence the brain at birth, 
 2 
subsequent postnatal experience provide crucial refinement to 
capacity. Perceptual processing largely depends on the past 
experience gained during early life development. This process is 
observed throughout the animal kingdom: from songbirds who teach 
their progeny how to sing in order to court mates to mammals who 
teach their offspring skills of survival. The postnatal stimulation young 
children receive from interactions with the environment during critical 
periods influences brain architecture and cognition later in life 
(Knudsen, 2004).  
During early years of development, the immature brain links millions of 
neurons together to form efficient circuits. Synaptic proliferation is the 
process of overproduction of synapses that gives an adolescent brain 
its remarkable adaptability (Huttenlocher and Dabholkar, 1997). 
Excess, non-functional synaptic connections in the brain are pruned in 
favour of functional synapses (Figure 1.1) governed by the ‘use it or 
lose it’ principle. 
1.2 Epigenetics: more than ATGC 
Epigenetics or the stable modification(s) of gene expression without 
any changes to primary DNA sequences, is a molecular process that 
serves as an interface by which the environment can regulate gene 
expression. The dynamic interplay between genes and environmental 
experience has been demonstrated by various studies, is well defined 
and biochemically driven (Sweatt et al., 2013). Epigenetics allows post- 







Figure 1.1. Regional differences in synaptogenesis in the human 
cerebral cortex1. Mean synaptic densities (synapses/100 µm3) in the 
auditory (filled circles, continuous line), visual (area 17; open circles, 
dotted line) and prefrontal (crosses, discontinuous line) cortex. 
Synapses are produced in abundance at birth before they are pruned 
away in early development by experience. 
 
 
                                            
1 Adapted and reproduced by permission from John Wiley & Sons: The 
Journal of Comparative Neurology (Huttenlocher and Dabholkar, 1997), 
copyright 1997. 
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mitotic neurons to dynamically regulate chromatin state. Eukaryotic 
chromatin can exist in two states: heterochromatin or euchromatin. In 
the heterochromatic state, genetic material is compact and condensed, 
and thus inaccessible to the transcriptional machinery. Conversely, in 
the euchromatic state, genetic material is less condensed, in an 
opened configuration and genetically active. At the centre of the 
chromatin is the nucleosome, where DNA is wrapped around a histone 
octamer (Felsenfeld and Groudine, 2003). Hence, the state of 
chromatin packing determines the accessibility of gene regulatory 
elements to environmentally regulated transcription factors that permit 
a dynamic response to environmental signals. This “epigenome” alters 
regulation of genetic material, is usually reversible and does not alter 
the primary DNA sequence. Some examples of common chromatin 
modifications are DNA cytosine methylation, histone 
acetylation/deacetylation, protein methylation and phosphorylation. 
There are variations in the definition of epigenetics (Bird, 2007; 
Ptashne, 2007), but for the purpose of this study, it is defined as 
consisting of all modification(s) to the chromatin, including both DNA 
and histone modifications. These post-translational modifications 
(PTMs) of histones or modifications to DNA are driven by their 
respective modifying enzymes such as histone acetyltransferases and 
deacetylases, histone methyltransferases and demethylases or DNA 
methyltransferases. Over the past few years, more reports have 
demonstrated the important roles of these chromatin-modifying 
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enzymes in neuroplasticity (Korzus et al., 2004; Putignano et al., 2007; 
Vecsey et al., 2007; Dash et al., 2009; Guan et al., 2009; Gupta et al., 
2010; Brunner et al., 2012).  
It has been established that the plasticity in visual cortical circuits is 
dependent on maturation of a specific class of inhibitory neurons, the 
PV+ interneurons, and their inhibitory action on overall circuit balance. 
As the organism approach adulthood, this extraordinary plasticity is 
reduced. This loss of this extraordinary plasticity may reflect sequential 
locks (e.g. PNN (Pizzorusso et al., 2002), Nogo receptors (McGee et 
al., 2005)/PirB (Atwal et al., 2008; Syken et al., 2006), Otx2 (Sugiyama 
et al., 2008)) placed on a molecular pathway as the visual cortex 
consolidates into a structurally elaborated circuitry. The critical period in 
mouse visual cortex has been linked to a specific molecular logic of 
gene regulation (Ossipow et al., 2004; Majdan and Shatz, 2006; 
Tropea et al., 2006; Plessy et al., 2008) and it has been proposed that 
epigenetics helps to fine-tune gene activity and their expression 
essential for various brain function and defining plasticity (Satterlee et 
al., 2015; Shin et al., 2015). I hypothesize that the interactions between 
genes and environment via epigenetics regulate CP plasticity, using 
the plastic period of the visual cortex as an ideal model for the study of 










Figure 1.2. Methylation of arginine residues in proteins by PRMTs. 
(From left to right) Types I, II or III PRMTs can generate mono-
methylated arginine (MMA) on one of the terminal nitrogen. 
Asymmetric dimethylation of arginine (aDMA) is catalysed by type I 
enzymes (PRMT1, PRMT2, PRMT3, PRMT4 (CARM1), PRMT6 or 
PRMT8). Alternatively, type II enzymes (PRMT5, PRMT7 or PRMT9) 
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1.3 Protein methylation and protein arginine methyltransferases 
Despite the surge in neuroepigenomics studies (Satterlee et al., 2015), 
protein arginine methylation is poorly understood and less established 
compared to their counterparts. 
Studies on arginine methylation originated almost 50 years ago (Paik 
and Kim, 1967). However, it was the discovery of PRMT4 (also known 
as coactivator-associated arginine methyltransferase - CARM1) that 
sparked wider interest in arginine methylation (McBride and Silver, 
2001). Protein arginine methylation has since been implicated in 
cellular functions such as transcriptional regulation, mRNA processing, 
nuclear-cytoplasmic shuttling, DNA repair and signal transduction 
(Bedford and Clarke, 2009; Jahan and Davie, 2015; Wolf, 2009; Yang 
and Bedford, 2013). The arginine residue is a positively charged amino 
acid, and the nitrogen’s can be post-translationally modified to contain 
methyl (-CH3) groups. Three types of methyl-arginine species are 
possible in mammalians (Figure 1.2). They are monomethylarginine 
(MMA), asymmetric dimethylarginine (aDMA) and symmetric 
dimethylarginine (sDMA).  
An important family of enzymes, known as protein arginine 
methyltranferases (PRMT), catalyse the formation of these methylated  
arginines (Table 1.1). Currently, there are 11 identified PRMT family 
members (Bedford and Clarke, 2009; Jahan and Davie, 2015; Wolf, 












Table 1.1. Cellular compartmentalization and putative histone 








PRMT Type Nuclear Cytoplasm Others Histone mark(s)
1 I + + H2R11me1, H4R3me2a
2 I + + H3R8me2a#, H4#
3 I + H4R3me2a
4 I + H3R17me2a, H3R26me2a, H3R42me2a
5 II + Golgi apparatus H2R3me2s, H3R2me2s, H3R8me2s, H4R3me2s
6 I + H2R3
#, H2R29me2a, H3R42me2a, 
H4R3me2a# 
7 II & III + + H3R2me1, H3R17me1 H3R19me1 
8 I Plasma membrane H4R3me2a
9 II + + ?
10 ? ? ? ?
# in vitro
Cellular localization
  9 
Type I enzymes produces asymmetrically methylated arginine and type 
II enzymes produces the symmetrically methylated arginine. 
PRMT1 (Gary et al., 1996; Katsanis et al., 1997; Tang et al., 2000), -2 
(Lakowski and Frankel, 2009) -3 (Tang, 1998), -4 (Chen, 1999), -6 
(Frankel et al., 2002), and -8 (J. Lee et al., 2005) are type I enzymes. 
PRMT5 (Pollack et al., 1999), -7 (J.-H. Lee et al., 2005; Miranda et al., 
2004) and -9 (Cook et al., 2006) are type II enzymes, although some 
controversies remain over the classification of PRMT7 (Zurita-Lopez et 
al., 2012). Although these enzymes are mechanistically different and 
have unique protein substrates, they share conserved four signature 
amino acid motifs and a threonine-histidine-tryptophan (THW) loop 
(Cheng et al., 2005; Katz et al., 2003). 
These 9 classical enzymes are also S-adenosyl-L-methionine (SAM, 
AdoMet) dependent. They derive their methyl groups from SAM, a 
common substrate for methyl transfers (Cantoni, 1952). In addition to 
the classical PRMTs, a subfamily of two members (FBXO10 and 
FBXO11/PRMT9) has been proposed. These newer members of the 
family are homologous to PRMT7 and PRMT9 respectively (Jahan and 
Davie, 2015). These are not similar to the classical arginine 
methyltransferases because they do not have the signature motifs and 
their methyltransferase activity requires more validation (Cook et al., 
2006). Compared to their lysine methyltransferase counterparts, 
research on the arginine methyltransferases is in its infancy and early 
work implicates PRMTs to cellular processes such as cell growth, 
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proliferation or differentiation. In the current stage of research, PRMT1 
is recognized as the major asymmetric methyltransferase, while 
PRMT5 is the major symmetric methyltransferase. Dysregulation or 
loss of either enzyme causes non-viability in cells or the organism (Tee 
et al., 2010; Yu et al., 2009). On the contrary, overexpression of 
PRMTs leads to the development of various cancers (Yang and 
Bedford, 2013). This highlights the role and importance of protein 
methylation in governing important cellular processes. As a result, 
many groups have begun looking to PRMTs as potential therapeutic 
targets (Cha and Jho, 2012), an indication of PRMTs as a crucial 
regulatory element.  
Arginine methylation is quantitatively one of the most extensive type of 
protein methylation in mammalian cells (Najbauer et al., 1993). 
Notwithstanding, the list of proteins that are methylated by PRMTs is 
extensive and still growing. Histones have been recognized as 
substrates for protein methyltransferases for a long time (Paik and Kim, 
1967) and is a well-defined substrate for PRMTs. This is the direct 
route by which PRMTs may contribute to epigenetic modulation of gene 
expression. However, the consequence of histone methylation is far 
subtler and does not affect residue charge than acetylation or 
phosphorylation, for example. Rather, methyl groups alter steric 
properties of the arginine residue, thus facilitating or interfering with 
recruitment of effectors or repressors that ultimately lead to a biological 
outcome. 
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Besides direct input into epigenetic regulation of gene expression via 
histone proteins, PRMTs also possess the capabilities to methylate 
diverse non-histone proteins, which include transcriptional regulators. 
For example, CARM1 (PRMT4) has been showed to repress CREB 
binding protein (CBP)/p300 complex by methylating it (Xu et al., 2001). 
In mammalians, PRMTs are found in various tissues in the body (Table 
1.1). However, the role of PRMTs has not been elicited in neuronal 
processes such as synaptic plasticity. Of particular interest might be 
PRMT8, which is specifically located within the central nervous system 
(Kousaka et al., 2009; Taneda et al., 2007). Due to its unique tissue 
localization, could PRMT8 possibly play important roles in 
neurodevelopment and/or synaptogenesis? Whether this is the case 
remains to be discovered, as there is very limited literature on PRMT8. 
There is evidence to suggest that it does play a role in early zebrafish 
neuronal development (Lin et al., 2013). Other studies have suggested 
that PRMT8 binds to proteins that may be neuronal in origin, such as 
caprin-1, α-, β-tubulin and β-actin (Pahlich et al., 2008), although these 
were conducted on cells in vitro. Also, expression of PRMT8 is found to 
be localized in the nuclei and axon of mice (Kousaka et al., 2009). 
Cortical and cerebellar immunostaining of PRMT8 has been showed to 
increase as the neurons develop in mice (Kousaka et al., 2009; Taneda 
et al., 2007). In a more recent study, PRMT8 was oddly identified to 
possess phospholipase activity that regulates dendritic arborisation in 
Purkinje neurons. (Kim et al., 2015). These are the strongest 
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suggestions of a possible role for PRMT8 in functional maturation of 
neurons.  
One can only infer that PRMT8 shares some similarities in function with 
PRMT1, the major methyltransferase in mammalian cells (Tang et al., 
2000) since it shares 80% homology (J. Lee et al., 2005). PRMT1 
methylates arginine 3 (H4R3me2a) asymmetrically on histone H4 
(Gayatri and Bedford, 2014; Huang et al., 2005; Wang et al., 2001). 
H4R3me2a marks are recognized by the Tudor domain of Tudor 
domain-containing 3 protein (TDRD3) (Yang et al., 2010) which is 
enriched in highly transcribed genes. TDRD3 indirectly implicated 
increases transcription by forming complexes with DNA topoisomerase 
iii β (TOP3β) (Yang et al., 2010). I speculate that PRMT8 may have 
similar functions due to its sequence homology to PRMT1, but in the 
central nervous system owing to its unique tissue distribution. 
Interestingly, PRMT8 expresses an N-terminal myristoylated tag that 
localizes PRMT8 onto plasma membranes (J. Lee et al., 2005). 
However, removal of the N-terminal domain results in large activation 
(Sayegh et al., 2007), suggesting the purpose of this localization is 
perhaps regulatory and serves as a means of compartmentalization.  
1.4 Statement of purpose 
Currently, the role of epigenetics, especially DNA methylation and 
histone acetylation, in neuronal function or disorder is a subject of 
intense study, with many groups attempting to decipher the epigenetic 
code or “epigenome” (Satterlee et al., 2015). However, the role of 
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protein methylation specifically in neuroplasticity is unexplored and 
lacking. The objective of this dissertation is to uncover the role of 
protein arginine methylation in neuroplasticity, specifically by Prmt8, 
due to its unique localization in the CNS.  
I hypothesize that the chromatin modifying enzymes PRMT8 acts as 
the major methyltransferase in the brain, and is a crucial regulator of 
genetic programs necessary for the initiation or maintenance of 
neuroplasticity in developing mice. Loss of this chromatin-modifying 
enzyme will therefore lead to perturbations in gene regulation, leading 
to impairment to proper neurodevelopment of plasticity or plastic 
periods, and finally culminating to a poorer phenotype later in 
adulthood. 
The main objective of this study is to characterize Prmt8 and its 









CHAPTER 2 Prmt8 is experience-dependent and is regulated 
during the critical period of visual cortex 
2.1 Background and objectives 
The visual system exhibits maximal plasticity during the critical period 
and this plasticity is lost by adulthood. Current literature suggests that 
cats (Hensch and Stryker, 2004; Hubel and Wiesel, 1970; Wiesel and 
Hubel, 1963), rodents (Antonini et al., 1999; Fagiolini et al., 1994; 
Gordon and Stryker, 1996), ferrets (Chiu and Weliky, 2002; Issa et al., 
1999) and non-human primates (Hubel and Wiesel, 1969, 1968; LeVay 
et al., 1980) display critical period plasticity early in visual development. 
There is no reason to believe that the human visual system is different 
based on its columnar architecture (Adams et al., 2007).  
This gain and loss of plasticity has been linked to many genes and their 
regulation (Lyckman et al., 2008; Majdan and Shatz, 2006; Morishita et 
al., 2010; Ossipow et al., 2004; Plessy et al., 2008; Sugiyama et al., 
2008; Tropea et al., 2006). Genetic programs help lay the foundation 
and drive essential processes for neural development. However, 
neuronal networks are shaped and sculpted by early postnatal 
experience. Therefore, in post-mitotic neurons, epigenetics may 
provide the necessary mechanisms for modulation of gene expression 
and the associated synaptic changes to effectively respond to changes 
in the neuronal input (Fagiolini et al., 2009; Guan et al., 2009; Nott et 
al., 2015; Woldemichael et al., 2014). Epigenetics is a control system 
of molecular switches, consisting of histone modifications, microRNA, 
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non-coding RNA and DNA methylation that help fine-tune to the degree 
in which a gene is activated or repressed. Modification of histones, 
which leads to changes in chromatin structure and function, is one of 
the major forms of epigenetic mechanism. Common histone 
modifications, such as acetylation or methylation, occur as a result of 
recruitment of chromatin modifying enzymes by transcription 
machinery. These enzymes catalyse various histone modifications that 
collectively form the histone code to direct distinct nuclear processes. 
Some examples of chromatin-modifying enzymes include histone 
acetylases (HATs), deacetylases (HDACs), methyltransferases (HMTs) 
(including PRMTs) and demethylases (HDMs).  
Dark rearing provides a model of deprived experience by removing any 
light stimuli from the time of birth till adulthood, thereby delaying the 
developmental critical period in animal models (Figure 2.1) (Fagiolini et 
al., 1994; Mower and Christen, 1985). Dark rearing has been shown to 
increase the expression of gene(s) regulating structural plasticity 
(Wallace and Bear, 2004) and neurotransmission, especially those 
associated with inhibitory transmission (Lee et al., 2006; Morales et al., 
2002), both of which play important roles in initiating and maintaining 
the critical period. Therefore, I postulate that for every genetic program 
or pathway that modulates the critical period, there will be an 
epigenetic program or code that dynamically regulates these genes. 
The CP of the visual cortex is an ideal model for the study of 









Figure 2.1. Removal of visual experience (light) by dark rearing 
delays the onset of the critical period. The critical period has 3 
distinct phases: the pre-critical period (pink), the critical period (yellow) 
and adulthood (cyan). Visual input begins at postnatal day 14 (P14) 
when the eyes open in mice. The critical period of the murine visual 
cortex begins at about P20, peaks at P27 and lasts for two weeks. 
Ocular dominance (OD) plasticity is highest during this critical period 
and plateaus by adulthood. In dark rearing, the onset of the critical 
period is delayed in mice devoid of visual stimuli from birth. However 
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hypothesis of environmental-epigenetics interaction. Using the classical 
dark rearing paradigm as a model of experience-dependent plasticity, 
the first objective of this project is to identify chromatin-modifying 
enzymes that are regulated in an experience-dependent manner. 
2.2 Materials and methods 
2.2.1 Animals used 
C57BL/6J wild type mice were maintained on a 12-hour light/dark (LD) 
cycle (except when noted for dark adaptation experiments) and had 
access to food and water ad libitum. Depending on the experimental 
needs, the mice were reared to the appropriate age before extracting 
cortical tissue samples. Samples were excised under a dissecting 
microscope and used for either RNA or protein extraction. For dark 
rearing (DR), mice were kept in a darkroom till adulthood (P60). 
Feeding or cage cleaning was performed whilst wearing an infrared 
visor. Littermates of dark reared animals were exposed to light for a 2-
day (DR+2d), 7-day (DR+7d) or a 35-day (DR+35d) period. All animal 
procedures have been approved by the Institutional Animal Care and 
Use Committee (IACUC) at Biopolis Resource Centre, A*STAR.  
2.2.2 RNA preparation and GeneChip hybridization 
Total RNA was isolated from visual cortex and other brain tissues using 
RNeasy® Lipid Tissue Mini Kit (Qiagen, cat. no. 74804). For every 
microarray experiment, independent pairs of visual cortex from 4 mice 
were used as biological replicates: DR, 4 biological replicates; DR+2d, 
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4 biological replicates; and DR+7d, 4 biological replicates. From each 
sample, 10 µg of total RNA was labelled, hybridized to Affymetrix 
Mouse Genome 430 GeneChip® (cat. no. 900495) according to the 
Affymetrix protocols and scanned at the Biopolis Shared Facilities, 
A*STAR. 
2.2.2 Microarray data analysis 
All analyses were performed using standard statistics-based Affymetrix 
GeneChip® Software; statistical algorithms were implemented using 
Affymetrix Microarray Suite version 5.0. 
2.2.3 Real-time quantitative PCR 
mRNA was converted to cDNA using the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, cat. no. 4368813). Real-time 
qPCR was done using TaqMan® primers (Applied Biosystems) on the 
FAST7900HT (Applied Biosystems) machine. TaqMan primers include 
Prmt1 (Mm00480133_m1), Prmt2 (Mm00459994_m1), Prmt3 
(mM00659701_m1), Prmt5 (Mm00550472_m1), Prmt6 
(Mm00619134_m1), Prmt7 (Mm01250624_m1), Prmt8 
(Mm00998598_m1) and Prmt10 (Mm00626834_m1). All analysis was 
done on the RQ Manager (Applied Biosystems) provided with the 
machine. Samples were normalized to their respective standard 
condition. Delta delta CT values were calculated with two 
housekeeping genes: eukaryotic 18S rRNA (Hs99999901_s1) and -
actin (Mm02619580_g1). The final fold-change is the average of the 
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two values.  
For SYBR® Green RT-qPCR analyses, these are the primers used: 
Prmt8 forward primer 5’ – ATTAAGGCCAATCACCTGGA – 3’; Prmt8 
reverse primer 5’ – AGCTCCACCTCCTCCACTTT – 3’; β-actin forward 
primer 5’ – CCACTGCCGCATCCTCTTCC – 3’; β-actin reverse primer 
5’ – CTCGTTGCCAATAGTGATGACCTG – 3’; eukaryotic 18S rRNA 
forward primer 5’ – GCTTCCTTACCTGGTTGATCCTG – 3’; eukaryotic 
18S rRNA reverse primer 5’ – TGATTTAATGAGCCATTCGCAG – 3’. 
Data were calculated in a similar manner as described in the previous 
paragraph for TaqMan® reactions. 
2.2.4 Immunohistochemistry 
Mice were fixed with 4% paraformaldehyde via cardiac perfusion. 
Brains were extracted carefully, post-fixed for 2 hours with 4% 
paraformaldehyde and sunk in 30% sucrose overnight. Perfused brains 
were sectioned at 40 µm thickness with a cryostat. The sections were 
then blocked with goat serum (Sigma-Aldrich) and detected with 
appropriate dilutions of primary and secondary antibodies. 
Immunofluorescence imaging was performed with a confocal laser-
scanning microscope (Nikon A1). Images settings were optimized with 
the control wild type sections and kept constant for all other 
acquisitions. 
2.2.5 Antibodies used 
Primary antibodies include anti-MAP2 antibody (MAP2, Millipore, cat. 
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no. MAB3418; 1:200 for immunofluorescence); anti-PRMT8 antibody 
(PRMT8, Santa Cruz Biotechnology, cat. no. sc-130853; 1:50 for 
immunofluorescence); 4',6-diamidino-2-phenylindole (DAPI, 1 mg/ml, 
1:200) was used to stain the nuclei of cells. Secondary antibodies 
include a range of Alexa Fluor® dyes for different excitation 
wavelengths, such as 488 and 546 (Molecular Probes; 1:200 for 
immunofluorescence). 
2.2.6 Statistical analysis 
Datasets were tested for normality using the Kolmogorov–Smirnov 
goodness-of-fit test when applicable. However, due to sample size 
limitations (n<5) for some experiments, normality tests are not 
conclusive. However, there is no reason to regard datasets as not 
normally distributed. For datasets with Gaussian distributions, they 
were analysed with the unpaired student’s t-test and presented as 
mean with standard errors (SEM), unless otherwise stated. For 
datasets without Gaussian distribution, they were analysed with the 
Mann-Whitney U-test and presented as median with interquartile 
range. 
2.3 Results 
2.3.1 Expression of Prmt8 is experience-dependent 
Using the Affymetrix U430 2.0 GeneChip® to explore the changes in 
gene expression as a consequence of manipulating external 
experience, Prmt and Hdac (Hdac data not shown) families were 
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observed to be differentially regulated by external experience amongst 
the different groups of chromatin modifying enzymes. This is consistent 
with our environmental-epigenetic hypothesis. A heatmap was 
generated to represent the gene expression profiles for the entire 
known family of Prmt (Figure 2.2 A). Results from the array data 
suggest that Prmt1, -2, -3, -6, -7, -8 showed a general increasing trend 
expression as the length of light exposure was increased, although this 
was not observed in Prmt4, -5, -9 and -10. A cross-validation was 
performed using real-time quantitative-PCR (RT-qPCR) to verify the 
expression of all Prmts (Figure 2.2 B) in this experience-dependent 
model. However, RT-qPCR analyses showed that Prmts are 
downregulated in dark reared mice after exposure to light, contrary to 
microarray data. Among all the Prmts, only Prmt8 expression was 
consistent on both array and cross-validation data (Figure 2.2 B) 
(DR+2d: 1.22 ± 0.11, p≤0.05; DR+7d: 1.34 ± 0.05, p≤0.0001). Prmt8 
showed an increasing expression pattern in DR with subsequent light 
exposure and is a potential candidate gene for experience-dependent 
plasticity. Prmt9 could not be validated, as TaqMan® probes were not 








Figure 2.2. Gene expression microarray analysis indicates that 
expression of Prmt8 is experience-dependent. Microarray analysis 
of Prmt expression levels in the dark rearing (DR) paradigm. (A) 
Heatmap of Prmt gene expression levels in the visual cortex during 
dark rearing. Each gene is represented by the highest scoring probe, 
based on p-values across the 3 treatment groups; dark reared (DR, 
blue colour coded), dark reared with 2 days of light exposure (DR+2d, 
green) and dark reared with 7 days of light exposure (DR+7d, purple) 
Gene expression is scored on a scale from -1.50 (blue, low expression) 
to 1.50 (red, high expression). Each individual square in the heatmap 
represents a pair of visual cortices from one biological replicate (n=4). 
(B) Validation of PRMT gene expression levels in dark reared mice 
using real-time qPCR analysis. Data shown represents mean fold 
difference, normalized to DR gene expression levels. (**** p≤0.001, *** 
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2.3.2 Prmt8 is upregulated during the critical period of the 
murine visual cortex but not Prmt1 
In order to investigate Prmt8 transcript expression in the developing 
V1, postnatal time points were selected corresponding to before eye-
opening (<P12), the peak of the CP (P27) and adulthood (P56) (Figure 
2.3 A) (Morishita and Hensch, 2008). Low expression of Prmt8 was 
observed in the pre-CP before a 1.7 fold upregulation upon entering the 
CP and was sustained into adulthood (Figure 2.3 B) (P27: 1.67 ± 0.14, 
p=0.003; P56: 1.70 ± 0.08, p=0.0001). This is in agreement with a 
previous study that showed PRMT8 is highly expressed in the whole 
brain at P28 (Kousaka et al., 2009). This also coincides with the peak 
of the V1 plasticity. However, this upregulation trend is not observed in 
a close homolog, Prmt1 (Figure 2.3 B) (P27: 0.81 ± 0.003, p≤0.0001; 
P56: 0.89 ± 0.03, p=0.01).  
As critical periods exist in various sensory modalities, it was interesting 
to examine the expression of Prmt8 in another sensory modality. The 
primary somatosensory cortex (S1) also displays CP but at a different 
developmental time point. Using a similar sampling method as in V1, 
the CP window of plasticity for S1 layer II/III is represented by P11, 
P14, and P30 (Erzurumlu and Gaspar, 2012).  Surprisingly, Prmt8 is 
also highly expressed at the peak of the critical period of layer II/III in 
S1 (Figure 2.3 C) (P14: 2.05 ± 0.25, p=0.01; P30: 1.55 ± 0.24, p=0.07) 
compared to expression levels at P11. Likewise, the close homolog of 
Prmt1 is not regulated during CP in S1 (Figure 2.3 C) (P14: 0.77 ± 
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formatting  
Figure 2.3. Prmt8, but not Prmt1, is highly expressed during 
critical periods of visual and somatosensory cortices. (A) 
Developmental plasticity of the visual cortex in the mouse (inset) can 
be split into 3 distinct phases: the critical period (yellow), the pre- and 
post-critical period (blue and pink respectively). The critical period of 
the visual cortex occurs from postnatal day 20 to 35 (P20-P35). Inset: 
cartoon depicts the location of the visual cortex (blue region) in mice. 
(B) Left plot: Expression of Prmt8 mRNA increases after eye opening 
at P12-14 (** p≤0.01, *** p≤0.001, n=4, unpaired student’s t-test). Right 
plot: A close homolog, Prmt1, is not regulated in a similar fashion (* 
p≤0.05, **** p≤0.0001, n=3, unpaired student’s t-test). (C) The critical 
period of layer II/II of the somatosensory cortex can also be split into 3 
distinct phases. The peak of plasticity of the S1 layer II/III is between 
P11-P14 (grey). Right plot: Prmt8 is also highly expressed in critical 
period of layer II/III of the S1 critical period. (p≤0.05, n=3, unpaired 
student’s t-test.). (F) This upregulation is not observed in a close 
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0.10, p=0.07; P30: 0.80 ± 0.16, p=0.28). Often, transcript levels and 
protein levels do not correlate (Vogel and Marcotte, 2012). 
Immunofluorescence staining was conducted to verify the distribution of 
protein PRMT8 in the binocular zone of V1. In agreement with our 
mRNA data, PRMT8 is highest at P27, especially in layer IV of V1 
(Figure 2.4 A). Hence, transcript and protein levels of Prmt8 (PRMT8) 
correlate well in CP of the visual system. On closer inspection, PRMT8 
is expressed in neuronal cells (Figure 2.4 B & C).  
2.4 Discussion 
The critical period is a multi-faceted, multi-factorial process that is 
governed by “genetic programs” (reviewed in Tropea et al., 2009), for 
example, the mitogen-activated protein kinase (MAPK) pathway 
(Majdan and Shatz, 2006; Tropea et al., 2006). The first objective of 
this project is to identify possible chromatin modifying enzymes that 
may control and refine such genetic programs that control plasticity in 
the visual cortex. Dark rearing paradigm was selected as the most 
ideal method to tease out the genes that are driven by visual 
simulation. Using a gene expression microarray platform, groups of 
chromatin modifying enzymes that may be experience-dependent were 
identified. However, the focus of this project will be on the family of 
Prmts or protein methyltransferases, specifically Prmt8. Prmt8 was 
identified as a potential target for further studies because it is 





Figure 2.4 Protein PRMT8 is highly expressed during critical 
periods of visual cortex. (A) Immunostaining of PRMT8 in coronal 
sections through the binocular zone of primary visual cortex (V1b) in 
the pre- (P11, second panel), peak CP (P27, third panel) and post- 
critical period (P59, fourth panel, n=3 per group). Reference DAPI 
stained sections flank the PRMT8 stained sections (side panels). 
Cortical layers (I-VI, WM-white matter) are indicated to the right. 10x 
magnification, scale bar 200 µm. (B) Immunostaining of PRMT8 in the 
binocular zone of primary visual cortex (V1b) at P27 showed that 
PRMT8 (red) is predominantly expressed in neuronal cells labelled by 
MAP2 (green). Cortical layers (I-VI, WM-white matter) are indicated to 
the right. 10x magnification, scale bar 200 µm. (C) High (60x) 
magnification photomicrograph of merged channels indicates 









































V1, layer IV 
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 also validated in separate independent biological samples (Figure 2.2 
B). Based on current literature, there is not much known of the role of 
Prmt8, besides its unique localization in the central nervous system 
(Kousaka et al., 2009; Taneda et al., 2007). Prmt8 is reported to be 
highly regulated in the developing cortex during the critical period 
(Kousaka et al., 2009) and is predominantly localized in the cortex 
(Figure 2.5) (Lein et al., 2007; Taneda et al., 2007). These findings are 
consistent with my results (Figure 2.3 and 2.4). In addition, I observed 
that PRMT8 protein is also highly expressed during the critical period. 
Moreover, protein PRMT8 is specifically confined to layer IV neurons, 
where thalamocortical afferents terminate. Layer IV neurons (mouse) or 
columns of neurons (cats, non-human primates, humans) receive 
inputs from each separate eye and play an important role in the 
formation of ocular dominance columns (Hubel and Wiesel, 1968; 
LeVay et al., 1980, 1978). Moreover, parvalbumin (PV+) inhibitory 
interneurons are found in this layer of the visual cortex. PV+ 
interneurons receive direct thalamocortical inputs and are strongly 
implicated in critical period formation (Chattopadhyaya et al., 2004; 
Huang et al., 1999). What remains to be discovered is why PRMT8 is 
localized in this layer, and whether it plays a functional role in layer IV. 
2.5 Conclusions 
Using an experience-dependent model of critical period plasticity, 










Figure 2.5. Elevated expression of Prmt8 in the cortex of adult 
mice. (A) Expression of Prmt8 is elevated compared to other parts of 
the adult murine brain. (B) in-situ hybridization (ISH) of Prmt8 
(NM_201371.1) on a sagittal section of the adult murine brain. ICX: 
Isocortex; OLF: Olfactory bulbs; HPF: Hippocampal formation; STR: 
Striatum; CB: Cerebellum; TH: Thalamus; HY: Hypothalamus. Data 
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experience-dependent gene expression profile. This has been 
independently validated on gene expression microarrays and by RT-
qPCR. In addition, Prmt8 is upregulated during the critical period of the 
visual system, as well as layer II/II of the somatosensory cortex. 
Protein PRMT8 levels correlated well with transcript levels in V1. 
PRMT8 expression is predominantly neuronal in the mouse V1 and is 
confined to layer IV of the cortex.  The next question to be answered is 
the role of Prmt8 during this period of heightened plasticity in the visual 














CHAPTER 3 Removal of epigenetic regulator Prmt8 upregulates 
synaptic proteins involved in nervous system and neurite 
development. 
3.1 Background and objectives 
During early stages of neurodevelopment, the juvenile neocortex 
displays enhanced neuroplasticity and synaptic pruning, which are 
driven by molecular changes at the synaptic level (Dahlhaus et al., 
2011; Maffei and Berardi, 2002).  Synaptic plasticity or changes in 
efficiency of communication between neurons reflects adaptive brain 
function and is often associated with learning. One long-term functional 
consequence of neuronal activity is changes in protein synthesis 
(Sutton et al., 2006, 2004). Long-lasting changes to synaptic 
connections are often accompanied by changes in the proteins 
(Alberini and Kandel, 2015; Bailey et al., 1992) involved in receptor (Ju 
et al., 2004) ion channel densities (Raab-Graham et al., 2006) or 
dendritic spine dynamics (Engert and Bonhoeffer, 1999). Protein 
synthesis may provide the molecular substrate necessary for synaptic 
plasticity. For example, protein synthesis is required for the initiation of 
ocular dominance plasticity (Taha et al., 2002). As such, a key question 
is what molecular changes can be observed at these sites of neuronal 
connection when genetic regulation is perturbed?  
In one of the first study of the synaptic proteome of the visual cortex 
during the critical period, Dahlhaus and colleagues measured and 
identified synaptic proteins that were differentially regulated during the 
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critical period by altering visual experience (Dahlhaus et al., 2011). 
Using monocular occlusion and dark rearing as different forms of visual 
deprivation, the authors discovered differentially regulated proteins that 
are either associated with the cytoskeleton, involved in signal 
transduction or regulates synaptic efficacy. Using this study as a 
reference, the objective of this chapter is to identify molecular changes 
between Prmt8+/+ and Prmt8-/- neurons at the synaptic proteome level. 
Since Prmt8 has been demonstrated to be experience-dependent and 
we hypothesize that Prmt8 is an important epigenetic regulator, the 
removal of Prmt8 should cause molecular changes that are important 
for synaptic plasticity during the critical period. In addition, a secondary 
objective is to undercover the regulatory mechanisms of PRMT8 on 
some of these protein targets using chromatin immunoprecipitation 
(ChIP) analysis. 
3.2 Materials and methods 
3.2.1 Animals used 
Both the wild type mice (Prmt8+/+) and Prmt8 null mice (Prmt8-/-; 
Prmt8tm1a (EUCOMM)Wtsi) were maintained on a 12 hour light/dark (LD) 
cycle and had access to food and water ad libitum. Depending on the 
experimental needs, the mice were reared to postnatal day 26-28 (P26-
P28) before extracting cortical tissue samples. Samples were excised 
under a dissecting microscope. All animal procedures have been 
approved by the Institutional Animal Care and Use Committee (IACUC) 
at Biopolis Resource Centre, A*STAR.  
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3.2.1.1 Transgenic Prmt8 knockout mice 
Transgenic Prmt8 knockout mice were purchased from EUCOMM, IKC 
(European Conditional Mouse Mutagenesis, International Knockout 
Mouse Consortium) and are gifts courtesy of Dr. Ernesto Guccione 
from the Institute for Molecular & Cellular Biology, A*STAR. The 
transgenic mice were derived from C57BL/6Dnk genetic background. 
The L1L2_Bact_P vector cassette was inserted upstream of the critical 
exon(s) on chromosome 6 (Figure 3.1). The cassette consists of a 
flippase recognition target (FRT) site, followed by lacZ sequence and a 
loxP site. This first loxP site is followed by neomycin under the control 
of the human β-actin promoter, SV40 polyA, a second FRT site and a 
second loxP site. A third loxP site is inserted downstream of the 
targeted exon(s). The critical exon(s) is/are thus flanked by loxP sites. 
Further manipulation of this transgenic line is possible with the flippase-
FRT recombination or cre-lox recombination.   
3.2.2 Synaptic proteome extraction 
The synaptic proteome was extracted as previously described in 
literature (Dahlhaus et al., 2011). Bilateral visual cortices of each 
sample were dissected and snap frozen immediately. 4 pairs of visual 
cortices are pooled together per replicate to obtain sufficient protein for 
analysis. The tissues were homogenized with a motorized pellet pestle 
(Sigma-Aldrich) in ice-cold 0.32 M sucrose buffer with 5 mM HEPES at 
pH 7.4 and protease inhibitors (Roche, cOmplete, Mini, EDTA-free 
Protease inhibitor, cat. no. 1183617001) until there are no visible cell 
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clumps. The mixture was centrifuged at 1000 g for 10 min at 4°C to 
remove cell debris. Supernatant was loaded on top of a discontinuous 
sucrose gradient consisting of 1.2 M and 0.85 M sucrose. After 
ultracentrifugation at 110 000 g for 2 hours at 4°C, the fraction at the 
interface of 0.85 M and 1.2 M sucrose, which contains the 
synaptosomes, was collected, resuspended and pelleted by 
ultracentrifugation at 70 000 g for 30 min at 4 °C. The pellet was 
subsequently resuspended in a hypotonic HEPES solution and lysed 
by pipetting. The resulting synaptic membrane fraction was recovered 
by ultracentrifugation using another discontinuous sucrose gradient 
with concentrations as described previously. The interface containing 
the synaptic membranes was collected and pelleted by 
ultracentrifugation at 70 000  g for 30 min at 4 °C before resuspension 
of pellet in 5 mM HEPES. Protein concentration was determined using 
the ProStain Protein Quantification kit (Active Motif, cat. no. 15001) 





Figure 3.1. Strategy used to create Prmt8 transgenic knockout 
mice, Prmt8tm1a (EUCOMM)Wtsi. (A) Creation of transgenic mice using the 
gene-trap method. The β-gal vector contains a splice acceptor (SA) site 
immediately upstream of the lacZ reporter gene followed by a 
neomycin resistance (neo) selectable marker that is driven by an 
autologous promoter (PGK). All insertions, regardless of whether the 
insertion occurs in an intron (as shown) or in intergenic regions, lead to 
neomycin resistance and selection. If the insertion occurs in an intron, 
a fusion transcript is generated between the lacZ reporter and the 
upstream exon of gene X on transcriptional activation of the locus 
(Stanford et al., 2001). (B) Transgenic mice are created by targeted 
mutagenesis of Prmt8 on chromosome 6. (C) Flp-FRT and Cre-lox 
sites are inserted, hence making conditional knockout mutants a 
possibility. Images in B and C are courtesy of Eucomm International 
Mouse Phenotyping Consortium3 (IMPC, Skarnes et al., 2011).  
 
                                            
3 Adapted and reproduced by permission from Macmilan Publishers 
Ltd: Nature (Skarnes et al., 2011), copyright June 15th 2011. 
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3.2.3 iTRAQ sample preparation, labelling and tandem LC-
MS 
All samples were collected and processed according to the protocols 
(Manavalan et al., 2012) from Dr. Newman Sze laboratory in National 
Technological University, Singapore.  
Isobaric tag for relative and absolute quantitation (iTRAQ) is a 
technique that allows a comprehensive comparative quantitative 
determination of protein expression (Ross et al., 2004) and was 
conducted using a previously described protocol (Goh et al., 2011). 
Synaptic proteins extracted from visual cortices of wild type Prmt8+/+ 
and   Prmt8-/- mice (n=1, which consists of 4 visual cortices pooled, 
200µg each) were separated via SDS-PAGE, excised, digested with 
trypsin and labelled with iTRAQ tags. The tagged peptides are then 
separated using Electrostatic Repulsion-Hydrophobic Interaction 
Chromatography (ERLIC) into 20 fractions. Each fraction was analysed 
using a QStar Elite LC-MS/MS system (AB SciEx). Proteins and 
peptides were identified and quantified using ProteinPilot (Paragon) 
(v2.01) against the International Protein Index (IPI) mouse database. 
Library search was performed using ProteinPilot (Paragon) (v2.01) and 
the International Protein Index (IPI) mouse database. Target-decoy 
database search was used to determine the global false discovery rate 
(FDR); which is set to 1%. Peptide quantitation is determined by 
absolute tag counts per channel. This is converted to ratios 116/114 
(Prmt8-/- / Prmt8+/+) and 115/114 (Prmt8+/- / Prmt8+/+). Protein 
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expression ratios are calculated from constituent unique peptides by 
averaging the ratios. The final data matrix contained 2358 proteins. 
3.2.4 Unifying nomenclature for gene and protein targets 
Due the wide usage of gene and protein databases across our 
analysis, gene symbols will be used as a unifying identifier over IPI, 
Uniprot and protein names for consistency and clarity. 
3.2.5 Overlap analysis 
Intersections and overlaps are diagrammatically represented using 
Venny, a Venn diagram visualizer (Oliveros, J.C.). 
3.2.6 Gene Ontology (GO) term functional analysis 
GO-term functional analysis was performed using Go::TermFinder 
(Boyle et al., 2004). To determine if a GO-term is enriched within a 
specified list of proteins at a frequency greater than expected by 
chance, GO::TermFinder calculates a p-value (P) using the 
hypergeometric distribution: 
! = 1− !! ! −!! − !!!
!!!
!!!  
Where N is the total number of genes in the reference distribution, M is 
the number of genes within reference annotated to the GO term, n is 
the size of the protein list and k is the number of proteins within 
annotated to the GO term. 
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3.2.7 Network analysis 
Gene-mania (http://www.genemania.org) is a powerful network 
visualizer tool, allowing users to determine the functional inter-
connections amongst their differential protein list as well as implicating 
additional proteins that are closely associated (Mostafavi et al., 2008). 
Functional interactions include protein-interaction data, pathway, 
protein and gene expressions and synthetic lethal relationships.  
Gene-Mania boasts a novel approach towards functional annotation 
based on network edge weights, which has been shown to outperform 
older ‘functional assignments based on query gene approaches’. In this 
approach, for a list of proteins, network weights are assigned based on 
how well it reproduces GO co-annotation patterns for that organism in 
the molecular function, biological process or cellular component 
hierarchies.  
3.2.8 Western blotting analysis 
Separate synaptic fractions were collected from 4 pairs of visual 
cortices from both sets of mice for Western blotting validation. 
Extraction protocol is similar to the one described previously (Section 
3.2.2). Synaptic fractions were separated on a 4.5% polyacrylamide 
stacking gel, followed by a 5-10% polyacrylamide resolving gel. A less 
dense PAGE gel was used to resolve and separate larger molecular 
weight proteins. The proteins on the gels were transferred to 
polyvinylidene difluoride (PVDF; Millipore cat. no. IPFL0010) 
membranes designed for use with fluorophores. The membranes were 
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block with 50% LI-COR Odyssey® Blocking Buffer (LI-COR, cat. no. 
927-4000) diluted with Tris-buffered saline with 0.1% v/v Tween-20 
(TBST) for an hour. Subsequently, the membranes were incubated with 
the appropriate primary antibodies diluted with 50% Odyssey® blocking 
buffer-TBST to the recommended concentrations as directed by the 
manufacturer (Section 3.2.5). Excess primary antibody was removed 
by washing with TBST. Fluorescent secondary antibodies (Section 
3.2.5) were applied to the blots and incubated at room temperature 
without excess exposure to ambient light. The membranes were placed 
onto the LI-COR Odyssey® scanner and process accordingly. 
Integrated intensities of the bands were calculated on the software 
provided with the scanner. Values were normalized to control samples 
and loading controls unless otherwise stated. 
3.2.9 Antibodies used 
Primary antibodies include anti-PRMT8 antibody (PRMT8, Abcam, cat. 
no. ab73686; 1:250 for western blotting and 4µg for ChIP); anti-GAPDH 
antibody (GAPDH, Sigma-Aldrich, cat. no. G8795; 1:10 000 for western 
blotting); anti-H4R3me2a antibody (Active Motif, cat. no. 39705, 4µg for 
ChIP); rabbit IgG antibody (Millipore, cat. no. 12-370, 4µg for ChIP); 
anti-MAP2 antibody (MAP2, Millipore, cat. no. MAB3418; 1:1000 for 
western blotting); anti-pan Shank antibody (SHANK, Millipore, cat. no. 
MABN24; 1:250 for western blotting); anti-Tenascin-R antibody (TNR, 
Santa Cruz Biotechnology, cat. no. sc-136098; 1:200 for western 
blotting). Secondary antibodies used include Alexa Fluor® 680 goat 
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anti-mouse and goat anti-rabbit (Molecular Probes, cat. no. A-21057 
and A-21076 respectively; 1:3000 for western blotting) antibodies or 
IRDye 800CW goat anti-mouse and goat anti-rabbit (LI-COR 
Bioscience, cat. no. 92632210 and 92632211 respectively; 1:3000 for 
western blotting) antibodies. 
3.2.10 Chromatin Immunoprecipitation (ChIP) and ChIP-
qPCR (Real-time quantitative PCR) 
We first confirmed the specificity of the antibodies by western blot and 
optimized the antibody amount for ChIP empirically to ensure efficient 
ChIP. Material from 8 pairs of visual cortex was required for each 
biological replicate (PRMT8 IP, n=6 for each genotype and H4R3me2a 
IP, n=3 for each genotype). The tissues were fixed with 1% 
formaldehyde, lysed and sheared with the Bioruptor® (Diagenode) for 
15 cycles of 30 seconds ON/OFF intervals. Samples were pre-cleared 
and incubated with PRMT8/H4R3me2a antibody and mouse IgG 
controls at 4oC overnight. Immune-complexes were pulled down with 
magnetic beads, reverse cross-linked and purified with phenol-
chloroform.  
The sheared chromatin was then used to analyse relative enrichment 
of Tenascin-R (Tnr) promoter regions (Putthoff et al., 2003). 4 sets of 
primers were designed to cover the entire promoter region (Figure 3.4 
A). They are: Tnr promoter region 1 (P1) forward primer 5’ – 
CCATCAGGACTGGGACTGTTT – 3’; Tnr promoter region 1 (P1) 
reverse primer 5’ – CCTTCTACAAGTAGCCCCCTA – 3’; Tnr promoter 
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region 2 (P2) forward primer 5’ – ACAGCTTAAAAATATGCTGCTGAA 
– 3’; Tnr promoter region 2 (P2) reverse primer 5’ – 
GTCTCTGCGTGTTGAGCCA – 3’;  Tnr promoter region 3 (P3) forward 
primer 5’ – GCAGCCTCAGAGACAGGGAA – 3’; Tnr promoter region 3  
(P3) reverse primer 5’ – AAACAGCAGCTGGTAGGTCT – 3’; Tnr 
promoter region 4 (P4) forward primer 5’ – 
GTGAAGCCTTCTCTCTGCCTC – 3’; Tnr promoter region 4 (P4) 
reverse primer 5’ – AGCTAGAGCAGCTTCCAAAGCA – 3’; 
chromosome 8 untranscribed region forward primer 5’ - 
GGGTCCCCAGAGGAACACA – 3’; chromosome 8 untranscribed 
region reverse primer 5’ - TGACCTCACTGCAGACAAGGA – 3’. 
Samples were added to SYBR® Green Master Mixes and run on the 
ABI HT7900 RT-qPCR machine. Raw Ct values were extrapolated and 
the Ct values for input samples were adjusted for dilution factor. Data 
was represented as fold enrichment and finally normalized to IgG 
(negative control). 
3.2.11 Statistical analysis 
Datasets were tested for normality using the Kolmogorov–Smirnov 
goodness-of-fit test when applicable. However, due to sample size 
limitations (n<5) for some experiments, normality tests are not 
conclusive. However, there is no reason to regard datasets as not 
normally distributed. For datasets with Gaussian distributions, they 
were analysed with the unpaired student’s t-test and presented as 
mean with standard errors (SEM), unless otherwise stated.  
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3.3 Results 
3.3.1 Proteome-wide analysis with iTRAQ indicates that 
structural proteins, such as Tenascin-R, are upregulated in 
Prmt8-/- mutants. 
To interrogate the molecular basis of Prmt8 knockout in the visual 
cortex, a quantitative proteomic analysis of the synaptic proteome was 
performed using the isobaric tag for relative and absolute quantification 
(Figure 3.1 A, iTRAQ flowchart). Preliminary checks indicate that 
Prmt8+/- / Prmt8+/+ and Prmt8-/- / Prmt8+/+ exhibited a largely correlated 
relationship (Figure 3.1 B). Following log-conversion and z-
transformation, the protein expression distributions for Prmt8-/- / 
Prmt8+/+ and Prmt8+/- / Prmt8+/+ were normally distributed. This meant 
that parametric statistical approaches could be applied without 
incurring strong bias. Hence, an alpha of 5% was introduced, with 
protein hits with z-scores below -1.96 and above 1.96 are considered 
as differentially expressed. 49 proteins were shared between the 
overlap of both comparisons (Prmt8+/- / Prmt8+/+ and Prmt8-/- / Prmt8+/+). 
The 49 IPI ids were mapped to 32 proteins with gene symbols. In order 
to be consistent, gene symbols will be used as a unifying identifier over 
IPI, Uniprot and protein names. Using these 32 proteins, we performed 
hierarchical clustering based on their z-normalized protein expressions 
(Euclidean distance, Ward’s linkage) (Figure 3.1 C). The majority of 
these 32 differential genes appear to be downregulated. Functional 
analysis based on gene ontology (GO)-terms (Boyle et al., 2004) 
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pointed strongly towards enrichment of GO-terms associated with 
nervous system development, in particular, axon regeneration (Figure 
3.1 D).  
Among the dysregulated proteins, almost all proteins were upregulated. 
Candidate proteins identified from iTRAQ analyses were validated by 
western blotting (Figure 3.1 E and F). Indeed, protein intensities of 
MAP2 (1.9 ± 0.28, p=0.03, n=3), TNR (1.3 ± 0.12, p=0.04, n=5) and 
SHANK (1.3 ± 0.13, p=0.05, n=4) were upregulated in  Prmt8-/- neurons 
compared to wild type protein levels. As a control, PRMT8 (0.46 ± 0.10, 
p≤0.01, n=4) was reduced in the null mice.   
These 32 gene symbols corresponding to the differential proteins with 
GeneMania returned a tightly inter-connected induced network 
(induced meaning the highly-clustered network inferred from the 
complete network based on the 32 query gene symbols) comprising 52 
(20 implicated genes + 32 gene symbols corresponding to the 
differential proteins) genes based on co-expression, co-localization, 
and predicted relationships (Figure 3.3 A and B). This induced network 
was enriched for neurological functional terms similar with Figure 3.2 E, 
but because it was more extensive, additional functional terms were 
implicated, such as microtubule-associated complex, energy 
metabolism and dynein complexes (Figures 3.3 B and C).  
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Figure 3.2. Proteome-wide analysis of Prmt8-/- transgenic mice 
using iTRAQ reveals that proteins involved in nervous system 
development and regeneration are increased. (A) Schematic 
representation of the workflow of a typical iTRAQ proteome-wide 
experiment. (B) The expression distributions for each isobaric tag (116 
for Prmt8-/-; 115 for Prmt8+/- & 114 for Prmt8+/+) are generally well-
correlated. Only proteins with values beyond ±1.96 are considered 
differentially expressed as determined by their z-normalized expression 
values. (C) Clustering of 49 genes reveals four major groups based on 
expressional intensity changes but most appear downregulated. (D) 
Functional analysis based on GO-terms pointed strongly towards 
enrichment of GO-terms associated with nervous system development, 
in particular, axon regeneration.  (E) Representative western blot 
analysis images of PRMT8, microtubule-associated protein 2 (MAP2), 
Tenascin-R (TNR), and SH3 and multiple ankyrin repeat domains 
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iTRAQ. (F) Quantitative analysis of the bands showed that the Prmt8-/- 
mice do express more MAP2 (* p≤0.05, n=3, unpaired student t-test), 
TNR (* p≤0.05, n=5, unpaired student t-test), and Shank (* p≤0.05, 
n=4, unpaired student t-test) than wild type Prmt8+/+ mice. As expected, 
PRMT8 (** p≤0.01, n=4, unpaired student t-test) is reduced in Prmt8-/- 
mutants. Integrated intensity of the bands was averaged when 
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Figure 3.3. The disrupted functional network induced by Prmt8 
knockout is enriched for relevant neuronal processes, in 
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from both heterozygous (Prmt8+/-) and homozygous (Prmt8-/-) Prmt8 
knockouts (32 mappable to gene names out of the original 49) induces 
a highly inter-connected network, further implicating an addition 20 
proteins excluded during the preliminary proteomics screen. (B) This 
network, induced by the differential proteins from the complete 
reference network, may be further subdivided into domains based on 
functionality, which includes axon regenration, microtubule association 
and formation of dynein complexes. (C) Table denoting enriched GO 
terms, coverage (ratio of differential proteins over all proteins mapped 
to particular term), associated false discovery rates (FDR) and 
















  47 
3.3.2 Chromatin immunoprecipitation (ChIP) analysis 
showed that Prmt8 and its putative mark, H4R3me2a, is 
enriched at Tnr promoter regions.  
Interestingly, Tenascin-R (TNR), a glycoprotein component of the 
extracellular matrix was also been found to be upregulated in the 
synaptic proteome of Prmt8-/- mutants. TNR is an integral part of the 
perineuronal nets (PNNs) and these nets are known to form around 
neurons, thereby, structurally consolidating the neural circuits. 
Therefore, in order to establish a direct association of PRMT8 in the 
regulation of TNR, chromatin immunoprecipitation (ChIP) analysis was 
carried out. PRMT8 ChIP-qPCR analysis of Tnr promoter region 
(Figure 3.4 A, Putthoff et al., 2003) showed relative enrichment of 
PRMT8 on each of the four regions (Figure 3.4 B, open bars) (P1: 2.22 
fold enrichment ± 0.98, p=0.32; P2: 1.88 fold ± 1.05, p=0.51; P3: 3.18 
fold ± 1.32, p=0.16; P4: 2.19 fold ± 0.63, p=0.01, n=6 each) compared 
to a non-transcribed region of chromosome 8 (Chr 8: 1.13 fold ± 0.33, 
n=6). As expected, ChIP analysis of Prmt8-/- samples abolished the 
enrichment on Tnr promoters (Figure 3.4 B, closed bars) (P1: 1.48 fold 
enrichment ± 0.98; P2: 0.66 fold ± 0.08; P3: 1.01 fold ± 0.16; P4: 1.36 
fold ± 0.36, n=6 each). Since PRMT8 has been demonstrated to 
interact with the promoter of Tnr, does its putative mark H4R3me2a 
(Yang and Bedford, 2013) also play a role in regulating Tnr 
expression? To answer this question, ChIP analysis was performed 
with the H4R3ma2a antibody. ChIP-qPCR data suggests that 
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H4R3me2a was highly enriched at promoter 4 (Figure 3.4 C, open 
bars) (P4: 79.93 fold ± 38.49, n=3) compared to the negative control 
(Chr 8: 10.04 fold ± 3.12, p=0.14, n=3). The other regions do not show 
a difference in enrichment compared to the untranscribed control 
region (P1: 25.34 fold ± 11.44, p=0.27; P2: 7.61 fold ± 0.42, p=0.48; 
P3: 14.19 fold ± 4.34, p=0.48, n=3 each). The enrichment of 
H4R3me2a on promoter region 4 is mediated by PRMT8 because 
enrichment levels are reduced in Prmt8-/- samples (Figure 3.4 C, closed 
bars) (P4: 17.25 fold ± 8.47, n=3, p=0.19). 
3.4 Discussion 
We have identified and characterized the proteomic changes due to 
Prmt8 ablation and its role in the developing visual cortex. Removal or 
disruption to Prmt8 via a transgenic mouse model perturbs proteins 
that are functionally important for axonal or dendritic development 
(Figure 3.2 and 3.3). These changes may negatively influence the 
development of the visual cortical circuits, as well as the visual 
performance of the animal. Amongst some of them are proteins that 
play important roles in synapse formation such as PCLO (Mukherjee et 
al., 2010), Shank (Roussignol et al., 2005; Sala et al., 2001) and MAP2 
(Dehmelt and Halpain, 2005). For example, PCLO, together with 
partner protein, Bassoon, is required for assembly and structural 
maintenance of the presynaptic active zone. PCLO acts on F-actin in 
the active zone and RNAi-mediated loss of PCLO leads to aberrant 
formatting 






Figure 3.4. Chromatin immunoprecipitation (ChIP) analysis 
indicates that PRMT8 and its putative histone mark, H4R3me2a, 
are enriched at Tnr promoter regions. (A) Schematic representation 
of Tnr promoter and the primers designed for ChIP. (B) PRMT8 ChIP of 
wild type Prmt8+/+ mice visual cortices (open bars, n=6) showed 
enrichment of PRMT8 at the promoter regions of Tnr, (p=0.01) 
compared to the untranscribed region on chromosome 8. Removal of 
Prmt8 abolished PRMT8 enrichment levels (closed bars, n=6) to levels 
comparable to control levels. (C) Further ChIP analyses with PRMT8’s 
putative mark, H4R3me2a antibody, revealed selective enrichment at 
promoter region 4 (open bars, p=0.14, n=3). PRMT8 is responsible for 
H4R3me2a mark at promoter 4 of the Tnr gene as loss of Prmt8 



























































degradation of presynaptic proteins, culminating in synapse 
degradation (Waites et al., 2013). Interestingly, PCLO gene mutation 
has been implicated in depression and bipolar disorders in humans. 
Shank family proteins promote dendritic spine maturation by recruiting 
another protein, Homer, to postsynaptic locations (Sala et al., 2001). 
On the other hand, MAP2, a structural protein crucial for neurite 
outgrowth (Jaworski et al., 2009), is crucial for cytoskeletal assembly 
and stabilization. Therefore, it is not surprising that GO analyses 
returned terms that focused on nervous system development and axon 
regeneration (Figure 3.2 C). 
From the overlap of differential genes from both Prmt8 homozygous    
(Prmt8-/-) and heterozygous (Prmt8+/-) mutants, 32 mappable genes 
were clustered into four functional subnets, which are associated with 
the development of the nervous system (Figure 3.3). The neurological 
functions associated with the functional subnets induced by the set of 
32 differential genes were in agreement with our expectation that 
PRMT8 might be an important player in regulating neurodevelopment 
and/or synaptogenesis during development of the visual cortex. 
Moreover, enriched GO terms point towards functionalities involving 
neurite formation, development or regeneration (Figure 3.3 C).  
TNR was identified and enriched in both screens of the synaptic 
proteome. Similar to the other proteins identified, TNR is implicated in 
neurite development, cell adhesion and movement (Pesheva and 
Probstmeier, 2000). Interestingly, TNR is only immunohistologically 
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detected from postnatal day 21 in the visual cortex (Brückner et al., 
2000). This coincides with the developmental expression (Chapter 2) of 
Prmt8 (Kousaka et al., 2009), as well as the onset of the critical period 
of the visual cortex (Hensch, 2004). Evidence from ChIP data (Figure 
3.4) indicate that PRMT8 regulates Tnr at its promoter region. 
Knockout of PRMT8 increases transcript levels of Tnr in the visual 
cortex, suggesting that PRMT8 may act as a molecular brake.  
However, it is not clear if PRMT8 acts on its putative histone H4 
arginine 3 asymmetric methylated mark (H4R3me2a) to regulate the 
transcriptional machinery. TNR is an integral ECM component of 
PNNs, acting as a cross-linker between hyaluronan and chondroitin 
sulphate proteoglycan (CPSGs), aggrecan (Lundell et al., 2004) (Figure 
3.5). Together, these three molecules (hyaluron, CPSG and TNR) form 
the three major components of the perineuronal net. TNR is suggested 
to more important than CPSGs, because nets in Tnr-deficient mice fail 
to aggregate properly (Weber et al., 1999) but CPSG-deficient mice still 
form normal nets (Brakebusch et al., 2002; Zhou et al., 2001). Besides 
protecting the neurons from extracellular chemicals or agents, PNNs 
also limit synaptic plasticity by stabilizing the functional, matured 
neuronal connections. This was demonstrated by enzymatic digestion 
of the PNNs, which reverted adult mice back to the juvenile state of 
ocular dominance plasticity (Pizzorusso et al., 2002). In addition, 






Figure 3.5. Structure and major components of brain ECM, 
perineuronal nets (PNNs)4. Perineuronal nets control the extracellular 
milieu by wrapping around the soma and proximal dendrites of 
neurons. The major components of PNNs are hyaluronic acid, 
proteoglycans, and tenascin-R molecules.  
                                            
4 Adapted and reproduced by permission from Macmilan Publishers 
Ltd: Nature Reviews Molecular Cell Biology (Mouw et al., 2014), 
copyright November 5th 2014. 
Figure 1.7 
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recovered in a second proteomics pipeline (data not shown), further 
supporting our observation that knockout of Prmt8 does affect 
formation of these nets. Similar to TNR, Acan has been implicated as a 
molecular controller of structural plasticity in the neocortex. A previous 
study demonstrated that Acan expression correlates with a decline in 
plasticity in the visual cortex of cats (Kind et al., 2013; Lander et al., 
1997).		
Since all the synaptic proteins were upregulated in Prmt8 knockout 
mice (Figure 3.2), it is tempting to suggest that Prmt8 acts as a 
molecular repressor at first glance. However, in order to determine if 
PRMT8 interacts and modulates transcriptional activity of Tnr, ChIP 
analyses were performed. From the ChIP-qPCR data, PRMT8 is 
selectively enriched in the promoter regions of the Tnr gene compared 
to an untranscribed control region (Figure 3.4 B), suggesting that 
PRMT8 binds to regulatory elements within this region. While the data 
suggests that PRMT8 does regulate Tnr, it is important to note that 
PRMTs often work in tandem with other proteins as “co-activators” and 
rarely act as effectors on their own. For example, PRMT1 and CARM1 
(PRMT4) work together to activate a wide range of transcription factors, 
which in turn controls gene expression (Kleinschmidt et al., 2008). On 
the other hand, PRMT5 interacts with methyl-DNA binding protein 
2/nucleosome remodelling deacetylase complex (MBD2/NuRD) to 
confer repression of gene expression via the H4R3me2s mark (Le 
Guezennec et al., 2006). Hence, it is plausible that PRMT8 may work 
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with either permissive or repressive regulatory elements on different 
regions within the Tnr promoter.  
Based on current literature, not much is understood about PRMT8 and 
its molecular function. It is speculated that PRMT8 has a similar 
function as PRMT1 due to its close homology at the amino acid level 
(J. Lee et al., 2005). Hence, using antibodies against its putative 
histone H4 mark, H4R3me2a, ChIP analysis demonstrates that the 
upstream promoter region 4 of Tnr was enriched (Figure 3.4 C), albeit 
not statistically significant. The removal of PRMT8 caused a drop in 
enrichment of H4R3me2a at promoter 4, suggesting that this mark 
maybe indeed mediated by PRMT8. By convention, the H4R3me2a 
mark is often described as an activation mark. However, our data 
suggests the contrary. It is noteworthy that this relationship is not 
linear. Various histone modifications have distinct effects at different 
loci, likely due to the interactions between histones and histone-
associated complexes. For example, H4R3 methylation is crucial for 
subsequent histone acetylation and lysine methylation (Huang et al., 
2005).  Data from figure 3.4 does not exclude other possibilities 
because PRMT8 may directly or indirectly modulate other regulatory 
elements. Therefore, because of these complexities, further ChIP 
analysis (such as ChIP-sequencing) will be required to uncover the 
specific transcriptional mechanisms of PRMT8 on histone H4R3 and 
other elements that may participate in gene regulation, preferably on 
neuronal population in vitro. An in vitro system will be advantageous as 
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more homogenous material can be obtained without having to pool 
tissue samples, thus reducing biological variation. In addition, it would 
be far easier to implement molecular bioengineering techniques on 
cultured cells than in biological tissues. These will aid in providing a 
clearer picture of the molecular mechanisms and partners of PRMT8. 
Interestingly, one recent study has suggested that stimulating the 
GABAA receptors in P19 neurons causes intracellular changes in pH. 
The subsequent alkalination of neurons from GABAA receptor 
activation modulates the activity of intracellular methyltransferases 
(Denman et al., 2014). Incidentally, this same GABA receptor subtype 
has been implicated in critical period formation (Fagiolini et al., 2004). 
This alkalination could be responsible for cleaving the membrane-
bound isoform of Prmt8 to its unbound active form (Sayegh et al., 
2007) during neuronal activation via GABAA receptors, releasing it to 
act on its substrates and cause functional changes. Interestingly, this 
study (Denman et al., 2014) draw links to the Fragile-X syndrome 
(FXS) by demonstrating that GABAAerigc mediated PRMT activation is 
impaired in hippocampal slices of a mouse model of FXS (Fmr1 KO). 
The FXS knockout model has many parallels to the Prmt8 knockout 
model. Firstly, FXS patients display aberrant, supernumerary cortical 
dendritic spines (Hinton et al., 1991; Rudelli et al., 1985), similar to 
Prmt8 KO mice (as we will see in Chapter 4). Secondly, as a result of 
this aberrant architecture of the cortex, FXS is often described as a 
disease of excitation dominance (Gatto and Broadie, 2010). Therefore, 
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it is very plausible that GABAergic dependent activity may influence 
methyltransferase activity via intracellular pH modulation in critical 
period plasticity. 
3.5 Conclusions 
Using proteome-wide analyses, I have identified and validated 
representative proteins from the synaptic fraction that were 
differentially regulated in Prmt8-/- mice. These were identified as 
proteins predominantly involved in nervous system development, 
neurite development or regeneration. One interesting protein, TNR, a 
crucial component of perineuronal nets was identified for further 
analysis. ChIP analysis suggests that PRMT8 interacts with promoter 
regions of the Tnr gene, regulating its expression. Although PRMT8 
acts on the Tnr promoter region via its putative histone H4 mark, 
H4R3me2a, more data is required to understand the specific 
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CHAPTER 4 Increased perineuronal nets cause decreased 
perisomatic inhibitory puncta leading to dendritic 
maldevelopment of neurons in Prmt8-/- mice. 
4.1 Background and objectives 
Perineuronal nets (PNN) are specialized ECM molecules that form 
around inhibitory neurons, specifically PV+ interneurons (Brückner et 
al., 1993; Härtig et al., 1994) in both visual and somatosensory 
modalities. As PV+ interneurons develop and mature, they gradually 
accumulate PNNs which encapsulates the PV+ interneurons tightly, 
signalling an end to plasticity. PNNs form around the soma and 
proximal dendrites of PV+ interneurons and they influence synapse 
development. PNNs are functionally important as they consolidate the 
synaptic connections established during development and restrain 
morphological changes to dendritic spines (Pizzorusso et al., 2002; 
Hensch, 2003; Pyka et al., 2011). Components of the perineuronal nets 
have activity-dependent expression (Sur et al., 1988; Lander et al., 
1997; Kind et al., 2013; Ye and Miao, 2013), reinforcing the idea that 
perineuronal nets plays an important role in maintaining synapses and 
neurotransmission. Interestingly, the expression of PNNs is 
concomitant to a decrease in plasticity, suggesting that PNNs 
consolidate synaptic connections to a mature state (Hensch, 2003) by 
acting as a structural brake. Not surprisingly, reduction or removal of 
activity by sensory deprivation paradigms, such as dark rearing 
(Hockfield et al., 1990) or monocular deprivation (Sur et al., 1988; 
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Pizzorusso et al., 2002, 2006) and whisker trimming (McRae et al., 
2007; Nakamura et al., 2009; Nowicka et al., 2009), reduces PNN 
expression and plasticity is maintained. On the contrary, removal of 
PNNs recovers ocular dominance plasticity in the visual system of adult 
rats (Pizzorusso et al., 2002). 
Neurons receive incoming signals at sites known as dendritic spines. 
The structure of dendrites and their protrusions determine where and 
how well the neuron receives information from the afferent neuron. 
Hence, the degree of dendrite arborisation (branching) and spine 
numbers may reflect the state of development of the neuron. Prior to 
eye opening and the onset of visual experience, synapses are driven 
by spontaneous activity. In the developing mouse visual cortex, it is 
reported that spine turnover occurs more frequently during early 
development (Holtmaat et al., 2005; Zuo et al., 2005a). As the mice 
reaches adulthood, the rate of spine formation is similar to spine 
elimination (Holtmaat et al., 2005; Zuo et al., 2005a). Spine motility 
decreases with developmental age in the visual cortex (Konur and 
Yuste, 2004). This reflects the overall stability of the neuronal circuits 
and causes a drop in structural plasticity of spines as the circuit 
develops. In one model of synaptogenesis (Huttenlocher and 
Dabholkar, 1997), the process is described as constitutively occurring 
where new spines are produced in abundance at a constant rate. 
Experience-dependent activity then drives spine dynamics by 
eliminating away excess, unused synapses, thereby preserving only 
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meaningful connections (Ruiz-Marcos and Valverde, 1969; Engert and 
Bonhoeffer, 1999; Trachtenberg et al., 2002; Mataga et al., 2004; 
Holtmaat et al., 2005). Conversely, weak synapses that are not used in 
the transmission of neuronal signals and eliminated by pruning (Cohen-
Cory, 2002). Spine turnover decreases with postnatal development 
(Lendvai et al., 2000), and by the onset of the critical period in mice, 
spines reach a relatively stable state (Majewska and Sur, 2003; Konur 
and Yuste, 2004). Studies on both the visual (Mataga et al., 2004; 
Wallace and Bear, 2004) and somatosensory (Lendvai et al., 2000) 
cortices have shown that synaptic pruning is experience-dependent 
and sensory deprivation causes disruptions in the rearrangement of 
synaptic connections.  
Dendritic arborisation and synaptic regulation is a highly concerted, 
multi-factorial process that depends on intrinsic developmental and 
extrinsic environmental cues (McAllister, 2000; Urbanska et al., 2008). 
Neuronal circuits possess the ability to adapt to changing sensory cues 
and functional synaptic changes underlying this adaptation are 
reflected as structural changes in excitatory neurons.  
In the previous chapter, I have shown that removal of Prmt8 leads to 
changes in the synaptic proteome. Many of the proteins identified play 
crucial roles in neurite formation and one such protein is tenascin-R 
(TNR). One of the objectives of this chapter, therefore, is to determine 
if PNNs are affected by the upregulation of Tenascin-R in the synaptic 
proteome as a result of Prmt8 knockout. In addition, how do changes in 
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PNN formation affect the structural plasticity and synapse formation of 
neurons in the visual cortex? Lastly, another objective of this chapter is 
to study the effects of removing Prmt8 and its consequence on dendrite 
development during the critical period using the Golgi-cox impregnation 
method (Das et al., 2013).  
4.2 Materials and methods 
4.2.1 Animals used 
Both the Prmt8+/+ and Prmt8-/- mice (Prmt8tm1a (EUCOMM)Wtsi) were 
maintained on a 12 hour light/dark (LD) cycle and had access to food 
and water ad libitum. The mice are reared to postnatal day 28 (P28) 
before extracting brain tissue samples. All animal procedures have 
been approved by the Institutional Animal Care and Use Committee 
(IACUC) at Biopolis Resource Centre, A*STAR.  
4.2.2 Immunohistochemistry 
P26-P28 Mice were fixed for 7 minutes with 4% paraformaldehyde via 
cardiac perfusion. Brains were extracted carefully, post-fixed for 2 
hours with 4% paraformaldehyde and sunk in 30% sucrose overnight. 
Perfused brains were sectioned at 40 µm thickness with a cryostat. The 
sections were then blocked with goat serum (Sigma-Aldrich) and 
detected with appropriate dilutions of primary and secondary antibodies 
(Section 4.2.3). Immunofluorescence imaging was performed with a 
confocal laser-scanning microscope (Nikon A1). Images settings were 
optimized with the control wild type sections and kept constant for all 
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other acquisitions. 
4.2.3 Antibodies used 
Primary antibodies include anti-Bassoon antibody (Abcam, cat. no. 
ab101772; 1:100 for immunolabelling); anti-PRMT8 antibody (PRMT8, 
Santa Cruz Biotechnology, cat. no. sc-130853; 1:50 for 
immunolabelling); anti-neuronal nuclei (NeuN, Millipore, cat. no. 
MAB377; 1:1000 for immunolabelling); anti-parvalbumin antibody (PV, 
Swant cat. no. PV235 (mouse) and PV28 (rabbit); 1:500 for 
immunolabelling); anti-post-synaptic density-95 antibody (PSD95, 
Abcam, cat. no. ab18258; 1:500 for immunolabelling); anti-Tenascin-R 
antibody (TNR, Santa Cruz Biotechnology, cat. no. sc-136098; 1:200 
for western blotting); anti-vesicular GABA transporter antibody (VGAT, 
Millipore, cat. no. AB5062P; 1:200 for immunolabelling); Biotinylated 
WFA lectin (Vector Laboratories, cat. no. B1355; 1:100 for 
immunolabelling); DAPI (1 mg/ml, 1:200) is used to stain the nuclei of 
cells if required. Secondary antibodies include a range of Alexa Fluor® 
dyes for different excitation wavelengths, such as 488, 546 and 633 
(Molecular Probes; 1:200 for immunofluorescence).Using Wisteria 
floribunda agglutinin (WFA) as a marker for PNN is extensively 
supported in literature. These lectins (carbohydrate-binding proteins) 
binds specifically to the galactosamine on the terminal end of the 
chondroitin sulphate chains (Kurokawa et al., 1976; Young and 
Williams, 1985).   
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4.2.4 Fluorescent imaging of perineuronal nets and puncta 
analysis 
Fluorescence imaging for synapse number was conducted as 
previously described (Ippolito and Eroglu, 2010). Briefly, brain sections 
were imaged at 0.33 µm intervals over a depth of 5 µm. 3 consecutive 
z-stack images representing 1 µm of depth were then merged 
(maximum intensity projection or MIP) for quantification. The Puncta 
Analyzer plugin (Barry Wark; Ippolito and Eroglu, 2010) for ImageJ 
(Schneider et al., 2012) was used for quantification. For perineuronal 
nets intensity analysis, 30-60 z-stack images were imaged at 0.3 µm 
intervals to cover the entire soma. MIP was performed to reveal the 
entire cell body. Fluorescence intensity of the PNNs around the soma 
is measured using the ImageJ software. Corrected total cell 
fluorescence (CTCF) was calculated using this formula (McCloy et al., 
2014): 
 
CTCF = integrated density – (area of ROI x mean fluorescence of 
background) 
 
Images settings were optimized with the control wild type sections and 
kept constant for all other acquisitions. 
4.2.5 Golgi-cox staining 
P28 Prmt8+/+ and P28 Prmt8-/- mice (n=5 each) were fixed with 4% 
paraformaldehyde via cardiac perfusion. Brains were extracted 
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carefully, post-fixed for 2 hours with 4% paraformaldehyde and 
processed in solutions from Rapid GolgiStainTM kit (FD 
Neurotechnologies, Inc) according to the manufacturer’s protocol. 
Impregnated brain tissues from both sets of mice were sectioned at 
150 µm thickness with a cryostat, stained and dehydrated according to 
the manufacturer’s protocol.  
4.2.6 3D dendritic reconstruction and analysis 
Neuron reconstruction and quantitative analyses were conducted by 
MicroBrightField Bioscience and were blind to sample genotype. A total 
of 9 neurons were fully constructed – N=4 neurons (sampled from n=5 
wild type Prmt8+/+ mice) and N=5 neurons (sampled from n=5 Prmt8-/-
mice). Neurons in the visual cortex selected for reconstruction were 
uniformly impregnated, with the soma positioned within the middle of 
the histological section. Chosen cells demonstrated distinct spines and 
dendritic arbors with minimal breaks or staining irregularities. Neurons 
were reconstructed using a modified light microscope (Zeiss 
AxioImager Z1; Germany) under 100x oil (Plan-Apochromat; 1.4 
numerical aperture) controlled by Neurolucida software (v.10.5, MBF 
Bioscience, Williston VT). The microscope system had an internal Z 
motor, a motorized specimen stage (Ludl Electronics; Hawthorne, NY, 
USA), external focus encoder (Heidenhain, Schaumburg, IL) and a 
CCD monochrome video camera (mRm, Zeiss). Neurons were traced 
in their entirety, matching dendritic diameter and location of dendritic 
spines. The soma was traced at its widest point in the two-dimensional 
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plane to estimate the cross-sectional area. Neurons that displayed 
breakages in dendrites were either not fully reconstructed or not 
included in final analysis. 
4.2.7 Statistical analysis 
Datasets were tested for normality using the Kolmogorov–Smirnov 
goodness-of-fit test when applicable. However, due to sample size 
limitations (n<5) for some experiments, normality tests are not 
conclusive. However, there is no reason to regard datasets as not 
normally distributed. For datasets with Gaussian distributions, they are 
analysed with the unpaired student’s t-test and presented as mean with 
standard errors (SEM), unless otherwise stated. For datasets without 
Gaussian distribution, they are analysed with the Mann-Whitney U-test 
and presented as median. 
4.3 Results 
4.3.1 PRMT8 is found predominantly in parvalbumin-
expressing neurons and removal of PRMT8 does not affect 
PV+ cell numbers.  
The role of PV+ interneurons in the formation of the critical period is 
very well established (Chattopadhyaya et al., 2004; Fagiolini et al., 
2004; Hensch et al., 1998). Therefore, immunofluorescence labelling 
was conducted to eliminate the possibility that Prmt8 knockout may 
disrupt PV+ interneurons development. Results indicate that PRMT8 
predominantly localizes in PV+ interneurons in the visual cortex (Figure 
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4.1 A and C) (Prmt8+/+: 67.6% ± 0.52, n=3). Despite a significant drop 
in co-localization events of PRMT8-PV in null mice (Figure 5.1 B) 
(Prmt8-/-: 17.09% ± 1.65, p≤0.0001, n=3), removal of Prmt8 does not 
significantly reduce PV+ interneurons cell numbers in the visual cortex 
(Figure 4.1 D) (Prmt8+/+ PV: 189.3 cells ± 22.67 versus Prmt8-/- PV: 
168.3 cells ± 4.10, p=0.41, n=3 for both sets). The decrease in number 
of colocalization events is attributed to the decrease of PRMT8 positive 
cells (Prmt8+/+ PRMT8-PV: 127.7 events ± 15.86; Prmt8-/- PMRT8-PV: 
29.33 ± 3.48, p=0.004, n=3 for both sets). This demonstrates that 
PRMT8 colocalizes in GABAergic PV+ interneurons where it exerts its 
epigenetic function. The removal of Prmt8 does not affect PV+ 
interneurons numbers but affects the formation of PNNs (next section) 
that subsequently wrap around, affecting the function of these 
interneurons. 
4.3.2 Knockout of Prmt8 increases perineuronal net 
formation around inhibitory interneurons 
As a result of increased TNR expression (Chapter 3), the next question 
is how this upregulation might impact perineuronal net formation since 
TNR is an integral component of PNNs. In order to answer this 
question, coronal sections of the visual cortex of P26-P28 wild type 
Prmt8+/+ and Prmt8-/- mice were immunostained with Wisteria 
floribunda agglutinin (WFA, Vector Laboratories) antibody. WFA or 







Figure 4.1. PRMT8 is found predominantly in parvalbumin-
expressing neurons and removal of PRMT8 does not affect PV+ 
cell numbers. (A) Representative photomicrograph (120x 
magnification, scale bar 20 µm) of PRMT8 co-localizing in the PV+ 
neurons in the visual cortex of wild type, Prmt8+/+ mice (n=3) (B) 
Representative photomicrograph (120x magnification, scale bar 20 
mm) of PRMT8 co-localizing in the parvalbumin (PV)+ neurons in the 
visual cortex of Prmt8-/- mice (n=3)  (C) 67.7% of PV+ inhibitory 
neurons also express PRMT8. In the Prmt8-/- mice, there is only 17.1% 
of co-localization (n=3 each). (D) Although, there is a reduction of PV-
PRMT8 co-localization events (** p≤0.01, unpaired student t-test), the 
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Figure 4.2. Knockout of Prmt8 causes perineuronal nets to form 
aberrantly. (A) Representative photomicrograph of wild type Prmt8+/+ 
(left) and Prmt8-/- (right) coronal sections of the binocular zone of the 
visual cortex stained with biotinylated WFA. WFA staining clearly 
indicates that PNN wraps around PV+ interneurons in layer IV of the 
visual cortex (4x magnification, scale bar 500 µm). (B) Quantification of 
PV+ interneurons that are wrapped with PNNs indicates that there are 
lesser PNNs wrapped PV+ interneurons in the wild type Prmt8+/+ mice 
in comparison to Prmt8-/- mice (**** p≤0.0001, n=3 each, unpaired 
student’s t-test). (C) Representative photomicrograph of wild type 
Prmt8+/+ (left) and Prmt8-/- (right) sections of the binocular zone of the 
visual cortex co-stained with biotinylated WFA and PV (20x 
magnification, scale bar 50 µm). Arrows indicate PV+ interneurons 
wrapped by PNNs. (D) Besides reducing the number of PNN 
enwrapped PV+ interneurons, Prmt8 knockout also reduces the density 
of PNN around the PV+ interneurons as measured using corrected 
total cell fluorescence (CTCF) compared to wild type (* p≤0.05, n=3 
each, Mann-Whitney U test). Data represented as median. (E) 
Representative maximum intensity projection (MIP) photomicrograph of 
wild type Prmt8+/+ (left) and Prmt8-/- (right) sections of the binocular 
zone of the visual cortex co-stained with biotinylated WFA and PV (60x 
magnification, scale bar 25 µm). Arrows indicate PV+ interneurons 
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perineuronal nets. PNNs predominantly form around PV+ interneurons 
in layer IV of the visual cortex (Figure 4.2 A) (Härtig et al., 1994; 
Nowicka et al., 2009; Pizzorusso et al., 2002; Ye and Miao, 2013). 
Quantification of WFA wrapped PV+ interneurons in layer IV of the 
visual cortex indicate that there are 10% more PV+ cells that are 
wrapped in PNNs in the null mice (Figure 4.2 B and C) (33.58% ± 1.23, 
p≤0.0001, n=3) than in the wild type (42.60% ± 1.31, n=3). Upon closer 
inspection, the PNNs are also more densely wrapped around PV+ 
neurons (Figure 4.2 D and E) in the mutants (n=3, N=111 PV+ somas, 
94310 A.U., p=0.02) than in the wild type (n=3, N=95 PV+ somas, 
103765 A.U.). 
4.3.3 Reduced PV+ inhibitory puncta on neurons of Prmt8 
mice 
Many groups have demonstrated that perineuronal nets formation 
affect synaptic connections, especially to perisomatic connections 
where the nets form around. Hence, I wanted to investigate if afferent 
connections are perturbed in Prmt8-/- mutants, especially incoming 
connections from parvalbumin interneurons which are crucial for critical 
period plasticity. In order to answer the question whether it is hyper-
excitability or insufficient inhibition, visual cortical sections were 
immunostained with two different sets of antibodies to represent and 
differentiate between excitatory and inhibitory synapses. 
To characterize inhibitory connections, antibodies against vesicular 
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GABA transporter (VGAT) and parvalbumin were used as a marker for 
pre- and post-synaptic markers (Figure 4.3 A and C). For excitatory 
synapses, antibodies against Bassoon and PSD-95 (postsynaptic 
density protein-95) were used as markers for pre- and post-synapses 
respectively (Figure 4.3 E). Quantification of inhibitory synapses within 
the binocular zone of the visual cortex showed that Prmt8 mutants 
have 23% lesser PV+ puncta on NeuN positive neurons (Figure 4.3 B) 
(+/+: 16.67 puncta ± 0.35, n=3, N = 159; -/-: 12.85 ± 0.35, p≤0.0001, 
n=3, N=158). In order to determine if these PV+ puncta were indeed 
GABAergic, VGAT positive (+) puncta was counted. VGAT+ puncta 
were also reduced in Prmt8-/- mutants compared to wild type (Figure 
4.3 D) (Prmt8+/+: 24.21 ± 0.49, n=3, N=142; Prmt8-/-: 20.99 ± 0.39, 
p≤0.0001, n=3, N=145). This indicates weaker inhibitory PV innervation 
onto excitatory principal neurons. However, no significant changes 
were observed to excitatory connections on PV+ interneurons (Figure 
4.3 F) (Prmt8+/+: 28.14 ± 1.13, n = 3, N = 118; Prmt8-/-: 30.51 ± 0.88, 
p=0.09, n=3, N=147). 
4.3.4 Pyramidal neurons from Prmt8-/- mice have longer 
dendrites and more dendritic spines. 
Firstly, the effects of Prmt8 loss on overall dendritic morphology in V1 
were assessed. Juvenile (P28) Prmt8+/+ wild type mice were compared 
to age-matched Prmt8-/- mutants to assess changes in dendritic 





Figure 4.3. Prmt8-/- mice have lesser inhibitory perisomatic 
synaptic connections. (A) Representative photomicrograph of coronal 
sections of the visual cortex from wild type Prmt8+/+ mice (top) and 
Prmt8-/ mice (bottom) stained with parvalbumin (green) and NeuN red 




















































































Merged Bassoon PSD95 PV C 
E 
  71 
up sections and arrows represent colocalized puncta measured by 
software. (B) The amount of PV+ puncta/soma is lower in Prmt8-/- mice 
(N=158 somas) compared to wild type (**** p≤0.0001, N=159 somas, 
unpaired student’s t-test). (C) Representative photomicrograph coronal 
sections of the primary visual cortex from P27 wild type Prmt8+/+ mice 
(top) and Prmt8-/- mice (bottom) stained with VGAT (green) and 
parvalbumin (red) (60x magnification, scale bar 10 µm). Image in inset 
represents close-up sections and arrows represent colocalized puncta 
measured by software. (D) Wild type neurons (N=142 somas) have 
more VGAT+ inhibitory synapses than neurons in Prmt8-/- mice (**** 
p≤0.0001, N=145 somas, unpaired student’s t-test). (E) Representative 
photomicrograph of coronal sections of the primary visual cortex from 
P27 wild type mice (top) and Prmt8-/- mice (bottom) stained with PSD95 
(green), Bassoon (red) and parvalbumin (magenta) (60x magnification, 
scale bar 10 µm). (F) There was no significant change excitatory 
puncta that synapse onto PV+ somas (wild type Prmt8+/+: N=118 













bottom panels respectively). From our neuronal reconstructions, the 
length of apical and basolateral dendrites was quantified from neurons 
of Prmt8+/+ and Prmt8-/- mice. The overall dendritic length is 1.34 fold 
higher in Prmt8-/- than Prmt8+/+ (Figure 4.4 B) (Prmt8-/-: 2085.82 µm ± 
276.70, N=5; Prmt8+/+: 1553.98 µm ± 167.90, N=4, p=0.17). 
Basolateral dendritic length is also 1.59 fold higher in Prmt8-/- than 
Prmt8+/+ neurons (Prmt8+/+: 792.03 µm ± 114.42; Prmt8-/-: 1264.54 µm 
± 234.2, p=0.14). However, there is no significance difference in apical 
dendrite length between both groups (Prmt8+/+: 761.95 µm ± 72.71; 
Prmt8-/-: 821.28 µm ± 50.61, p=0.51).  
Next, the effects of Prmt8 loss on spine density were assessed. Total 
spine number is 1.95 higher in the Prmt8-/- neurons compared to the 
wild type neurons (Figure 4.4 C) (Total spine numbers, Prmt8+/+: 
1020.25 ± 82.0; Prmt8-/-: 1985.0 ± 310.92, p=0.03. Apical, Prmt8+/+: 
548.0 ± 31.37; Prmt8-/-: 832.0 ± 64.82, p=0.0085. Basolateral, Prmt8+/+: 
472.25 ± 65.43, Prmt8-/-: 1153.0 ± 258.61 p=0.06). Likewise, spine 
density is observed to be higher in Prmt8-/- neurons. (Figure 4.4 D) 
(Total spine density, Prmt8+/+: 0.67 ± 0.04; Prmt8-/-: 0.94 ± 0.02, 
p=0.0007. Apical, Prmt8+/+: 0.74 ± 0.08; Prmt8-/-: 1.01 ± 0.03, p=0.01. 
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Figure 4.4. Prmt8-/- mutants have longer dendrites and more 
spines compared to the wild type. (A) Representative close up 
photomicrograph of the basolateral dendrite on Prmt8-/- neurons 
(bottom) showed more spines in comparison to the wild type (top, 4x 
magnification, scale bar 10 µm). Quantitative analysis of dendritic 
length (B), spine number (C) and spine density (D) showed that    
Prmt8-/- neurons have longer dendrites with more spines and at a 
higher density. (*** p≤0.005, ** p≤0.01 and * p≤0.05; n=5 for Prmt8-/-, 
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4.3.5 Prmt8-/- mice have neurons that have more complex 
dendritic morphology compared to age-matched wild type 
Prmt8+/+ mice. 
As neurons are complex specialized cells with long processes, a 3-D 
Sholl analysis is required to evaluate the overall dendritic complexity in 
V1 of both sets of mice (Figure 4.5 A, B and 4.4). Measurements of 
convex hull, dendritic length, number of intersections and number of 
spines in 25 µm incremental radii from the soma were analysed. There 
was a two-fold overall increase in volumetric complexity in Prmt8-/- 
neurons compared to the wild type neurons of the same age (Figure 
4.5 C) (Prmt8+/+: 1.0 ± 0.16; Prmt8-/-: 2.094 ± 0.29, p=0.02). The apical 
and basolateral dendrites were examined separately for dendritic 
length, spine numbers and spine density (Figure 4.5 D-I). Prmt8-/- 
neurons are more complex than wild type neurons because they have 
more intersections on the basolateral dendrite 75-100 µm away from 
the soma (Figure 4.5 D) (75 µm, Prmt8+/+: 2.75 ± 0.63, Prmt8-/-: 7.4 ± 
2.23, p=0.03; 100µm, Prmt8+/+: 1.25 ± 0.48; Prmt8-/-: 5.0 ± 1.79, 
p=0.03). Basolateral dendritic length is longer in Prmt8-/- neurons 
compared to wild type neurons (Figure 4.5 E, please also refer to 
Figure 4.6 and 4.7) (125 µm, Prmt8+/+: 27.73 ± 11.12; Prmt8-/-: 141.9 ± 
45.39, † p=0.06). At 50 µm from the soma, Prmt8-/- neurons have 
formatting 




Figure 4.5. Prmt8-/- mutants have more complex pyramidal 
neurons compared to the wild type. (A) Sholl analysis with 
concentric circles around the soma of wild type Prmt8+/+ neurons within 
the visual cortex compared to (B) Prmt8-/- neurons at P27. (C) Convex 
hull analysis showed that Prmt8-/- neurons (filled circles, N=5) in the 
visual cortex have more spreading ramifications than wild type Prmt8+/+ 
neurons (open squares, N=4), which are tighter and more compact (* 
p≤0.05, unpaired student t-test). In the Sholl analysis, the radii of each 
ring increase incrementally by 25 µm. Interestingly, Sholl analyses 
indicate that the Prmt8-/- mutants (filled circles) have more basolateral 
branching (D), longer basolateral dendrites (E) and more spines (F) 
than wild type neurons (open squares). The biggest differences lie 
between the 75 µm - 125 µm region (* p≤0.05, † p=0.0657, ‡ 
p=0.0623, unpaired student t-test,). (G-I) On the contrary, no significant 
changes were observed on the apical dendrites. 
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dendrites studded with more spines compared to wild type Prmt8+/+ 
neurons (Figure 4.5 F) (50 µm, Prmt8+/+: 196.0 ± 26.40; Prmt8-/-: 318.0 
± 37.46, p=0.04; 125µm, Prmt8+/+: 21.75 ± 10.91; Prmt8-/-: 145.20 ± 
48.40, ‡ p=0.06). No significant difference was observed in the apical 
dendrites of neurons from both null and wild type neurons for all three 
measured parameters (Figure 4.5 G-I). 
4.4 Discussion 
Cortical plasticity decreases upon the maturation of circuitry and its 
connections. This decrease in plasticity is not likely due to age-related 
loss of neuronal numbers but more likely due to locks placed on the 
brain circuits. One such structural regulator is the perineuronal net, a 
group of extracellular matrix molecules whose formation is often 
associated with the closure of the critical period in the visual cortex 
(Hensch, 2004; Pizzorusso et al., 2002). One of the key findings in the 
previous chapter is that a major component of PNNs, Tenascin-R 
(TNR), was significantly increased in the synaptic proteome of Prmt8-/- 
mice (Figure 4.2). As a result, PNNs are also increased in the visual 
cortex, both in terms of number of PNN-wrapped PV neurons and 
intensity around each PV cell (Figure 4.2) soma. An increase in PNN 
density around PV cell soma of Prmt8-/- mice during the critical period 
implies that the formation of these nets is premature before the 
termination of the critical period. This will restrict synaptic plasticity or 
the proper development of synapses, leading to functional 
consequences, which we will discuss in the following chapter. During 
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data collection, PNN was quantified by WFA staining and quantification 
of fluorescence intensity around the perisoma of PV+ interneurons. 
Quantifying intensity this way represents a simplistic way to measure 
absolute quantity. However, it is observed that PNNs of Prmt8-/-
neurons seem to be more clustered around the perisoma rather than 
the proximal neurites (Figure 4.2). This raises questions on intracellular 
transportation, and whether the accumulation of PNNs around the 
perisoma is a result of an inability to transfer the excess net 
components towards the more distal locations of the neuron. Since 
components of the nets are produced and secreted by both neurons 
and glia (Ruoslahti, 1996), could there also be an effect of Prmt8 
removal on PNNs in glial cells?  
Maturation of intracortical inhibition is closely associated with CP 
progression (Fagiolini et al., 2004) and achieving sufficient inhibition is 
an important cue for the onset of the critical period (Fagiolini and 
Hensch, 2000; Hensch et al., 1998). Hence, modulation of excitatory 
connections by inhibitory neurons is a crucial component of 
experience-dependent plasticity. Results from the 3D reconstruction of 
neurons from both genotypes demonstrated that Prmt8-/- cortical 
pyramidal neurons are more complex and have more spines, which 
suggest that synaptic pruning is affected. In the first half of this chapter, 
PNNs were shown to form more densely around the PV cell soma, 
inhibiting synaptic plasticity (Figure 4.2). This supports the view that the 
neuronal circuits are locked in a precocious, premature state, where 
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excitatory connections may dominate. To substantiate the impact of 
Prmt8 knockout on connectivity in the visual cortex, I examined both 
excitatory and inhibitory puncta with immunohistochemistry. Results 
suggest that Prmt8-/- mice have far fewer PV+ inhibitory puncta than 
their wild type counterpart (Figure 4.3). In addition, these PV+ puncta 
have lesser VGAT colocalization, indicative of weaker PV-mediated 
inhibition (Chattopadhyaya et al., 2004; Gogolla et al., 2014; Huang et 
al., 1999). Moreover, no significant effects on afferent excitatory 
connections on PV+ interneurons (Figure 4.3) were observed between 
both sets of mice, suggesting that knockout of Prmt8 does not lead to 
hyperexcitability in cortical circuits. However, specific 
electrophysiological recordings may be necessary to further support 
this finding. In addition, Npas4 is reduced in Prmt8-/- mice (not shown). 
Activity-dependent Npas4 is implicated in the regulation of inhibitory 
synapses necessary for neuroplasticity (Bloodgood et al., 2013; Lin et 
al., 2008), as well as adult plasticity in the visual cortex (Maya-
Vetencourt et al., 2012). The removal of Npas4 in vitro caused a 
reduction of inhibitory synapses without affecting excitatory synapses 
(Lin et al., 2008), similar to what was observed in Prmt8-/- mice.  
Imaging the visual cortices of Prmt8-/- mice have shown that pyramidal 
neurons have more spines and are more complex compared to wild 
type, especially in the basolateral dendrites (Figure 4.4 and 4.5). 
Complexity described here is two-fold. There are more dendritic 
protrusions and also more arborisation or branching events observed.  
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This possibly indicates that neurons in the null mice are unable to 
eliminate and prune away the excess spines despite receiving the 
same amounts of visual experience. This may suggest that the neurons 
are locked in a juvenile state by a brake(s), which prevents the neurons 
from switching from developmental to mature forms of synaptic 
plasticity (Figure 4.6). A myriad of explanations can be suggested. One 
possibility is the ECM, which when mature, structurally consolidates 
neuronal connections (Mataga et al., 2004, 2002; Oray et al., 2004; 
Pizzorusso et al., 2002). Conversely, removal of the restrictive ECM 
reverts circuits to their plastic state (Gogolla et al., 2009; Mataga et al., 
2002; Pizzorusso et al., 2002).  
In neurons of Prmt8-/- mice, the amount of spines was higher than age-
matched wild type neurons, suggesting that the mutants do not have 
the same rate of turnover as the wild type. In parallel studies in the 
barrel cortex, sensory deprivation reduces rate of elimination but does 
not affect rate of formation of dendritic spines (Zuo et al., 2005a, 
2005b). In terms of spine dynamics, Prmt8-/- mice mimic transgenic 
mice lacking the synaptic isoform of GABA-synthetic enzyme glutamic 
acid decarboxylase (GAD65 KO). It is reported that there was no loss 
in dendritic spines in these mice lacking GABA despite monocular 
deprivation (Mataga et al., 2004). This is also supported by evidence 
that reduced inhibitory GABAergic neurotransmission increases 








Figure 4.6. Schematic representation of local cortical circuit 
arrangement involving an excitatory (Pyr; pyramidal) and an 
inhibitory (PV; parvalbumin) neuron. In cortex of wild type Prmt8+/+ 
mice, experience sculpts excitatory circuit connections modulated by 
inhibitory neurons before consolidation of feed forward inhibitory 
connections by perineuronal nets (left). In the cortex of Prmt8-/- mice, 
formation of excess PNNs restricts structural plasticity of inhibitory 
neurons, preventing the establishment of inhibitory connections for 
pruning and maturation of visual cortical circuitry. Grey bar with roman 
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Although static imaging may not fully represent the dynamic nature of 
dendritic plasticity, simple quantification of dendritic spines will provide 
information about the state of the neuron. Juvenile neurons might 
response to decreased afferent activity by increasing the growth of 
processes to search for active synaptic targets, while developed 
neurons might simply retract/eliminate their dendrites/spines. 
4.5 Conclusions 
In conclusion, I found that removal of Prmt8 causes increased PNN 
formation around PV+ interneurons. As a result, the circuits are not 
sufficiently sculpted and pruned by visual experience, causing a 
reduction in inhibitory synapses and inhibitory modulation of excitatory 
principal neurons. Three-dimensional reconstruction of neurons from 
wild type Prmt8+/+ and Prmt8-/- mice have shown that removal of Prmt8 
causes neurons to have more spines and is more complex. However, 
simple quantification of spine numbers and branching patterns does 
not necessarily fully represent the state of synaptic connectivity of the 
visual cortical circuits. In the next chapter, I will demonstrate results 
that suggest that Prmt8-/- mediated increased of PNNs cumulate into 













Figure 4.7. Reconstructed Golgi-Cox stained neurons from   
Prmt8-/- mutants at P26-P28. All reconstructed neurons used for data 
analyses. Radii of each concentric ring increases incrementally by 25 
µm from the soma. Neurons displayed are scaled according to size. 
Red and blue boxes indicate apical and basolateral dendrites 
respectively. Do note that in some of the images, overlapping of boxes 









































Figure 4.8. Reconstructed Golgi-Cox stained neurons from wild 
type Prmt8+/+ mice at P26-P28. All reconstructed neurons used for 
data analyses. Radii of each concentric ring increases incrementally by 
25 µm from the soma. Neurons displayed are scaled according to size. 
Red and blue boxes indicate apical and basolateral dendrites 
respectively. Do note that in some of the images, overlapping of boxes 






















CHAPTER 5 Visual acuity is reduced in Prmt8-/- mice. 
5.1 Background and objectives 
Visual experience in early life sculpts visual acuity. Experience-
dependent competition from both eyes shape visuocortical circuitry 
during the critical period, whereas monocular deprivation causes circuit 
rearrangements. A clinical manifestation of this plasticity is amblyopia, 
where the weaker eye develops improperly due to reduced visual cues. 
Disruption of visual inputs by ocular deprivation is often accompanied 
by reduction in visual acuity in the deprived eye (Giffin and Mitchell, 
1978; Prusky et al., 2000) due to dysfunctional sensory processing.  
Although inhibitory neurons compromise approximately 20% of the 
cortical neuron population, local cortical inhibition is crucial for shaping 
the activity of the visual cortex. These GABA (γ-aminobutyric acid) 
releasing neurons are crucial for the initiation of the critical period of the 
visual cortex (Fagiolini et al., 2004; Fagiolini and Hensch, 2000). 
Weaken or reduced cortical inhibition prevents the development of 
experience-dependent plasticity as demonstrated in transgenic mice 
with disrupted GABA synthesis (Fagiolini and Hensch, 2000). Ocular 
dominance shift, however, can be rescued by enhancement of 
GABAergic transmission with pharmacological agents such as 
benzodiazepines (Fagiolini et al., 2004).  
Using the visual water task, the physiological consequences of reduced 
intracortical inhibition in Prmt8-/- mice will be explored in this chapter. I 
hypothesize that as a result of reduced PV-mediated cortical inhibition, 
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onset of the CP plasticity in Prmt8-/- mice will be delayed, as observed 
in GAD65KO mice (Chattopadhyaya et al., 2007; Fagiolini and Hensch, 
2000; Iwai et al., 2003). Consequently, these mice will have an 
undeveloped visual circuit leading to poorer visual acuity compared to 
their wild type counterparts.  
It is also important to note that genetic redundancy is not observed in 
PRMTs (Bedford and Clarke, 2009), where null mice of different PRMT 
isoforms display clear phenotypes (Yadav et al., 2003; Ganesh et al., 
2006; Swiercz et al., 2007; Nicholson et al., 2009; Tee et al., 2010; 
Neault et al., 2012). 
5.2 Materials and methods 
5.2.1 Animals used 
Both the C57BL/6J wild type mice (Prmt8+/+) and Prmt8 null mice 
(Prmt8-/-; Prmt8tm1a (EUCOMM)Wtsi) were maintained on a 12 hour light/dark 
(LD) cycle and had access to food and water ad libitum. All mice were 
handled and housed in similar standard conditions.  All animal 
procedures have been approved by the Institutional Animal Care and 
Use Committee (IACUC) at Biopolis Resource Centre, A*STAR.  
5.2.2 Visual water task 
The visual water task (VWT) is a visual discrimination task based on 
reinforcement learning (Prusky et al., 2000; Prusky and Douglas, 
2004). The task consists of a trapezoidal aluminium tank (183 cm long 
x 82 cm wide x 73 cm high). A large 30” display monitor split into two 
 86 
windows depicting either vertical striations or an equiluminant grey 
stimulus was presented at the wider end (Figure 5.1 A). Black and 
contrast levels on both screens are equated with a mean luminance of 
43cd/m2 (Prusky et al., 2000). Mice are natural swimmers but have the 
inclination to escape from water. The VWT capitalizes on this 
behaviour. For this task, animals were initially pre-trained to associate 
getting to a solid substrate (hidden platform) by swimming towards a 
low spatial frequency vertically striated screen (positive stimuli). Once 
the animals have grasped the reward concept, they were put through 
series of trials in the training and testing phases where their abilities 
are shaped to distinguish between the vertical gratings and the 
equiluminant grey stimulus at a short distance (training) and at a longer 
distance (testing). The position of the grating and the platform was 
alternated in a pseudorandom sequence over the training and test 
trials. Once 70% or greater accuracy was achieved in a series of 10 
trials, the spatial frequency of the grating increases until trial 
performance falls below 70% accuracy. The maximum visual acuity 
was measured with 3 consecutive passes of the highest spatial 
frequency. The mice were trained from postnatal day P28 for 2-3 
months to obtain the discrimination threshold (Figure 5.1 B).   
5.2.3 Statistical analysis for VWT 
Datasets were tested for normality using the Kolmogorov–Smirnov 
goodness-of-fit test when applicable. However, due to sample size 
limitations (n<5) for some experiments, normality tests are not 
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conclusive. However, there is no reason to regard datasets as not 
normally distributed. For datasets with Gaussian distributions, they 
were analysed with the unpaired student’s t-test and presented as 
mean with standard errors (SEM), unless otherwise stated.  
 
5.3 Results 
5.3.1 Prmt8 mutants have poorer visual acuity 
Based on the results so far, Prmt8-/- mice display abnormalities in 
neuroanatomy (Chapters 3 and 4) compared to their wild type 
counterparts. It is intriguing to see if these changes would manifest as 
behavioural phenotype(s) at the systemic level. In order to test visual 
performance, the visual water task (ACUMEN, Cerebral Mechanics Inc) 
(Prusky and Douglas, 2004; Prusky et al., 2008, 2000) was used as a 
measurement of both visual discrimination and acuity (Figure 5.1 A). 
The initial phase involves a brief training prior to testing that reinforces 
the learning task (experimental outline, Figure 5.1 B). The time taken to 
train both sets of mice were identical (Figure 5.1 C) (+/+: 16.75 days ± 
1.25, n=16; -/-: 14.75 days ± 1.80, n=9, p=0.40), indicating that 
hippocampal learning and memory consolidation are not disrupted in 
Prmt8 mutant mice. Cognitive skills such decision-making and motor 
control were also not affected in these Prmt8 transgenic mice as the 
latency time to complete the task was not significantly different in both 







Figure 5.1. Prmt8-/- mice have decreased visual acuity in mice 
without affecting training time or latency. (A) A schematic 
representation of the visual water task (VWT) for visual acuity from 
Acumen. One monitor screen (with mean luminance of 43cd/m2) 
presents into two separate windows either vertical gratings or the 
equiluminant grey stimulus at one end of a trapezoidal-shaped 
aluminium tank. A hidden platform is present in the channel with 
gratings for the mice to swim to safety if they can distinguish between 
the stimuli. (B) Experimental timeline (not drawn to scale) for the visual 
water task from pre-training, beginning from P21, to testing. Pre-
training is usually a 3-4 days, training takes up to a week and testing 
can be up to a month. (C) Prmt8-/- mice took the same time in days as 
wild type Prmt8+/+ mice to be trained with the test barrier. This is an 
indication that learning and memory are not affected. (D) There is also 
no significant difference in the time taken for the two sets of mice to 
find the platform. (n=16 for wild type Prmt8+/+ and n=9 for Prmt8-/-). (E) 
Visual acuity at 70% threshold is lower in Prmt8-/- mice (0.51 cyc/deg, * 
p≤0.05, n=9, unpaired student t-test) than wild type Prmt8+/+ mice (0.56 
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the Prmt8-/- mice by 8.8% (Figure 5.1 E) (Prmt8+/+: 0.56 cyc/deg ± 0.01; 
Prmt8-/-: 0.52 cyc/deg ± 0.02, p=0.02). 
5.4 Discussion and conclusion 
My findings demonstrate that knockout of Prmt8 in mice caused a 
reduction in visual acuity, as measured using the visual water task 
(Figure 5.1). In the pre-training phase, both wild type and Prmt8-/- mice 
learned to associate swimming towards the platform as an escape from 
water. In the training phase, both wild type and Prmt8-/- mice learned 
the task within a similar timeframe (Figure 5.1 C), indicating that there 
are no learning deficiencies observed between the two genotypes. 
During the testing phase, both sets of mice also took similar a time to 
locate the platform, indicating that there are no motor defects in these 
transgenic mice as compared to the wild type Prmt8+/+ mice. As a 
result, Prmt8-/- mice suffer from poorer visual acuity compared to wild 
type Prmt8+/+ mice.  
If inhibition is poorly developed, the ability for modulation or 
suppression of poor visual signals will be lost, leading to less tuned 
receptive fields (Prusky and Douglas, 2003).  Prusky and colleagues 
have previously predicted that due to insufficient inhibition present to 
depress poorly patterned inputs, GAD65 null mice will have lower 
visual acuity (Prusky and Douglas, 2003). My data demonstrates that 
reduced inhibitory modulation of visual circuits caused by Prmt8 
knockout does indeed negatively affect visual acuity. Moreover, it has 
been demonstrated that suppressing V1 activity via optogenetic 
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modulation of PV+ interneurons impairs visual performance (Glickfeld 
et al., 2013). These null mice do not suffer from any learning or motor 
defects because there was no significant difference between the 
number of days taken to train or the time taken for these mice to 
complete the task. Despite a recent report (Kim et al., 2015) indicating 
that Prmt8-/- mice displayed motor defects in the open field task, my 
data indicates that Prmt8-/- mice did not display any form of abnormal 
motor behavioural in the water task (Figure 5.1 C and D). This clearly 
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CHAPTER 6 Does the removal of Prmt8 in mice affect ocular 
dominance plasticity? 
6.1 Background and objectives 
6.1.1 The visual cortex: a model for critical periods of 
neurodevelopment. 
During the critical periods of early brain development, neuronal circuits 
that process sensory information are shaped by patterns of cellular 
activity induced by interactions with environmental stimuli (Hensch, 
2005a). The term ‘critical period’ refers to a specific developmental 
window during which target systems are especially sensitive to specific 
environmental stimulation such as visual, auditory or somatosensory 
cues depending upon the target sensory system. Critical periods occur 
in several sensory systems in the brain, such as the barrel 
representation of whiskers in somatosensory cortex, tonotopic map 
refinement in auditory cortex and human language acquisition in the 
Broca’s area but the best-described case is the role of light in the 
development of the visual system (O’Leary et al., 1994; Hensch 2004; 
Knudsen, 2004; Hensch, 2005a; Daw, 2006; Hooks and Chen, 2007). 
Neurons of the primary visual cortex exhibit a property known as ocular 
dominance (OD), where they preferentially respond to stimulation from 
one or the other eye (Wiesel and Hubel, 1963). The thalamocortical 
connections serving both eyes form the basic architecture of alternating 
columns of ocular dominance in the mammalian neocortex (LeVay et 
al., 1980). The critical period for the formation of ocular dominance 
 92 
columns of the visual cortex has been the most intensively studied 
model for critical period plasticity since its discovery by Hubel and 
Wiesel (Hubel and Wiesel, 1962). The length and timing of the critical 
period are relative to the organism’s lifespan. For example, in cats, the 
critical period is between 3 weeks to 3 months of age (Daw et al., 1992; 
Hubel and Wiesel, 1970, 1962; Olson and Freeman, 1980), compared 
to up to 6 months in non-human primates (Hubel et al., 1977; LeVay et 
al., 1980). 
During this critical period, cortical responses are particularly sensitive 
to deprivation of visuosensory inputs. In their seminal work on kittens, 
Hubel and Wiesel discovered that careful occlusion of one eye by lid 
suture during the critical period resulted in experience-dependent loss 
of visual acuity of the occluded eye (Wiesel and Hubel, 1963). The 
competitive rewiring of responses towards the non-deprived eye during 
this specific window of extraordinary plasticity is known as the shifting 
of ocular dominance plasticity (Hubel and Wiesel, 1970). This process 
is followed by pruning and regrowth of dendritic spines on pyramidal 
neurons, leading to functional loss of responses to the deprived eye 
(Mataga et al., 2004; Oray et al., 2004). Ocular dominance columns 
expand or shrink as cortical reorganization takes place in response to 
changes in activity of deprived and non-deprived eye (Hensch, 2005b) . 
Much of the subsequent studies have been carried out in mouse 
models, taking advantage of the ease of directly manipulating its 
genome, the availability of molecular techniques and the relative length 
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of the critical period. In rodents, the visual cortical circuits exhibit 
maximal plasticity during the critical period (postnatal day 20-35) and 
this plasticity is lost by the end of this period (Gordon and Stryker, 
1996; Antonini et al., 1999; Hensch, 2004). Since its discovery, many 
groups have uncovered how this critical period might be regulated and 
manipulated. Two main concepts have emerged (Takesian and 
Hensch, 2013). 
(1) A specific GABAergic circuit has been identified as an important 
regulator of critical period timing (Fagiolini et al., 2004; Fagiolini 
and Hensch, 2000). Sufficient inhibition through GABA 
signalling is then the permissive trigger for the onset critical 
period. As a result, ocular dominance plasticity can be 
manipulated via genetic (Fagiolini and Hensch, 2000; 
Chattopadhyaya et al., 2007), pharmacological (Hensch et al., 
1998; Fagiolini and Hensch, 2000; Iwai et al., 2003) or physical 
methods such as dark rearing (DR, Fagiolini et al., 1994; 
Morales et al., 2002; Lee et al., 2006) that associate with 
alterations in GABA activity. These findings demonstrate the 
importance of GABAergic inhibition as a permissive cue for 
critical period formation. (Figure 6.1) 
The critical period for the formation of ocular dominance can be 










Figure 6.1. GABAergic modulation of visual cortical critical 
period. The onset of the critical period can be delay by enhancing 
GABAergic transmission. For example, administration of GABA 
agonists (e.g. benzodiazepines) or overexpression of Bdnf leads to 
precocious critical period formation. On the contrary, eliminating or 
reducing GABAergic transmission with transgenic mice that lack the 
GABA-synthesizing enzyme (GAD65KO) or by dark rearing form birth 
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Figure 6.2. Aberrant critical period formation when 
molecular/structural brakes are perturbed. Regulation of the critical 
period is dependent on both permissive and restrictive molecular cues 
(please refer to text for more examples). Dysregulation of epigenetic 
markers may perturb intrinsic molecular cues, leading to extended 
developmental plasticity. Ultimately, this aberrant critical period leads 
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inhibition such as brain-derived neurotrophic factor (BDNF, Hanover et 
al., 1999; Huang et al., 1999), orthodenticle homeobox 2 (Otx2, M. 
Beurdeley et al., 2012; Sugiyama et al., 2008) or brakes such as 
perineuronal nets  (PNNs, Marine Beurdeley et al., 2012; Pizzorusso et 
al., 2002), Ly6/neurotoxin-1 (Lynx1, Morishita et al., 2010) can limit or 
disrupt plasticity (Figure 6.2). 
Therefore, the objective of this chapter is to determine if ocular 
dominance plasticity is affected by Prmt8 knockout using 
electrophysiological recordings. 
6.2 Materials and methods 
6.2.1 Animals used 
Both the C57BL/6J wild type mice (Prmt8+/+) and Prmt8 null mice 
(Prmt8-/-; Prmt8tm1a (EUCOMM)Wtsi) were maintained on a 12 hour light/dark 
(LD) cycle and had access to food and water ad libitum. Transgenic 
Channelrhodopsin-2 (B6.Cg-Tg(Thy1-COP4/EYFP)18Gfng/J, Jackson 
Laboratories) mice are gifts courtesy of Prof. George Augustine from 
the Lee Kong Chian School of Medicine, Nanyang Technological 
University. All mice were handled and housed in similar standard 
conditions.  All animal procedures have been approved by the 
Institutional Animal Care and Use Committee (IACUC) at Biopolis 
Resource Centre, A*STAR.  
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6.2.2 Multi-unit recording 
6.2.2.1 Surgical procedures 
In vivo electrophysiological procedures were adapted from the early 
work of Drager (Drager, 1975) and Wagor (Wagor et al., 1980) and 
modified based on more recent studies (Durand et al., 2012; Fagiolini 
et al., 2003; Gordon and Stryker, 1996; Hensch and Stryker, 2004). 
Mice were lightly anesthetized with isofluorane (2-3% induction, 0.5%-
1% for maintenance) in medical oxygen. Chlorprothixene (2 mg/kg; 
Sigma-Aldrich) was administered via intramuscular routes to 
supplement the isoflurane, thereby reducing the amount of 
anaesthetics required while maintaining a sufficient depth of 
anaesthesia. Atropine (Ilium Atrosite; 1 mg/kg; Troy Laboratories) and 
dexamethasone (Ilium Dexasone; 2 mg/kg; Troy Laboratories) were 
injected subcutaneously to reduce secretions and to counter the 
parasympathomimetic effect of the aesthetic agents and reduce 
cerebral oedema respectively. The animal’s temperature was 
monitored throughout the recording experiment by a rectal probe. 
Mouse Ox (with electrocardiograph and oxygen leads; Starr Life 
Sciences) was attached to the left hind limb and the heart, breath and 
oxygen saturation rate were monitored continuously throughout the 
experiment when possible. This enables us to monitor closely the 
depth of the anaesthesia in these animals to minimize any 
unnecessary stress or pain. The animal’s eyes were kept closed with a 
homemade eye patch and moisturized with an ophthalmic gel (Vidisic; 
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0.2% w/w; Bausch & Lomb) throughout the ensuing surgical 
procedures to prevent them from drying out. To keep the animal’s 
airway patent, tracheotomy was performed with a bent capillary glass 
tube (1.0 mm outer diameter and 0.75 mm inner diameter) inserted into 
the open end of the trachea just below the larynx. The animal was then 
placed on a custom-built stereotaxic holder. An incision along the 
midline is performed to expose the cranium. A dental drill is used to drill 
a small window. Multichannel Neuronexus probes (A1 x 16-3mm-50-
177-A16) were used to record extracellular single units from the cortex. 
The probes were inserted to depths of 500-550 µm measured from the 
dura mater, between 2.5-4.0 µm with reference to lambda.  
6.2.2.1.1 Monocular deprivation 
For monocular deprivation studies, 4 days of monocular deprivation 
(MD) is sufficient to induce a shift in ocular dominance (Chen et al., 
2011; Gordon and Stryker, 1996; Majdan and Shatz, 2006; McGee et 
al., 2005). For juvenile mice, mice were deprived from P23-26 and 
recorded at P27-P30. For adult mice, mice were deprived from P56-60 
and recorded from P60-P64. All mice were anesthetized with isoflurane 
(2-3% induction, 0.5%-1% for maintenance) in medical oxygen. Eyelids 
were trimmed carefully to aid fusion of lids after suturing. Prior to 
closure, ophthalmic gel (Vidisic; 0.2% w/w; Bausch & Lomb) was 
applied to moisturize the eye. The eyelids were then sutured with 
sterile silk 6-0 sutures (Silkam®, B. Braun). A thin film of Topical 
ophthalmic antibiotic ointment (Ilium Opticin; Troy Laboratories) was 
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applied to prevent infection. Analgesics (NSAID; 1-meloxicam; 5mg/kg) 
were also administered to the mice to aid pain management during and 
after the procedure. All MD procedures were always performed in the 
morning and recording began on the morning of the fourth day. 
Surgical sutures were checked to see if they were intact or infected at 
least twice a day. Mice whose eyes reopened during the deprivation 
period were excluded from analyses. 
6.2.2.2 Visual stimulus for in vivo recording 
Stimuli were generated in Octave using the Psychophysics Toolbox 
extensions (Brainard, 1997; Pelli, 1997) and displayed on a monitor 
(View Sonic, 22 inch monitor) placed 25-30 cm from the mouse. 
Episodic stimuli were repeated 10 times, with stimulus conditions 
randomly interleaved, and a grey blank condition (mean luminance) 
was included in all stimulus sets to estimate the spontaneous firing 
rate. Episodic stimuli consisted of drifting sinusoidal gratings of 10 s 
duration, temporal frequency of 1 Hz, and 10 spatial frequencies evenly 
distributed between 0.1 and 1 cycle per degree (cyc/deg). Intertrial 
interval consisted of a grey blank screen of 2 s duration to measure 
baseline spontaneous firing. The orientations of the grating were 
chosen online to maximise evoked activity at each site. The stimuli 
were shown at 100% contrast with the background at mean luminance.  
6.2.2.3 Spike sorting and data analysis 
Broadband extracellular signals were sampled at 50 kHz and stored for 
off-line analysis. The data were high-pass filtered between 0.5 and 10 
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kHz, and spiking events were detected by identifying peaks in the 
voltage signal exceeding 5 standard deviations of the background 
noise. A 1 ms waveform sample was acquired around the time of the 
peak. All spikes recorded on a given channel were grouped together to 
form multi-unit spike clusters. Channels or clusters included for 
analysis when the evoked activity exceeded the baseline. 
6.2.2.4 Data analysis - ocular dominance scores 
(ODS) and contralateral bias index (CBI) 
Ocular dominance scores (ODS) were calculated based on previously 
published material (Montey and Quinlan, 2011). Briefly, ocular 
dominance scores were calculated based on mean responses of 
individual eye in poststimulus time. 
 
ODS = (contra eye − ipsi eye) / (contra eye + ipsi eye) 
 
The OD scores were binned into a modified version of contralateral 
bias index (CBI) scale introduced by Hubel and Wiesel. The bins are: 1 
= 1.00 to 0.60, 2 = 0.59 to 0.20, 3 = 0.19 to − 0.19, 4 = − 0.20 to − 
0.59, 5 = − 0.60 to − 1.00, where 1 represents units primarily driven by 
the contralateral eye and 5 represents units primarily driven by the 
ipsilateral eye. Contralateral bias index was calculated using the 
formula:  
 
[(N1 – N5) + (N2 – N4) + (Ntot) / 2Ntot],  
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where N(tot) is the total number of cells and N1 – 5 is the number of 
neurons in bins 1 – 5 respectively. A value of more than 0.5 is primarily 
driven by the contralateral eye and vice versa, a value less than 0.5 is 
driven by the ipsilateral eye. 
6.2.3 Implantation of optogenetics stimulator 
6.2.3.1 Surgical procedures 
Mice were lightly anesthetized with isofluorane (2-3% induction, 0.5%-
1% for maintenance) in medical oxygen. Atropine (Ilium Atrosite; 1 
mg/kg; Troy Laboratories) and dexamethasone (Ilium Dexasone; 2 
mg/kg; Troy Laboratories) were injected subcutaneously to reduce 
secretions and to counter the parasympathomimetic effect of the 
aesthetic agents and reduce cerebral oedema respectively. 
A rectal thermoprobe monitored the animal’s body temperature 
throughout the experiment. Mouse Ox (with electrocardiograph and 
oxygen leads; Starr Life Sciences) was attached to the left hind limb 
and the heart, breath and oxygen saturation rate were monitored 
continuously throughout the experiment when possible. This enables 
us to monitor closely the depth of the anaesthesia in these animals so 
they do not feel any unnecessary stress or pain. The animal’s eyes 
were kept closed with a homemade eye patch and moisturized with an 
ophthalmic gel (Vidisic; 0.2% w/w; Bausch & Lomb) throughout the 
ensuing surgical procedures to prevent them from drying out. For 
implantation of the LED stimulator, the animal was placed on a custom-
built stereotaxic holder. The mice were prepared for surgery and an 
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incision was made to reveal the cranium. The cranium above the region 
of interest was thinned down using a dental drill. The hardware setup 
was then lightly attached on the cranium with cyanoacrylate glue 
before it was firmly held in place with dental cement. Care was taken to 
prevent the glue or cement from impeding the light source from the 
stimulator. The surgical area was cleaned up with sterile saline and the 
scalp was sutured back around the stimulator. A topical antibiotic 
cream was applied post-operation. 1-meloxicam (5 mg/mL) is provided 
as a painkiller post-surgery. 
6.2.4 Real-time quantitative PCR 
mRNA was converted to cDNA using the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, cat. no. 4368813). Real-time 
qPCR was done using TaqMan® primers (Applied Biosystems) on the 
FAST7900HT (Applied Biosystems) machine and c-fos (Applied 
Biosystems, Mm00487425_m1) TaqMan primers were used. All 
analysis was done on the RQ Manager (Applied Biosystems) provided 
with the machine. Samples were normalized to unstimulated visual 
cortices in the opposite hemisphere of the mouse. Delta delta CT 
values were calculated with two housekeeping genes: eukaryotic 18S 
rRNA (Hs99999901_s1) and  -actin (Mm02619580_g1). The final 
fold-change is the average of the two values.  
  103 
6.2.5 Statistical analysis 
Datasets were tested for normality using the Kolmogorov–Smirnov 
goodness-of-fit test when applicable. However, due to sample size 
limitations (n<5), normality tests are not conclusive. However, there is 
no reason to regard datasets as not normally distributed. For datasets 
with Gaussian distributions, they are analysed with the unpaired 
student’s t-test and presented as mean with standard errors (SEM), 
unless otherwise stated. 
6.3 Results 
6.3.1 Removal of Prmt8 may influence ocular dominance 
plasticity and the shifting of ocular dominance 
The shifting of neuronal responses in favour of the undeprived eye after 
monocular sensory deprivation is a phenomenon observed early in 
development. This effect is restricted to a specific time window, and is 
not seen in adult animals. In order to determine if Prmt8 regulates the 
critical period of the visual cortex, I recorded neurons from the visual 
cortex of both juvenile and adult mice after monocular deprivation 
(MD). As controls, neurons from juvenile wild type Prmt8+/+ mice were 
recorded after 4 days of monocular deprivation. A small shift in visual 
responses from the closed eye to the open eye (Figure 6.3 A, left and 
C) (Prmt8+/+ juvenile + MD: CBI=0.46, n=4, N=101) was observed. 




Figure 6.3. Removal of Prmt8 may affect ocular dominance 
plasticity. (A) A small shift in ocular dominance was observed in 
juvenile mice from both wild type (left panel, n=4, N=101) and Prmt8-/- 
mice (right panel, n=4, N=83) after 4 days of monocular deprivation. (B) 
A shift in ocular dominance was still observed in adult Prmt8-/- mice 
after 4 days of monocular deprivation (right panel, n=4, N=109), but not 
in adult wild type animals (left panel, n=3, N=71). (C) As described in 
(A), CBI values were reduced (<0.5) for juvenile mice that displayed a 
shift in ocular dominance after 4 days of monocular deprivation (open 
triangles, wild type; closed triangles, Prmt8-/-). Non-deprived adult 
control mice still maintained a contralateral eye bias (open squares, 
wild type, n=3, N=57; closed squares, Prmt8-/-, n=3, N=131). As 
described in (B), brief deprivation of adult wild type mice (open circles) 
did not induce a shift in ocular dominance plasticity as expected and 
this is similar to non-deprived wild type mice (p=0.5667). However, 
adult Prmt8-/- mice retained some ocular dominance plasticity by 
displaying a small shift in CBI (<0.5) after brief monocular deprivation. 
These responses are similar to the shift observed in juvenile deprived 
mice (p=0.8204) but different from those observed in non-deprived (* 















 Juvenile + MD
n=4,
N=101
1 2 3 4 5
CBI = 0.47
Prmt8 -/-
 Juvenile + MD
n=4,
N=83
































4d MD no MD 4d MD
†*
‡
  105 
shift in ocular dominance was also observed (Figure 6.3 A, right and C) 
(Prmt8-/-juvenile + MD: CBI=0.47, n=4, N=83). As mentioned, shifting of 
visual responses towards the undeprived eye is confined within the 
critical period for ocular dominance plasticity. However, in order to test 
if ocular dominance plasticity is still present in Prmt8-/- mice beyond the 
critical period, neurons of adult mice were recorded. In control non-
deprived adult mice, a natural bias towards the contralateral eye was 
observed (Figure 6.3 C) (Prmt8+/+: open squares, CBI=0.55 n=3, N=57; 
Prmt8-/-: closed squares, CBI=0.59, n=3, N=131). Similarly, 
contralateral bias was observed in wild type Prmt8+/+ adult mice that 
were monocularly deprived for 4 days (Figure 6.3 B, left and C) (Prmt8 
+/+ adult + MD: open circles, CBI=0.53, p=0.57, n=3, N=71). However, 
there was a slight shift of visual responses in Prmt8-/- mice (Figure 
6.3B, right and C) (Prmt8-/- adult + MD: closed circles, CBI=047, ‡ 
p=0.0805, n=4, N=109) compared to wild type Prmt8+/+ (* p=0.0487) 
and Prmt8-/- († p=0.0574) non-MD controls.   
6.4 Discussion 
Prmt8-/- mice showed increased perineuronal net expression, which 
leads to a restriction of structural reorganization of the visual cortex 
(Chapter 3 and 4). As a result of this precocious formation of brakes 
and restriction in plasticity, cortical circuits have reduced inhibitory 
connections and may not be function normally. As sufficient inhibition is 
required for activation and closure of the critical period (Fagiolini and 
Hensch, 2000), we would expect that MD would evoke no shift of 
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neuronal spiking responses in these null mutants. Visual responses of 
juvenile Prmt8-/- mice displayed a small shift of responses towards the 
undeprived eye during brief monocular deprivation, suggesting that 
ocular dominance plasticity may still exist despite removal of Prmt8. 
Deprived adult Prmt8-/- mice continued to show a modest shift in ocular 
responses towards the undeprived eye (Figure 6.3 B, left) compared to 
deprived adult wild type Prmt8+/+ mice. This is in contrary to what we 
expected. However, due to the small sample size and weaker signals 
that were seen during the recording process, it is difficult to conclude 
that critical period for ocular dominance has indeed been perturbed in 
the Prmt8-/- mouse model.  
One of the difficulties encountered when measuring neuronal activity 
was obtaining robust signals, which can be differentiated from noise. In 
the electrophysiology experiments, silicon multi-electrode arrays 
(Neuronexus Technologies) were selected over traditional single 
channel probes for its ability to record multiple neurons per penetration. 
Although these arrays allow the users to increase output by recording 
from multiple sites simultaneously, these probes suffer from poor 
spatial resolution and poor signal-to-noise ratio (Spira and Hai, 2013). 
This is in comparison to published data where results are more robust 
when recording from a single site using tungsten electrode (Mataga et 
al., 2002; Montey and Quinlan, 2011), for example. These could 
possibly account for some of the differences in signals observed in this 
study compared to other published data. Another difficulty arose from 
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the current setup in the laboratory. While this setup is capable of 
recording signals, more refinement (e.g. a appropriate amplifier) may 
be required to make data acquisition more robust and consistent. 
6.4.1 Optogenetics as a form of rescue – preliminary data 
From the results from previous chapters, it has been established that 
Prmt8 transgenic mice have reduced inhibitory perisomatic puncta, an 
indication of weakening local inhibitory modulation of visual cortical 
circuits, as a result of aberrant regulation of ECM formation. Although 
further investigations may be required to unravel the role of Prmt8 in 
regulation of ocular dominance plasticity, the removal of Prmt8 
manifests itself phenotypically as a drop in visual acuity. 
Key players in this narrative are the parvalbumin interneurons. Many 
studies have shown that GABAergic connections, specifically from PV+ 
interneurons, are crucial for the onset of the critical period (Hensch, 
2005b). In chapter 4, I have shown that Prmt8 predominantly co-
localizes in PV+ interneurons of the visual cortex and their subsequent 
removal causes increased PNN to aggregate around these 
interneurons. Therefore, I hypothesize that we could functionally rescue 
these Prmt8-/- mice using optogenetics, by selectively increasing PV+ 
inhibitory modulation of principal neurons. This can be achieved easily 
because these Prmt8-/- mice are designed for Cre-Lox recombination, 






Figure 6.4. Using optogenetics as therapy to improve vision: 
preliminary data. (A) Current prototype of stimulators used for 
different purposes. Left: Prototype for surface stimulation. Right: 
Prototype with fibre optic for invasive deep brain stimulation. (B) An 
example of a wireless surface stimulator being mounted safely on a live 
mouse. (C) Top panel: Evoked spikes recorded from a multi-electrode 
array (MEA; channel 8) from brain surface stimulation with blue light. 
Blue regions indicate the onset of blue light. Bottom panel, left: (Pre- 
and post-stimulation spikes occurrences measured over 50 trials. 
Right: Spike rates as a function of time measured during three 
consecutive optical stimulation sequences through the same electrode 
(right). (D) Activity-dependent IEG (intermediate early gene) c-fos was 
upregulated in cortical tissues that have been briefly stimulated by blue 
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The following work was done in collaboration with Dr. Sudip Nag and 
Dr. Roger Herikstad from Singapore Institute for Neurotechnology 
(SINapse). The data from this section has been published5. 
Successful implantation of the optogenetic stimulator (Figure 6.4 A) has 
been demonstrated on adult mice (Figure 6.4 B). Optical stimulation 
was performed separately on both the motor and visual cortex areas.  
Controlled tail flicks from mice under partially anesthetized conditions 
were observed in successful optogenetic stimulation of motor cortex. 
The effects of stimulation on the visual cortex were gauged by means 
of evoked potential recording. Neuronexus 16-channel multi-electrode 
array probes (A1 x 16-3mm-50-177-A16, Neuronexus, USA) were used 
to record multi-unit action potentials from the visual cortex. The probes 
were inserted to depths of 500-550 µm, between 2.5-4.0 mm with 
reference to lambda. Spontaneous and optically evoked responses 
were recorded in response to LED-based blue light stimulation pulses 
(0.08 to 33.33 ms width), at frequencies ranging between 10 Hz and 
100 Hz. Blue light stimulation evoked neuronal firing and spike 
activities were measured (Figure 6.4 C, top panel) from a sample 
channel (channel 8). The bottom panel of figure 6.4 C shows spike 
occurrences over 50 consecutive trials (left) and spike rate (right) of a 
specific time window (red box in top panel) before and after optogenetic 
stimulation (33.33 ms width pulses, 40 Hz). Spikes were detected 
                                            
5 S. Nag, P. Lee, R. Herikstad, J. Sng, S. C. Yen, N. V. Takor. Multi-
wavelength optogenetic stimulator and neural amplifier for wirelessly 
controlled interface. (Nag et al., 2015) 
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offline by using a custom developed script based on threshold 
magnitude. In addition, the visual cortices of these mice were collected 
post-stimulation to check for intermediate-early gene (IEG) expression. 
Activity-dependent IEG c-fos was upregulated in cortical tissues post-
optical stimulation (Figure 6.4 D) (stim: 1.43 fold ± 0.13, n=3, 
p=0.0069) compared to unstimulated tissue controls. The above results 
indicate a successful demonstration of optogenetic stimulation and the 
subsequent evoked neuronal responses, measured physiologically and 
through molecular markers of activity.  
Since Karl Deisseroth and co-workers popularized optogenetics in 
2005 (Boyden et al., 2005), it is quickly becoming an attractive 
technique for studying neuronal networks and their individual 
connections. Optogenetics allows researchers to study specific 
neuronal subpopulations and their roles in the entire circuit. I have 
demonstrated that the Prmt8-/- transgenic mice display deficiencies in 
inhibitory modulation from decreased puncta numbers causing visual 
performance to be diminished. Based on this preliminary exploratory 
data, I propose that optogenetics can be used as a therapy to restore 
inhibitory balance in Prmt8-/- mice that can potentially rescue visual 
acuity (Figure 6.5). Optogenetic control of inhibitory interneurons as 
therapy has already been demonstrated in modulating epilepsy (Kokaia 
et al., 2013; Ledri et al., 2014), which also manifests itself as 
excitatory-inhibitory E-I circuit imbalances. This experiment can be 
Formatting 




Figure 6.5. Proposed model for the rescue of phenotype using 
optogenetics. Using transgenic mice that carry the Prmt8 knockout 
and express ChR2, we can increase PV+ inhibitory neuron modulation 
of cortical circuits via (A) optogenetic stimulation of ChR2. In Prmt8-/- 
cortex, formation of excess PNNs restricts structural plasticity of 
inhibitory neurons, preventing the establishment of inhibitory 
connections for pruning and maturation of visual cortical circuitry. 
Therefore, (B) pharmacological intervention, such as chondrotinase 
ABC (ChABC), may be necessary to remove these brakes and 
maximise efficiency of treatment. Removal of structural brakes (PNNs), 
in tandem with ChR2 stimulation of PV+ cells may cause functional 
rearrangement of inhibitory connections and proper pruning of cortical 
pyramidal neurons leading to recovery of visual function (changes in 
yellow dotted lines). Grey bar with roman numerals represent the 
































achieved by crossing the Prmt8 transgenic mice (Figure 3.1) with mice 
expressing the cre recombinase in parvalbumin interneurons (e.g. 
B6;129P2-Pvalbtm1(cre)Arbr/J; Jackson Laboratory). However, a triple 
cross is required to achieve knockout of Prmt8 in PV+ cells, while also 
expressing channelrhodopsin (ChR2). 
This process is laborious and requires many generations of cross-
breeding to achieve. However, technicalities notwithstanding, 
optogenetics can, in concept, be used a form of functional rescue for 
Prmt8 transgenic mice, restoring proper visual function and perhaps 
ocular dominance plasticity during development.  
The current stimulator (Figure 6.4 A) is already capable of inducing 
ChR2 activity, measured with molecular signals and neuronal firing 
rates (Figure 6.4 C-D). However, further refinement is required. For 
example, more data is required to determine a suitable stimulation 
paradigm. What length of blue light stimulation is required for sufficient 
restoration of inhibition? Plus, how many times and when should these 
stimulations be delivered throughout the day? Does chronic stimulation 
affect the animal adversely? These are some questions that we will 
have to answer first. 
 In addition, the prototype photostimulator needs to be improved on. 
Size, biocompatibility, and safety are crucial considerations when 
designing a better prototype. The mouse is not a big animal. Hence, a 
huge stimulator may physically affect the mouse and its behaviour. On 
top of that, if chronic implantation is required, the stimulator needs to 
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be durable but not be made of materials that will adversely affect the 
wellbeing of the test animals (for example, inflammation). Here we 
demonstrated a prototype that can be safely mounted on a living and 
behaving mouse for up to 2 weeks (Figure 6.4 B). A current limitation 
with this prototype is the battery pack, which the mouse carries 
whenever a stimulator is attached. It also poses a question of safety 
when the mice are tested on water-based tasks, such as the visual 
water task (Figure 5.1). A smaller and truly wireless prototype is 
already developed and being tested, but new data is unavailable at 
time of submission of this dissertation. 
On top of engineering considerations, refinements to experimental 
strategies and paradigms are also paramount. Prmt8-/- transgenic mice 
have insufficient perisomatic inhibition (Figure 4.3) and resembles mice 
that lack the GABA-synthesizing enzyme therefore restoring local 
inhibition via activation of PV+ interneurons may reverse the negative 
effects. However, if this therapy is to be effectively used on adult 
animals, where circuit connections are fixed and consolidated, will 
there be a need to pair optogenetic stimulation with the removal of 
structural locks such as perineuronal nets? For example, in a study 
conducted by Maffei’s laboratory (Pizzorusso et al., 2006), they 
discovered that chondroitinase ABC (an enzyme that digests PNN) 
administration facilitated anatomical (spine density), functional (ocular 
dominance) and behavioural (visual acuity) recovery from the effects of 
monocular deprivation. Hence, in order to unlock the full potential of 
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this proposed optogenetic therapy to restore visual function in Prmt8-/- 
mice, chemical or enzymatic digestion of PNNs may also be required in 
tandem to optogenetic stimulation.  
6.5 Conclusions 
In previous chapters, it has been demonstrated that Prmt8-/- mice have 
reduced inhibitory connections within the visual cortical circuitry. 
Reduced inhibition during the critical period of the visual cortex causes 
mechanisms that tune and hone visual performance to be reduced or 
disabled. As a result, these transgenic mice perform poorly in the visual 
water task. However, in order to establish if removal of Prmt8 does 
affect ocular dominance plasticity, more data has to be collected as my 
data proved inconclusive. In addition, I have described and provided 
preliminary data that supports optogenetics as a potential therapy to 
address visual deficiencies in Prmt8 transgenic mice by rescuing 
insufficient inhibition. In principle, this technique will improve the 
phenotype of these mice, although more tests need to be conducted for 
a suitable stimulation paradigm. More preliminary work on the 
prototype also needs to be done to make it safe to use on mice and on 
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CHAPTER 7 Final conclusions 
During early development, circuits in the visual cortex are skewed 
towards an excitatory state. As these sensory circuits mature and 
develop, inhibition increases and provides the permissive cues for the 
formation of the critical period, where the plastic brain is readily shaped 
and moulded by external environmental conditions (Figure 7.1, grey 
arrow). 
In this study, Prmt8 was identified from a vast category of chromatin 
modifying enzymes to be upregulated during the experience-dependent 
paradigm of dark rearing. As expected, Prmt8 was also observed to be 
upregulated during the developmental critical period of the visual 
cortex. Due to its unique tissue localization, it was postulated that 
Prmt8 could play a crucial role in protein methylation in the CNS. Using 
a loss-of-function approach with transgenic mice, this study has 
demonstrated that removal of Prmt8 increases expression of Tenascin-
R (TNR) and specialized ECM structure, perineuronal nets (PNNs). 
ChIP data suggests that PRMT8 acts and influences transcription of 
TNR via its promoter region, possibly via its putative histone mark 
H4R3. However, further studies are required to uncover specific 
molecular and biochemical mechanisms of PRMT8 and arginine 
methylation. This may be confounded by the promiscuous nature of 
PRMTs, as they are capable of methylating not only histone proteins. 
On top of that, most PRMTs often function as co-activators, working in 









Figure 7.1. Effects of PMRT8 knockout on visual circuits: a 
proposed model. In normal development (grey arrow), visual cortical 
circuits begin as unpruned circuits that are predominantly driven by 
spontaneous activity. Experience-dependent refinement of circuit 
functions is required after eye opening to prune connection and 
modulate maturation. When PRMT8 is removed from the system 
(orange arrows), TNR/PNN is upregulated before time and this 
structurally locks the circuit in an immature state. Consequently, visual 
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As a result of this increased TNR/PNN expression during the CP 
window, visual cortical circuits are structurally “locked” in an immature 
state, with lesser synaptic connections and reduced modulation of 
principal neurons. The functional consequence of disrupted 
development of synaptic connections is the reduction of visual acuity, 
demonstrating the importance of E-I balance of circuits for the proper 
development of vision in mice (Figure 7.1, orange arrows). Although 
this result supports the idea that the visual circuits of Prmt8 mice are 
immature and have reduced or insufficient local inhibition to initiate the 
critical period, more evidence from electrophysiological recordings may 
be required to prove that Prmt8 may regulate the critical period for 
ocular dominance.  
With the rapid advancement of optogenetic technologies in recent 
years, selective stimulation of PV+ interneurons is now a reality. I 
propose and have demonstrated preliminary results for a potential 
therapy for E-I imbalances in cortical circuitry connections by 
specifically targeting modulators of local inhibition. If successful, 
strengthening of inhibition may rescue visual acuity in these mice 
lacking PRMT8. It will also be exciting to apply this optogenetic therapy 
to other disease models that have imbalances in E-I connections, such 
as autism spectrum disorders and schizophrenia.   
In this dissertation, I have demonstrated that protein arginine 
methyltransferase, Prmt8, regulates the structural plasticity of visual 
circuits by acting as an epigenetic regulator of PNNs via control of a 
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principal component, TNR. Loss of regulatory control of TNR/PNN 
leads to perturbations of synaptic connections by consolidation of 
circuits with insufficient inhibitory inputs, leading to a disruption in 
development of proper vision. This developmental defect is then 
manifested as weakened visual acuity as measured as a behavioural 
phenotype. Although more evidence is required to conclude if Prmt8 
regulates critical period plasticity, we know that removal of Prmt8 does 































  119 
References 
Adams, D.L., Sincich, L.C., Horton, J.C., 2007. Complete pattern of 
ocular dominance columns in human primary visual cortex. J. 
Neurosci. 27, 10391–403. doi:10.1523/JNEUROSCI.2923-07.2007 
Alberini, C.M., Kandel, E.R., 2015. The regulation of transcription in 
memory consolidation. Cold Spring Harb. Perspect. Biol. 7, 
a021741. doi:10.1101/cshperspect.a021741 
Antonini, A., Fagiolini, M., Stryker, M.P., 1999. Anatomical correlates of 
functional plasticity in mouse visual cortex. J. Neurosci. 19, 4388–
406. 
Atwal, J.K., Pinkston-Gosse, J., Syken, J., Stawicki, S., Wu, Y., Shatz, 
C., Tessier-Lavigne, M., 2008. PirB is a functional receptor for 
myelin inhibitors of axonal regeneration. Science 322, 967–70. 
doi:10.1126/science.1161151 
Bailey, C.H., Montarolo, P., Chen, M., Kandel, E.R., Schacher, S., 
1992. Inhibitors of protein and RNA synthesis block structural 
changes that accompany long-term heterosynaptic plasticity in 
Aplysia. Neuron 9, 749–758. doi:10.1016/0896-6273(92)90037-E 
Bedford, M.T., Clarke, S.G., 2009. Protein arginine methylation in 
mammals: who, what, and why. Mol. Cell 33, 1–13. 
doi:10.1016/j.molcel.2008.12.013 
Beurdeley, M., Spatazza, J., Lee, H.H.C., Sugiyama, S., Bernard, C., Di 
Nardo, A.A., Hensch, T.K., Prochiantz, A., 2012. Otx2 binding to 
perineuronal nets persistently regulates plasticity in the mature 
 120 
visual cortex. J. Neurosci. 32, 9429–37. 
doi:10.1523/JNEUROSCI.0394-12.2012 
Bird, A., 2007. Perceptions of epigenetics. Nature 447, 396–8. 
doi:10.1038/nature05913 
Bloodgood, B.L., Sharma, N., Browne, H.A., Trepman, A.Z., 
Greenberg, M.E., 2013. The activity-dependent transcription factor 
NPAS4 regulates domain-specific inhibition. Nature 503, 121–5. 
doi:10.1038/nature12743 
Boyden, E.S., Zhang, F., Bamberg, E., Nagel, G., Deisseroth, K., 2005. 
Millisecond-timescale, genetically targeted optical control of neural 
activity. Nat. Neurosci. 8, 1263–8. doi:10.1038/nn1525 
Boyle, E.I., Weng, S., Gollub, J., Jin, H., Botstein, D., Cherry, J.M., 
Sherlock, G., 2004. GO::TermFinder--open source software for 
accessing Gene Ontology information and finding significantly 
enriched Gene Ontology terms associated with a list of genes. 
Bioinformatics 20, 3710–5. doi:10.1093/bioinformatics/bth456 
Brainard, D.H., 1997. The Psychophysics Toolbox. Spat. Vis. 10, 433–
6. 
Brakebusch, C., Seidenbecher, C.I., Asztely, F., Rauch, U., Matthies, 
H., Meyer, H., Krug, M., Böckers, T.M., Zhou, X., Kreutz, M.R., 
Montag, D., Gundelfinger, E.D., Fässler, R., 2002. Brevican-
deficient mice display impaired hippocampal CA1 long-term 
potentiation but show no obvious deficits in learning and memory. 
Mol. Cell. Biol. 22, 7417–27. 
  121 
Brückner, G., Brauer, K., Härtig, W., Wolff, J.R., Rickmann, M.J., 
Derouiche, A., Delpech, B., Girard, N., Oertel, W.H., Reichenbach, 
A., 1993. Perineuronal nets provide a polyanionic, glia-associated 
form of microenvironment around certain neurons in many parts of 
the rat brain. Glia 8, 183–200. doi:10.1002/glia.440080306 
Brückner, G., Grosche, J., Schmidt, S., Härtig, W., Margolis, R.U., 
Delpech, B., Seidenbecher, C.I., Czaniera, R., Schachner, M., 
2000. Postnatal development of perineuronal nets in wild-type 
mice and in a mutant deficient in tenascin-R. J. Comp. Neurol. 
428, 616–29. 
Brunner, A.M., Tweedie-Cullen, R.Y., Mansuy, I.M., 2012. Epigenetic 
modifications of the neuroproteome. Proteomics 12, 2404–20. 
doi:10.1002/pmic.201100672 
Cantoni, G.L., 1952. The nature of the active methyl donor formed 
enzymatically from L-methionine and adenosinetriphosphate 1,2. 
J. Am. Chem. Soc. 74, 2942–2943. doi:10.1021/ja01131a519 
Cha, B., Jho, E.-H., 2012. Protein arginine methyltransferases 
(PRMTs) as therapeutic targets. Expert Opin. Ther. Targets 16, 
651–64. doi:10.1517/14728222.2012.688030 
Chattopadhyaya, B., Di Cristo, G., Higashiyama, H., Knott, G.W., 
Kuhlman, S.J., Welker, E., Huang, Z.J., 2004. Experience and 
activity-dependent maturation of perisomatic GABAergic 
innervation in primary visual cortex during a postnatal critical 
period. J. Neurosci. 24, 9598–9611. 
 122 
doi:10.1523/JNEUROSCI.1851-04.2004 
Chattopadhyaya, B., Di Cristo, G., Wu, C.Z., Knott, G., Kuhlman, S., 
Fu, Y., Palmiter, R.D., Huang, Z.J., 2007. GAD67-mediated GABA 
synthesis and signaling regulate inhibitory synaptic innervation in 
the visual cortex. Neuron 54, 889–903. 
doi:10.1016/j.neuron.2007.05.015 
Chen, D., 1999. Regulation of Transcription by a Protein 
Methyltransferase. Science (80-. ). 284, 2174–2177. 
doi:10.1126/science.284.5423.2174 
Chen, J.L., Lin, W.C., Cha, J.W., So, P.T., Kubota, Y., Nedivi, E., 2011. 
Structural basis for the role of inhibition in facilitating adult brain 
plasticity. Nat. Neurosci. 14, 587–94. doi:10.1038/nn.2799 
Cheng, X., Collins, R.E., Zhang, X., 2005. Structural and sequence 
motifs of protein (histone) methylation enzymes. Annu. Rev. 
Biophys. Biomol. Struct. 34, 267–94. 
doi:10.1146/annurev.biophys.34.040204.144452 
Chiu, C., Weliky, M., 2002. Relationship of correlated spontaneous 
activity to functional ocular dominance columns in the developing 
visual cortex. Neuron 35, 1123–34. 
Cohen-Cory, S., 2002. The developing synapse: construction and 
modulation of synaptic structures and circuits. Science 298, 770–
6. doi:10.1126/science.1075510 
Cook, J.R., Lee, J.-H., Yang, Z.-H., Krause, C.D., Herth, N., Hoffmann, 
R., Pestka, S., 2006. FBXO11/PRMT9, a new protein arginine 
  123 
methyltransferase, symmetrically dimethylates arginine residues. 
Biochem. Biophys. Res. Commun. 342, 472–81. 
doi:10.1016/j.bbrc.2006.01.167 
Dahlhaus, M., Li, K.W., van der Schors, R.C., Saiepour, M.H., van 
Nierop, P., Heimel, J.A., Hermans, J.M., Loos, M., Smit, A.B., 
Levelt, C.N., 2011. The synaptic proteome during development 
and plasticity of the mouse visual cortex. Mol. Cell. Proteomics 10, 
M110.005413. doi:10.1074/mcp.M110.005413 
Das, G., Reuhl, K., Zhou, R., 2013. The Golgi-Cox method. Methods 
Mol. Biol. 1018, 313–21. doi:10.1007/978-1-62703-444-9_29 
Dash, P.K., Orsi, S.A., Moore, A.N., 2009. Histone deactylase inhibition 
combined with behavioral therapy enhances learning and memory 
following traumatic brain injury. Neuroscience 163, 1–8. 
doi:10.1016/j.neuroscience.2009.06.028 
Daw, N., 2006. Visual Development. Kluwer Academic Publishers, 
Boston. doi:10.1007/0-387-30484-3 
Daw, N.W., Fox, K., Sato, H., Czepita, D., 1992. Critical period for 
monocular deprivation in the cat visual cortex. J. Neurophysiol. 67, 
197–202. 
Dehmelt, L., Halpain, S., 2005. The MAP2/Tau family of microtubule-
associated proteins. Genome Biol. 6, 204. doi:10.1186/gb-2004-6-
1-204 
Denman, R.B., Xie, W., Merz, G., Sung, Y.-J., 2014. GABAAergic 
stimulation modulates intracellular protein arginine methylation. 
 124 
Neurosci. Lett. 572, 38–43. doi:10.1016/j.neulet.2014.04.036 
Drager, U.C., 1975. Receptive fields of single cells and topography in 
mouse visual cortex. J. Comp. Neurol. 160, 269–289. 
doi:10.1002/cne.901600302 
Durand, S., Patrizi, A., Quast, K.B., Hachigian, L., Pavlyuk, R., Saxena, 
A., Carninci, P., Hensch, T.K., Fagiolini, M., 2012. NMDA receptor 
regulation prevents regression of visual cortical function in the 
absence of Mecp2. Neuron 76, 1078–90. 
doi:10.1016/j.neuron.2012.12.004 
Engert, F., Bonhoeffer, T., 1999. Dendritic spine changes associated 
with hippocampal long-term synaptic plasticity. Nature 399, 66–70. 
doi:10.1038/19978 
Erzurumlu, R.S., Gaspar, P., 2012. Development and critical period 
plasticity of the barrel cortex. Eur. J. Neurosci. 35, 1540–53. 
doi:10.1111/j.1460-9568.2012.08075.x 
Fagiolini, M., Fritschy, J., Lo, K., 2004. Specific GABA A Circuits for 
Visual Cortical Plasticity. Science (80-. ). 303, 1681–1683. 
doi:10.1126/science.1091032 
Fagiolini, M., Hensch, T.K., 2000. Inhibitory threshold for critical-period 
activation in primary visual cortex. Nature 404, 183–6. 
doi:10.1038/35004582 
Fagiolini, M., Jensen, C.L., Champagne, F.A., 2009. Epigenetic 
influences on brain development and plasticity. Curr. Opin. 
Neurobiol. 19, 207–12. doi:10.1016/j.conb.2009.05.009 
  125 
Fagiolini, M., Katagiri, H., Miyamoto, H., Mori, H., Grant, S.G.N., 
Mishina, M., Hensch, T.K., 2003. Separable features of visual 
cortical plasticity revealed by N-methyl-D-aspartate receptor 2A 
signaling. Proc. Natl. Acad. Sci. U. S. A. 100, 2854–9. 
doi:10.1073/pnas.0536089100 
Fagiolini, M., Pizzorusso, T., Berardi, N., Domenici, L., Maffei, L., 1994. 
Functional postnatal development of the rat primary visual cortex 
and the role of visual experience: Dark rearing and monocular 
deprivation. Vision Res. 34, 709–720. doi:10.1016/0042-
6989(94)90210-0 
Felsenfeld, G., Groudine, M., 2003. Controlling the double helix. Nature 
421, 448–53. doi:10.1038/nature01411 
Frankel, A., Yadav, N., Lee, J., Branscombe, T.L., Clarke, S., Bedford, 
M.T., 2002. The novel human protein arginine N-methyltransferase 
PRMT6 is a nuclear enzyme displaying unique substrate 
specificity. J. Biol. Chem. 277, 3537–43. 
doi:10.1074/jbc.M108786200 
Ganesh, L., Yoshimoto, T., Moorthy, N.C., Akahata, W., Boehm, M., 
Nabel, E.G., Nabel, G.J., 2006. Protein methyltransferase 2 
inhibits NF-kappaB function and promotes apoptosis. Mol. Cell. 
Biol. 26, 3864–74. doi:10.1128/MCB.26.10.3864-3874.2006 
Gary, J.D., Lin, W.-J., Yang, M.C., Herschman, H.R., Clarke, S., 1996. 
The Predominant Protein-arginine Methyltransferase from 
Saccharomyces cerevisiae. J. Biol. Chem. 271, 12585–12594. 
 126 
doi:10.1074/jbc.271.21.12585 
Gatto, C.L., Broadie, K., 2010. Genetic controls balancing excitatory 
and inhibitory synaptogenesis in neurodevelopmental disorder 
models. Front. Synaptic Neurosci. 2, 4. 
doi:10.3389/fnsyn.2010.00004 
Gayatri, S., Bedford, M.T., 2014. Readers of histone methylarginine 
marks. Biochim. Biophys. Acta 1839, 702–10. 
doi:10.1016/j.bbagrm.2014.02.015 
Giffin, F., Mitchell, D.E., 1978. The rate of recovery of vision after early 
monocular deprivation in kittens. J. Physiol. 274, 511–37. 
Glickfeld, L.L., Histed, M.H., Maunsell, J.H.R., 2013. Mouse primary 
visual cortex is used to detect both orientation and contrast 
changes. J. Neurosci. 33, 19416–22. 
doi:10.1523/JNEUROSCI.3560-13.2013 
Gogolla, N., Caroni, P., Lüthi, A., Herry, C., 2009. Perineuronal nets 
protect fear memories from erasure. Science 325, 1258–61. 
doi:10.1126/science.1174146 
Gogolla, N., Takesian, A.E., Feng, G., Fagiolini, M., Hensch, T.K., 
2014. Sensory integration in mouse insular cortex reflects GABA 
circuit maturation. Neuron 83, 894–905. 
doi:10.1016/j.neuron.2014.06.033 
Goh, W.W.B., Oikawa, H., Sng, J.C.G., Sergot, M., Wong, L., 2011. 
The role of miRNAs in complex formation and control. 
Bioinformatics 28, 453–456. doi:10.1093/bioinformatics/btr693 
  127 
Gordon, J.A., Stryker, M.P., 1996. Experience-Dependent Plasticity of 
Binocular Responses in the Primary Visual Cortex of the Mouse. J. 
Neurosci. 16, 3274–3286. 
Guan, J.-S., Haggarty, S.J., Giacometti, E., Dannenberg, J.-H., Joseph, 
N., Gao, J., Nieland, T.J.F., Zhou, Y., Wang, X., Mazitschek, R., 
Bradner, J.E., DePinho, R.A., Jaenisch, R., Tsai, L.-H., 2009. 
HDAC2 negatively regulates memory formation and synaptic 
plasticity. Nature 459, 55–60. doi:10.1038/nature07925 
Gupta, S., Kim, S.Y., Artis, S., Molfese, D.L., Schumacher, A., Sweatt, 
J.D., Paylor, R.E., Lubin, F.D., 2010. Histone methylation regulates 
memory formation. J. Neurosci. 30, 3589–99. 
doi:10.1523/JNEUROSCI.3732-09.2010 
Hanover, J.L., Huang, Z.J., Tonegawa, S., Stryker, M.P., 1999. Brain-
derived neurotrophic factor overexpression induces precocious 
critical period in mouse visual cortex. J. Neurosci. 19, RC40. 
Härtig, W., Brauer, K., Bigl, V., Brückner, G., 1994. Chondroitin sulfate 
proteoglycan-immunoreactivity of lectin-labeled perineuronal nets 
around parvalbumin-containing neurons. Brain Res. 635, 307–11. 
Hensch, T.K., 2005a. Recovery in the blink of an eye. Neuron 48, 166–
8. doi:10.1016/j.neuron.2005.10.007 
Hensch, T.K., 2005b. Critical period plasticity in local cortical circuits. 
Nat. Rev. Neurosci. 6, 877–88. doi:10.1038/nrn1787 
Hensch, T.K., 2004. Critical period regulation. Annu. Rev. Neurosci. 27, 
549–79. doi:10.1146/annurev.neuro.27.070203.144327 
 128 
Hensch, T.K., 2003. Controlling the critical period. Neurosci. Res. 47, 
17–22. doi:10.1016/S0168-0102(03)00164-0 
Hensch, T.K., Fagiolini, M., Mataga, N., Stryker, M.P., Baekkeskov, S., 
Kash, S.F., 1998. Local GABA Circuit Control of Experience-
Dependent Plasticity in Developing Visual Cortex. Science (80-. ). 
282, 1504–1508. doi:10.1126/science.282.5393.1504 
Hensch, T.K., Stryker, M.P., 2004. Columnar architecture sculpted by 
GABA circuits in developing cat visual cortex. Science 303, 1678–
81. doi:10.1126/science.1091031 
Hinton, V.J., Brown, W.T., Wisniewski, K., Rudelli, R.D., 1991. Analysis 
of neocortex in three males with the fragile X syndrome. Am. J. 
Med. Genet. 41, 289–94. doi:10.1002/ajmg.1320410306 
Hockfield, S., Kalb, R.G., Zaremba, S., Fryer, H., 1990. Expression of 
neural proteoglycans correlates with the acquisition of mature 
neuronal properties in the mammalian brain. Cold Spring Harb. 
Symp. Quant. Biol. 55, 505–14. 
Holtmaat, A.J.G.D., Trachtenberg, J.T., Wilbrecht, L., Shepherd, G.M., 
Zhang, X., Knott, G.W., Svoboda, K., 2005. Transient and 
persistent dendritic spines in the neocortex in vivo. Neuron 45, 
279–91. doi:10.1016/j.neuron.2005.01.003 
Hooks, B.M., Chen, C., 2007. Critical periods in the visual system: 
changing views for a model of experience-dependent plasticity. 
Neuron 56, 312–26. doi:10.1016/j.neuron.2007.10.003 
Huang, S., Litt, M., Felsenfeld, G., 2005. Methylation of histone H4 by 
  129 
arginine methyltransferase PRMT1 is essential in vivo for many 
subsequent histone modifications. Genes Dev. 19, 1885–93. 
doi:10.1101/gad.1333905 
Huang, Z.J., Kirkwood, A., Pizzorusso, T., Porciatti, V., Morales, B., 
Bear, M.F., Maffei, L., Tonegawa, S., 1999. BDNF regulates the 
maturation of inhibition and the critical period of plasticity in mouse 
visual cortex. Cell 98, 739–755. doi:10.1016/S0092-
8674(00)81509-3 
Hubel, D.H., Wiesel, T.N., 1970. The period of susceptibility to the 
physiological effects of unilateral eye closure in kittens. J. Physiol. 
206, 419–36. 
Hubel, D.H., Wiesel, T.N., 1969. Anatomical demonstration of columns 
in the monkey striate cortex. Nature 221, 747–50. 
Hubel, D.H., Wiesel, T.N., 1968. Receptive fields and functional 
architecture of monkey striate cortex. J. Physiol. 195, 215–43. 
Hubel, D.H., Wiesel, T.N., 1962. Receptive fields, binocular interaction 
and functional architecture in the cat’s visual cortex. J. Physiol. 
160, 106–154. doi:10.1113/jphysiol.1962.sp006837 
Hubel, D.H., Wiesel, T.N., LeVay, S., 1977. Plasticity of ocular 
dominance columns in monkey striate cortex. Philos. Trans. R. 
Soc. Lond. B. Biol. Sci. 278, 377–409. doi:10.1098/rstb.1977.0050 
Huttenlocher, P.R., Dabholkar, A.S., 1997. Regional differences in 
synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387, 
167–78. 
 130 
Ippolito, D.M., Eroglu, C., 2010. Quantifying synapses: an 
immunocytochemistry-based assay to quantify synapse number. J. 
Vis. Exp. e2270. doi:10.3791/2270 
Issa, N.P., Trachtenberg, J.T., Chapman, B., Zahs, K.R., Stryker, M.P., 
1999. The Critical Period for Ocular Dominance Plasticity in the 
Ferret’s Visual Cortex. J. Neurosci. 19, 6965–6978. 
Iwai, Y., Fagiolini, M., Obata, K., Hensch, T.K., 2003. Rapid critical 
period induction by tonic inhibition in visual cortex. J. Neurosci. 23, 
6695–702. 
Jahan, S., Davie, J.R., 2015. Protein arginine methyltransferases 
(PRMTs): role in chromatin organization. Adv. Biol. Regul. 57, 
173–84. doi:10.1016/j.jbior.2014.09.003 
Jaworski, J., Kapitein, L.C., Gouveia, S.M., Dortland, B.R., Wulf, P.S., 
Grigoriev, I., Camera, P., Spangler, S.A., Di Stefano, P., Demmers, 
J., Krugers, H., Defilippi, P., Akhmanova, A., Hoogenraad, C.C., 
2009. Dynamic microtubules regulate dendritic spine morphology 
and synaptic plasticity. Neuron 61, 85–100. 
doi:10.1016/j.neuron.2008.11.013 
Ju, W., Morishita, W., Tsui, J., Gaietta, G., Deerinck, T.J., Adams, S.R., 
Garner, C.C., Tsien, R.Y., Ellisman, M.H., Malenka, R.C., 2004. 
Activity-dependent regulation of dendritic synthesis and trafficking 
of AMPA receptors. Nat. Neurosci. 7, 244–53. doi:10.1038/nn1189 
Katsanis, N., Yaspo, M.L., Fisher, E.M., 1997. Identification and 
mapping of a novel human gene, HRMT1L1, homologous to the rat 
  131 
protein arginine N-methyltransferase 1 (PRMT1) gene. Mamm. 
Genome 8, 526–9. 
Katz, J.E., Dlakić, M., Clarke, S., 2003. Automated identification of 
putative methyltransferases from genomic open reading frames. 
Mol. Cell. Proteomics 2, 525–40. doi:10.1074/mcp.M300037-
MCP200 
Kim, J.-D., Park, K.-E., Ishida, J., Kako, K., Hamada, J., Kani, S., 
Takeuchi, M., Namiki, K., Fukui, H., Fukuhara, S., Hibi, M., 
Kobayashi, M., Kanaho, Y., Kasuya, Y., Mochizuki, N., Fukamizu, 
A., 2015. PRMT8 as a phospholipase regulates Purkinje cell 
dendritic arborization and motor coordination. Sci. Adv. 1, 
e1500615. doi:10.1126/sciadv.1500615 
Kind, P.C., Sengpiel, F., Beaver, C.J., Crocker-Buque, A., Kelly, G.M., 
Matthews, R.T., Mitchell, D.E., 2013. The development and 
activity-dependent expression of aggrecan in the cat visual cortex. 
Cereb. Cortex 23, 349–60. doi:10.1093/cercor/bhs015 
Kleinschmidt, M.A., Streubel, G., Samans, B., Krause, M., Bauer, U.-
M., 2008. The protein arginine methyltransferases CARM1 and 
PRMT1 cooperate in gene regulation. Nucleic Acids Res. 36, 
3202–13. doi:10.1093/nar/gkn166 
Knudsen, E.I., 2004. Sensitive periods in the development of the brain 
and behavior. J. Cogn. Neurosci. 16, 1412–25. 
doi:10.1162/0898929042304796 
Kokaia, M., Andersson, M., Ledri, M., 2013. An optogenetic approach 
 132 
in epilepsy. Neuropharmacology 69, 89–95. 
doi:10.1016/j.neuropharm.2012.05.049 
Konur, S., Yuste, R., 2004. Developmental regulation of spine and 
filopodial motility in primary visual cortex: reduced effects of 
activity and sensory deprivation. J. Neurobiol. 59, 236–46. 
doi:10.1002/neu.10306 
Korzus, E., Rosenfeld, M.G., Mayford, M., 2004. CBP histone 
acetyltransferase activity is a critical component of memory 
consolidation. Neuron 42, 961–72. 
doi:10.1016/j.neuron.2004.06.002 
Kousaka, A., Mori, Y., Koyama, Y., Taneda, T., Miyata, S., Tohyama, 
M., 2009. The distribution and characterization of endogenous 
protein arginine N-methyltransferase 8 in mouse CNS. 
Neuroscience 163, 1146–57. 
doi:10.1016/j.neuroscience.2009.06.061 
Kurokawa, T., Tsuda, M., Sugino, Y., 1976. Purification and 
characterization of a lectin from Wistaria floribunda seeds. J. Biol. 
Chem. 251, 5686–93. 
Lakowski, T.M., Frankel, A., 2009. Kinetic analysis of human protein 
arginine N-methyltransferase 2: formation of monomethyl- and 
asymmetric dimethyl-arginine residues on histone H4. Biochem. J. 
421, 253–61. doi:10.1042/BJ20090268 
Lander, C., Kind, P., Maleski, M., Hockfield, S., 1997. A family of 
activity-dependent neuronal cell-surface chondroitin sulfate 
  133 
proteoglycans in cat visual cortex. J. Neurosci. 17, 1928–39. 
Le Guezennec, X., Vermeulen, M., Brinkman, A.B., Hoeijmakers, 
W.A.M., Cohen, A., Lasonder, E., Stunnenberg, H.G., 2006. 
MBD2/NuRD and MBD3/NuRD, two distinct complexes with 
different biochemical and functional properties. Mol. Cell. Biol. 26, 
843–51. doi:10.1128/MCB.26.3.843-851.2006 
Ledri, M., Madsen, M.G., Nikitidou, L., Kirik, D., Kokaia, M., 2014. 
Global Optogenetic Activation of Inhibitory Interneurons during 
Epileptiform Activity. J. Neurosci. 34, 3364–3377. 
doi:10.1523/JNEUROSCI.2734-13.2014 
Lee, E.-J.J., Gibo, T.L., Grzywacz, N.M., 2006. Dark-rearing-induced 
reduction of GABA and GAD and prevention of the effect by BDNF 
in the mouse retina. Eur. J. Neurosci. 24, 2118–34. 
doi:10.1111/j.1460-9568.2006.05078.x 
Lee, J.-H., Cook, J.R., Yang, Z.-H., Mirochnitchenko, O., Gunderson, 
S.I., Felix, A.M., Herth, N., Hoffmann, R., Pestka, S., 2005. 
PRMT7, a new protein arginine methyltransferase that synthesizes 
symmetric dimethylarginine. J. Biol. Chem. 280, 3656–64. 
doi:10.1074/jbc.M405295200 
Lee, J., Sayegh, J., Daniel, J., Clarke, S., Bedford, M.T., 2005. PRMT8, 
a new membrane-bound tissue-specific member of the protein 
arginine methyltransferase family. J. Biol. Chem. 280, 32890–6. 
doi:10.1074/jbc.M506944200 
Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, 
 134 
A., Boe, A.F., Boguski, M.S., Brockway, K.S., Byrnes, E.J., Chen, 
L., Chen, L., Chen, T.-M., Chin, M.C., Chong, J., Crook, B.E., 
Czaplinska, A., Dang, C.N., Datta, S., Dee, N.R., Desaki, A.L., 
Desta, T., Diep, E., Dolbeare, T.A., Donelan, M.J., Dong, H.-W., 
Dougherty, J.G., Duncan, B.J., Ebbert, A.J., Eichele, G., Estin, 
L.K., Faber, C., Facer, B.A., Fields, R., Fischer, S.R., Fliss, T.P., 
Frensley, C., Gates, S.N., Glattfelder, K.J., Halverson, K.R., Hart, 
M.R., Hohmann, J.G., Howell, M.P., Jeung, D.P., Johnson, R.A., 
Karr, P.T., Kawal, R., Kidney, J.M., Knapik, R.H., Kuan, C.L., 
Lake, J.H., Laramee, A.R., Larsen, K.D., Lau, C., Lemon, T.A., 
Liang, A.J., Liu, Y., Luong, L.T., Michaels, J., Morgan, J.J., 
Morgan, R.J., Mortrud, M.T., Mosqueda, N.F., Ng, L.L., Ng, R., 
Orta, G.J., Overly, C.C., Pak, T.H., Parry, S.E., Pathak, S.D., 
Pearson, O.C., Puchalski, R.B., Riley, Z.L., Rockett, H.R., 
Rowland, S.A., Royall, J.J., Ruiz, M.J., Sarno, N.R., Schaffnit, K., 
Shapovalova, N. V, Sivisay, T., Slaughterbeck, C.R., Smith, S.C., 
Smith, K.A., Smith, B.I., Sodt, A.J., Stewart, N.N., Stumpf, K.-R., 
Sunkin, S.M., Sutram, M., Tam, A., Teemer, C.D., Thaller, C., 
Thompson, C.L., Varnam, L.R., Visel, A., Whitlock, R.M., 
Wohnoutka, P.E., Wolkey, C.K., Wong, V.Y., Wood, M., Yaylaoglu, 
M.B., Young, R.C., Youngstrom, B.L., Yuan, X.F., Zhang, B., 
Zwingman, T.A., Jones, A.R., 2007. Genome-wide atlas of gene 
expression in the adult mouse brain. Nature 445, 168–76. 
doi:10.1038/nature05453 
  135 
Lendvai, B., Stern, E.A., Chen, B., Svoboda, K., 2000. Experience-
dependent plasticity of dendritic spines in the developing rat barrel 
cortex in vivo. Nature 404, 876–81. doi:10.1038/35009107 
LeVay, S., Stryker, M.P., Shatz, C.J., 1978. Ocular dominance columns 
and their development in layer IV of the cat’s visual cortex: a 
quantitative study. J. Comp. Neurol. 179, 223–44. 
doi:10.1002/cne.901790113 
LeVay, S., Wiesel, T.N., Hubel, D.H., 1980. The development of ocular 
dominance columns in normal and visually deprived monkeys. J. 
Comp. Neurol. 191, 1–51. doi:10.1002/cne.901910102 
Lin, Y., Bloodgood, B.L., Hauser, J.L., Lapan, A.D., Koon, A.C., Kim, 
T.-K., Hu, L.S., Malik, A.N., Greenberg, M.E., 2008. Activity-
dependent regulation of inhibitory synapse development by Npas4. 
Nature 455, 1198–1204. doi:10.1038/nature07319 
Lin, Y., Tsai, Y.-J., Liu, Y.-F., Cheng, Y.-C., Hung, C.-M., Lee, Y.-J., 
Pan, H., Li, C., 2013. The critical role of protein arginine 
methyltransferase prmt8 in zebrafish embryonic and neural 
development is non-redundant with its paralogue prmt1. PLoS One 
8, e55221. doi:10.1371/journal.pone.0055221 
Lundell, A., Olin, A.I., Mörgelin, M., al-Karadaghi, S., Aspberg, A., 
Logan, D.T., 2004. Structural basis for interactions between 
tenascins and lectican C-type lectin domains: evidence for a 
crosslinking role for tenascins. Structure 12, 1495–506. 
doi:10.1016/j.str.2004.05.021 
 136 
Lyckman, A.W., Horng, S., Leamey, C.A., Tropea, D., Watakabe, A., 
Van Wart, A., McCurry, C., Yamamori, T., Sur, M., 2008. Gene 
expression patterns in visual cortex during the critical period: 
synaptic stabilization and reversal by visual deprivation. Proc. Natl. 
Acad. Sci. U. S. A. 105, 9409–14. doi:10.1073/pnas.0710172105 
Maffei, L., Berardi, N., 2002. Protein Synthesis in the Visual Cortex Is 
Needed for Ocular Dominance Plasticity. Neuron 34, 328–331. 
doi:10.1016/S0896-6273(02)00688-8 
Majdan, M., Shatz, C.J., 2006. Effects of visual experience on activity-
dependent gene regulation in cortex. Nat. Neurosci. 9, 650–9. 
doi:10.1038/nn1674 
Majewska, A., Sur, M., 2003. Motility of dendritic spines in visual cortex 
in vivo: changes during the critical period and effects of visual 
deprivation. Proc. Natl. Acad. Sci. U. S. A. 100, 16024–9. 
doi:10.1073/pnas.2636949100 
Manavalan, A., Feng, L., Sze, S.K., Hu, J.-M., Heese, K., 2012. New 
insights into the brain protein metabolism of Gastrodia elata-
treated rats by quantitative proteomics. J. Proteomics 75, 2468–
79. doi:10.1016/j.jprot.2012.02.029 
Mataga, N., Mizuguchi, Y., Hensch, T.K., 2004. Experience-dependent 
pruning of dendritic spines in visual cortex by tissue plasminogen 
activator. Neuron 44, 1031–41. doi:10.1016/j.neuron.2004.11.028 
Mataga, N., Nagai, N., Hensch, T.K., 2002. Permissive proteolytic 
activity for visual cortical plasticity. Proc. Natl. Acad. Sci. U. S. A. 
  137 
99, 7717–21. doi:10.1073/pnas.102088899 
Maya-Vetencourt, J.F., Tiraboschi, E., Greco, D., Restani, L., Cerri, C., 
Auvinen, P., Maffei, L., Castrén, E., 2012. Experience-dependent 
expression of NPAS4 regulates plasticity in adult visual cortex. J. 
Physiol. 590, 4777–87. doi:10.1113/jphysiol.2012.234237 
McAllister, A.K., 2000. Cellular and Molecular Mechanisms of Dendrite 
Growth. Cereb. Cortex 10, 963–973. doi:10.1093/cercor/10.10.963 
McBride, A.E., Silver, P.A., 2001. State of the arg: protein methylation 
at arginine comes of age. Cell 106, 5–8. 
McCloy, R.A., Rogers, S., Caldon, C.E., Lorca, T., Castro, A., Burgess, 
A., 2014. Partial inhibition of Cdk1 in G 2 phase overrides the SAC 
and decouples mitotic events. Cell Cycle 13, 1400–12. 
doi:10.4161/cc.28401 
McGee, A.W., Yang, Y., Fischer, Q.S., Daw, N.W., Strittmatter, S.M., 
2005. Experience-driven plasticity of visual cortex limited by myelin 
and Nogo receptor. Science 309, 2222–6. 
doi:10.1126/science.1114362 
McRae, P.A., Rocco, M.M., Kelly, G., Brumberg, J.C., Matthews, R.T., 
2007. Sensory deprivation alters aggrecan and perineuronal net 
expression in the mouse barrel cortex. J. Neurosci. 27, 5405–13. 
doi:10.1523/JNEUROSCI.5425-06.2007 
Miranda, T.B., Miranda, M., Frankel, A., Clarke, S., 2004. PRMT7 is a 
member of the protein arginine methyltransferase family with a 
distinct substrate specificity. J. Biol. Chem. 279, 22902–7. 
 138 
doi:10.1074/jbc.M312904200 
Montey, K.L., Quinlan, E.M., 2011. Recovery from chronic monocular 
deprivation following reactivation of thalamocortical plasticity by 
dark exposure. Nat. Commun. 2, 317. doi:10.1038/ncomms1312 
Morales, B., Choi, S.-Y., Kirkwood, A., 2002. Dark Rearing Alters the 
Development of GABAergic Transmission in Visual Cortex. J. 
Neurosci. 22, 8084–8090. 
Morishita, H., Hensch, T.K., 2008. Critical period revisited: impact on 
vision. Curr. Opin. Neurobiol. 18, 101–7. 
doi:10.1016/j.conb.2008.05.009 
Morishita, H., Miwa, J.M., Heintz, N., Hensch, T.K., 2010. Lynx1, a 
cholinergic brake, limits plasticity in adult visual cortex. Science 
330, 1238–40. doi:10.1126/science.1195320 
Mostafavi, S., Ray, D., Warde-Farley, D., Grouios, C., Morris, Q., 2008. 
GeneMANIA: a real-time multiple association network integration 
algorithm for predicting gene function. Genome Biol. 9 Suppl 1, S4. 
doi:10.1186/gb-2008-9-s1-s4 
Mouw, J.K., Ou, G., Weaver, V.M., 2014. Extracellular matrix 
assembly: a multiscale deconstruction. Nat. Rev. Mol. Cell Biol. 15, 
771–785. doi:10.1038/nrm3902 
Mower, G.D., Christen, W.G., 1985. Role of visual experience in 
activating critical period in cat visual cortex. J Neurophysiol 53, 
572–589. 
Mukherjee, K., Yang, X., Gerber, S.H., Kwon, H.-B., Ho, A., Castillo, 
  139 
P.E., Liu, X., Südhof, T.C., 2010. Piccolo and bassoon maintain 
synaptic vesicle clustering without directly participating in vesicle 
exocytosis. Proc. Natl. Acad. Sci. U. S. A. 107, 6504–9. 
doi:10.1073/pnas.1002307107 
Murphy, D., Cole, N.B., Greenberger, V., Segal, M., 1998a. Estradiol 
Increases Dendritic Spine Density by Reducing GABA 
Neurotransmission in Hippocampal Neurons. J. Neurosci. 18, 
2550–2559. 
Murphy, D., Cole, N.B., Segal, M., 1998b. Brain-derived neurotrophic 
factor mediates estradiol-induced dendritic spine formation in 
hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 11412–7. 
Nag, S., Lee, P., Herikstad, R., Sng, J., Yen, S.C., Thakor, N. V., 2015. 
Multi-function optogenetic stimulator and neural amplifier for 
wirelessly controlled neural interface, in: 2015 IEEE Biomedical 
Circuits and Systems Conference (BioCAS). IEEE, pp. 1–4. 
doi:10.1109/BioCAS.2015.7348341 
Najbauer, J., Johnson, B.A., Young, A.L., Aswad, D.W., 1993. Peptides 
with sequences similar to glycine, arginine-rich motifs in proteins 
interacting with RNA are efficiently recognized by 
methyltransferase(s) modifying arginine in numerous proteins. J. 
Biol. Chem. 268, 10501–9. 
Nakamura, M., Nakano, K., Morita, S., Nakashima, T., Oohira, A., 
Miyata, S., 2009. Expression of chondroitin sulfate proteoglycans 
in barrel field of mouse and rat somatosensory cortex. Brain Res. 
 140 
1252, 117–29. doi:10.1016/j.brainres.2008.11.022 
Neault, M., Mallette, F.A., Vogel, G., Michaud-Levesque, J., Richard, 
S., 2012. Ablation of PRMT6 reveals a role as a negative 
transcriptional regulator of the p53 tumor suppressor. Nucleic 
Acids Res. 40, 9513–21. doi:10.1093/nar/gks764 
Nicholson, T.B., Chen, T., Richard, S., 2009. The physiological and 
pathophysiological role of PRMT1-mediated protein arginine 
methylation. Pharmacol. Res. 60, 466–74. 
doi:10.1016/j.phrs.2009.07.006 
Nott, A., Cho, S., Seo, J., Tsai, L.-H., 2015. HDAC2 expression in 
parvalbumin interneurons regulates synaptic plasticity in the 
mouse visual cortex. Neuroepigenetics 1, 34–40. 
doi:10.1016/j.nepig.2014.10.005 
Nowicka, D., Soulsby, S., Skangiel-Kramska, J., Glazewski, S., 2009. 
Parvalbumin-containing neurons, perineuronal nets and 
experience-dependent plasticity in murine barrel cortex. Eur. J. 
Neurosci. 30, 2053–63. doi:10.1111/j.1460-9568.2009.06996.x 
O’Leary, D.D., Ruff, N.L., Dyck, R.H., 1994. Development, critical 
period plasticity, and adult reorganizations of mammalian 
somatosensory systems. Curr. Opin. Neurobiol. 4, 535–44. 
Oliveros, J.C., n.d. Venny. An interactive tool for comparing lists with 
Venn’s diagrams. [WWW Document]. URL 
http://bioinfogp.cnb.csic.es/tools/venny/index.html 
Olson, C.R., Freeman, R.D., 1980. Profile of the sensitive period for 
  141 
monocular deprivation in kittens. Exp. Brain Res. 39, 17–21. 
doi:10.1007/BF00237065 
Oray, S., Majewska, A., Sur, M., 2004. Dendritic spine dynamics are 
regulated by monocular deprivation and extracellular matrix 
degradation. Neuron 44, 1021–1030. 
doi:10.1016/j.neuron.2004.12.001 
Ossipow, V., Pellissier, F., Schaad, O., Ballivet, M., 2004. Gene 
expression analysis of the critical period in the visual cortex. Mol. 
Cell. Neurosci. 27, 70–83. doi:10.1016/j.mcn.2004.05.003 
Pahlich, S., Zakaryan, R.P., Gehring, H., 2008. Identification of proteins 
interacting with protein arginine methyltransferase 8: the Ewing 
sarcoma (EWS) protein binds independent of its methylation state. 
Proteins 72, 1125–37. doi:10.1002/prot.22004 
Paik, W.K., Kim, S., 1967. Enzymatic methylation of protein fractions 
from calf thymus nuclei. Biochem. Biophys. Res. Commun. 29, 
14–20. 
Pelli, D.G., 1997. The VideoToolbox software for visual psychophysics: 
transforming numbers into movies. Spat. Vis. 10, 437–42. 
Pesheva, P., Probstmeier, R., 2000. The yin and yang of tenascin-R in 
CNS development and pathology. Prog. Neurobiol. 61, 465–493. 
doi:10.1016/S0301-0082(99)00061-1 
Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J.W., 
Maffei, L., 2002. Reactivation of ocular dominance plasticity in the 
adult visual cortex. Science 298, 1248–51. 
 142 
doi:10.1126/science.1072699 
Pizzorusso, T., Medini, P., Landi, S., Baldini, S., Berardi, N., Maffei, L., 
2006. Structural and functional recovery from early monocular 
deprivation in adult rats. Proc. Natl. Acad. Sci. U. S. A. 103, 8517–
22. doi:10.1073/pnas.0602657103 
Plessy, C., Fagiolini, M., Wagatsuma, A., Harasawa, N., Kuji, T., 
Asaka-Oba, A., Kanzaki, Y., Fujishima, S., Waki, K., Nakahara, H., 
Hensch, T.K., Carninci, P., 2008. A resource for transcriptomic 
analysis in the mouse brain. PLoS One 3, e3012. 
doi:10.1371/journal.pone.0003012 
Pollack, B.P., Kotenko, S. V., He, W., Izotova, L.S., Barnoski, B.L., 
Pestka, S., 1999. The Human Homologue of the Yeast Proteins 
Skb1 and Hsl7p Interacts with Jak Kinases and Contains Protein 
Methyltransferase Activity. J. Biol. Chem. 274, 31531–31542. 
doi:10.1074/jbc.274.44.31531 
Prusky, G.T., Douglas, R.M., 2004. Characterization of mouse cortical 
spatial vision. Vision Res. 44, 3411–8. 
doi:10.1016/j.visres.2004.09.001 
Prusky, G.T., Douglas, R.M., 2003. Developmental plasticity of mouse 
visual acuity. Eur. J. Neurosci. 17, 167–173. doi:10.1046/j.1460-
9568.2003.02420.x 
Prusky, G.T., Silver, B.D., Tschetter, W.W., Alam, N.M., Douglas, R.M., 
2008. Experience-dependent plasticity from eye opening enables 
lasting, visual cortex-dependent enhancement of motion vision. J. 
  143 
Neurosci. 28, 9817–27. doi:10.1523/JNEUROSCI.1940-08.2008 
Prusky, G.T., West, P.W., Douglas, R.M., 2000. Behavioral 
assessment of visual acuity in mice and rats. Vision Res. 40, 
2201–9. 
Ptashne, M., 2007. On the use of the word “epigenetic.” Curr. Biol. 17, 
R233–R236. doi:10.1016/j.cub.2007.02.030 
Putignano, E., Lonetti, G., Cancedda, L., Ratto, G., Costa, M., Maffei, 
L., Pizzorusso, T., 2007. Developmental downregulation of histone 
posttranslational modifications regulates visual cortical plasticity. 
Neuron 53, 747–59. doi:10.1016/j.neuron.2007.02.007 
Putthoff, P., Akyüz, N., Kutsche, M., Zardi, L., Borgmeyer, U., 
Schachner, M., 2003. Structure of the murine tenascin-R gene and 
functional characterisation of the promoter. Biochem. Biophys. 
Res. Commun. 308, 940–9. 
Pyka, M., Wetzel, C., Aguado, A., Geissler, M., Hatt, H., Faissner, A., 
2011. Chondroitin sulfate proteoglycans regulate astrocyte-
dependent synaptogenesis and modulate synaptic activity in 
primary embryonic hippocampal neurons. Eur. J. Neurosci. 33, 
2187–202. doi:10.1111/j.1460-9568.2011.07690.x 
Raab-Graham, K.F., Haddick, P.C.G., Jan, Y.N., Jan, L.Y., 2006. 
Activity- and mTOR-dependent suppression of Kv1.1 channel 
mRNA translation in dendrites. Science 314, 144–8. 
doi:10.1126/science.1131693 
Ross, P.L., Huang, Y.N., Marchese, J.N., Williamson, B., Parker, K., 
 144 
Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., 
Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., 
Jacobson, A., Pappin, D.J., 2004. Multiplexed protein quantitation 
in Saccharomyces cerevisiae using amine-reactive isobaric 
tagging reagents. Mol. Cell. Proteomics 3, 1154–69. 
doi:10.1074/mcp.M400129-MCP200 
Roussignol, G., Ango, F., Romorini, S., Tu, J.C., Sala, C., Worley, P.F., 
Bockaert, J., Fagni, L., 2005. Shank expression is sufficient to 
induce functional dendritic spine synapses in aspiny neurons. J. 
Neurosci. 25, 3560–3570. doi:10.1523/JNEUROSCI.4354-04.2005 
Rudelli, R.D., Brown, W.T., Wisniewski, K., Jenkins, E.C., Laure-
Kamionowska, M., Connell, F., Wisniewski, H.M., 1985. Adult 
fragile X syndrome. Clinico-neuropathologic findings. Acta 
Neuropathol. 67, 289–95. 
Ruiz-Marcos, A., Valverde, F., 1969. The temporal evolution of the 
distribution of dendritic spines in the visual cortex of normal and 
dark raised mice. Exp. brain Res. 8, 284–94. 
Ruoslahti, E., 1996. Brain extracellular matrix. Glycobiology 6, 489–92. 
Sala, C., Piëch, V., Wilson, N.R., Passafaro, M., Liu, G., Sheng, M., 
2001. Regulation of dendritic spine morphology and synaptic 
function by Shank and Homer. Neuron 31, 115–30. 
Satterlee, J.S., Beckel-Mitchener, A., Little, R., Procaccini, D., Rutter, 
J.L., Lossie, A.C., 2015. Neuroepigenomics: Resources, 
Obstacles, and Opportunities. Neuroepigenetics 1, 2–
  145 
doi:10.1016/j.nepig.2014.10.001 
Sayegh, J., Webb, K., Cheng, D., Bedford, M.T., Clarke, S.G., 2007. 
Regulation of protein arginine methyltransferase 8 (PRMT8) 
activity by its N-terminal domain. J. Biol. Chem. 282, 36444–53. 
doi:10.1074/jbc.M704650200 
Schneider, C.A., Rasband, W.S., Eliceiri, K.W., 2012. NIH Image to 
ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675. 
doi:10.1038/nmeth.2089 
Shin, J., Ming, G., Song, H., 2015. Seeking a Roadmap toward 
Neuroepigenetics. Neuron 86, 12–15. 
doi:10.1016/j.neuron.2015.03.051 
Skarnes, W.C., Rosen, B., West, A.P., Koutsourakis, M., Bushell, W., 
Iyer, V., Mujica, A.O., Thomas, M., Harrow, J., Cox, T., Jackson, 
D., Severin, J., Biggs, P., Fu, J., Nefedov, M., de Jong, P.J., 
Stewart, A.F., Bradley, A., 2011. A conditional knockout resource 
for the genome-wide study of mouse gene function. Nature 474, 
337–42. doi:10.1038/nature10163 
Spira, M.E., Hai, A., 2013. Multi-electrode array technologies for 
neuroscience and cardiology. Nat. Nanotechnol. 8, 83–94. 
doi:10.1038/nnano.2012.265 
Stanford, W.L., Cohn, J.B., Cordes, S.P., 2001. Gene-trap 
mutagenesis: past, present and beyond. Nat. Rev. Genet. 2, 756–
68. doi:10.1038/35093548 
Sugiyama, S., Di Nardo, A.A., Aizawa, S., Matsuo, I., Volovitch, M., 
 146 
Prochiantz, A., Hensch, T.K., 2008. Experience-dependent 
transfer of Otx2 homeoprotein into the visual cortex activates 
postnatal plasticity. Cell 134, 508–20. 
doi:10.1016/j.cell.2008.05.054 
Sur, M., Frost, D.O., Hockfield, S., 1988. Expression of a surface-
associated antigen on Y-cells in the cat lateral geniculate nucleus 
is regulated by visual experience. J. Neurosci. 8, 874–82. 
Sutton, M.A., Ito, H.T., Cressy, P., Kempf, C., Woo, J.C., Schuman, 
E.M., 2006. Miniature neurotransmission stabilizes synaptic 
function via tonic suppression of local dendritic protein synthesis. 
Cell 125, 785–99. doi:10.1016/j.cell.2006.03.040 
Sutton, M.A., Wall, N.R., Aakalu, G.N., Schuman, E.M., 2004. 
Regulation of dendritic protein synthesis by miniature synaptic 
events. Science 304, 1979–83. doi:10.1126/science.1096202 
Sweatt, J.D., Nestler, E.J., Meaney, M.J., Akbarian, S., 2013. An 
Overview of the Molecular Basis of Epigenetics, in: Epigenetic 
Regulation in the Nervous System. pp. 3–33. doi:10.1016/B978-0-
12-391494-1.00001-X 
Swiercz, R., Cheng, D., Kim, D., Bedford, M.T., 2007. Ribosomal 
protein rpS2 is hypomethylated in PRMT3-deficient mice. J. Biol. 
Chem. 282, 16917–23. doi:10.1074/jbc.M609778200 
Syken, J., Grandpre, T., Kanold, P.O., Shatz, C.J., 2006. PirB restricts 
ocular-dominance plasticity in visual cortex. Science 313, 1795–
800. doi:10.1126/science.1128232 
  147 
Taha, S., Stryker, M.P., Androutsellis-Theotokis, A., McCormack, W.J., 
Bradford, H.F., Stern, G.M., Pliego-River, F.B., Antonini, A., 
Stryker, M.P., Antonini, A., Fagiolini, M., Stryker, M.P., Bailey, C.H., 
Chen, M., Bailey, C.H., Montarolo, P., Chen, M., Kandel, E.R., 
Schacher, S., Bailey, C.H., Bartsch, D., Kandel, E.R., Barea-Rodrı́guez, 
E.J., Rivera, D.T., Jaffe, D., Martinez, J.J., Bear, M.F., 
Kleinschmidt, A., Gu, Q., Singer, W., Bozdagi, O., Shan, W., 
Tanaka, H., Benson, D.L., Huntley, G.W., Cabelli, R.J., Hohn, A., 
Shatz, C.J., Daw, N.W., Stein, P.S., Fox, K., Dubnau, J., Tully, T., 
Engert, F., Bonhoeffer, T., Feng, G., Mellor, R.H., Bernstein, M., 
Keller-Peck, C., Nguyen, Q.T., Wallace, M., Nerbonne, J.M., 
Lichtman, J.L., Sanes, J.R., Flexner, J.B., Flexner, L.B., Stellar, E., 
Frank, M.G., Issa, N.P., Stryker, M.P., Freeman, R.D., Olson, C., 
Frey, U., Krug, M., Reymann, K.G., Matthies, H., Gillespie, D.C., 
Crair, M.C., Stryker, M.P., Gordon, J.A., Stryker, M.P., Gordon, 
J.A., Cioffi, D., Silva, A.J., Stryker, M.P., Hanover, J.L., Huang, 
Z.J., Tonegawa, S., Stryker, M.P., Hensch, T.K., Fagiolini, M., 
Mataga, N., Stryker, M.P., Baekkeskov, S., Kash, S.F., Hubel, 
D.H., Wiesel, T.N., Huber, K.M., Kayser, M.S., Bear, M.F., 
Kennedy, C., Suda, S., Smith, C.B., Miyaoka, M., Ito, M., Sokoloff, 
L., Krug, M., Lossner, B., Ott, T., Kurontani, T., Higashi, S., 
Inokawa, H., Toyama, K., Lein, E.S., Shatz, C.J., Levenes, C., 
Daniel, H., Crépel, F., Linden, D.J., Mayford, M., Kandel, E.R., 
McAllister, A.K., Lo, D.C., Katz, L.C., Movshon, J.A., Dursteler, 
 148 
M.R., Muller, C.M., Griesinger, C.B., Olson, C.R., Freeman, R.D., 
Pham, T.A., Impey, S., Storm, D.R., Stryker, M.P., Porciatti, V., 
Pizzorusso, T., Maffei, L., Qian, Z., Gilbert, M.E., Colicos, M.A., 
Kandel, E.R., Kuhl, D., Reiter, H.O., Stryker, M.P., Reiter, H.O., 
Waitzman, D.M., Stryker, M.P., Roberts, E.B., Meredith, M.A., 
Ramoa, A.S., Rose, S.P.R., Stewart, M.G., Schoups, A.A., Elliott, 
R.C., Friedman, W.J., Black, I.B., Shaw, C., Cynader, M., Silver, 
M.A., Stryker, M.P., Soderling, T.R., Trachtenberg, J.T., Stryker, 
M.P., Trachtenberg, J.T., Trepel, C., Stryker, M.P., Wiesel, T.N., 
Hubel, D.H., Wu, L., Wells, D., Tay, J., Mendis, D., Abbott, M., 
Barnitt, A., Quinlan, E., Heynen, A., Fallon, J.R., Richter, J.D., 
Zafra, F., Lindholm, D., Castrén, E., Hartikka, J., Thoenen, H., 
2002. Rapid Ocular Dominance Plasticity Requires Cortical but Not 
Geniculate Protein Synthesis. Neuron 34, 425–436. 
doi:10.1016/S0896-6273(02)00673-6 
Takesian, A.E., Hensch, T.K., 2013. Changing Brains - Applying Brain 
Plasticity to Advance and Recover Human Ability, Progress in 
Brain Research, Progress in Brain Research. Elsevier. 
doi:10.1016/B978-0-444-63327-9.00001-1 
Taneda, T., Miyata, S., Kousaka, A., Inoue, K., Koyama, Y., Mori, Y., 
Tohyama, M., 2007. Specific regional distribution of protein 
arginine methyltransferase 8 (PRMT8) in the mouse brain. Brain 
Res. 1155, 1–9. doi:10.1016/j.brainres.2007.03.086 
Tang, J., 1998. PRMT 3, a Type I Protein Arginine N-Methyltransferase 
  149 
That Differs from PRMT1 in Its Oligomerization, Subcellular 
Localization, Substrate Specificity, and Regulation. J. Biol. Chem. 
273, 16935–16945. doi:10.1074/jbc.273.27.16935 
Tang, J., Kao, P.N., Herschman, H.R., 2000. Protein-arginine 
methyltransferase I, the predominant protein-arginine 
methyltransferase in cells, interacts with and is regulated by 
interleukin enhancer-binding factor 3. J. Biol. Chem. 275, 19866–
76. doi:10.1074/jbc.M000023200 
Tee, W.-W., Pardo, M., Theunissen, T.W., Yu, L., Choudhary, J.S., 
Hajkova, P., Surani, M.A., 2010. Prmt5 is essential for early mouse 
development and acts in the cytoplasm to maintain ES cell 
pluripotency. Genes Dev. 24, 2772–7. doi:10.1101/gad.606110 
Trachtenberg, J.T., Chen, B.E., Knott, G.W., Feng, G., Sanes, J.R., 
Welker, E., Svoboda, K., 2002. Long-term in vivo imaging of 
experience-dependent synaptic plasticity in adult cortex. Nature 
420, 788–94. doi:10.1038/nature01273 
Tropea, D., Kreiman, G., Lyckman, A., Mukherjee, S., Yu, H., Horng, 
S., Sur, M., 2006. Gene expression changes and molecular 
pathways mediating activity-dependent plasticity in visual cortex. 
Nat. Neurosci. 9, 660–8. doi:10.1038/nn1689 
Tropea, D., Van Wart, A., Sur, M., 2009. Molecular mechanisms of 
experience-dependent plasticity in visual cortex. Philos. Trans. R. 
Soc. Lond. B. Biol. Sci. 364, 341–55. doi:10.1098/rstb.2008.0269 
Urbanska, M., Blazejczyk, M., Jaworski, J., 2008. Molecular basis of 
 150 
dendritic arborization. Acta Neurobiol. Exp. (Wars). 68, 264–88. 
Vecsey, C.G., Hawk, J.D., Lattal, K.M., Stein, J.M., Fabian, S.A., 
Attner, M.A., Cabrera, S.M., McDonough, C.B., Brindle, P.K., Abel, 
T., Wood, M.A., 2007. Histone deacetylase inhibitors enhance 
memory and synaptic plasticity via CREB:CBP-dependent 
transcriptional activation. J. Neurosci. 27, 6128–40. 
doi:10.1523/JNEUROSCI.0296-07.2007 
Vogel, C., Marcotte, E.M., 2012. Insights into the regulation of protein 
abundance from proteomic and transcriptomic analyses. Nat. Rev. 
Genet. 13, 227–32. doi:10.1038/nrg3185 
Wagor, E., Mangini, N.J., Pearlman, A.L., 1980. Retinotopic 
organization of striate and extrastriate visual cortex in the mouse. 
J. Comp. Neurol. 193, 187–202. doi:10.1002/cne.901930113 
Waites, C.L., Leal-Ortiz, S. a, Okerlund, N., Dalke, H., Fejtova, A., 
Altrock, W.D., Gundelfinger, E.D., Garner, C.C., 2013. Bassoon 
and Piccolo maintain synapse integrity by regulating protein 
ubiquitination and degradation. EMBO J. 32, 954–69. 
doi:10.1038/emboj.2013.27 
Wallace, W., Bear, M.F., 2004. A morphological correlate of synaptic 
scaling in visual cortex. J. Neurosci. 24, 6928–38. 
doi:10.1523/JNEUROSCI.1110-04.2004 
Wang, H., Huang, Z.Q., Xia, L., Feng, Q., Erdjument-Bromage, H., 
Strahl, B.D., Briggs, S.D., Allis, C.D., Wong, J., Tempst, P., Zhang, 
Y., 2001. Methylation of histone H4 at arginine 3 facilitating 
  151 
transcriptional activation by nuclear hormone receptor. Science 
293, 853–7. doi:10.1126/science.1060781 
Weber, P., Bartsch, U., Rasband, M.N., Czaniera, R., Lang, Y., 
Bluethmann, H., Margolis, R.U., Levinson, S.R., Shrager, P., 
Montag, D., Schachner, M., 1999. Mice deficient for tenascin-R 
display alterations of the extracellular matrix and decreased axonal 
conduction velocities in the CNS. J. Neurosci. 19, 4245–62. 
Wiesel, T.N., Hubel, D.H., 1963. Single-cell responses in striate cortex 
of kittens deprived of vision in one eye. J. Neurophysiol. 26, 1003–
17. 
Woldemichael, B.T., Bohacek, J., Gapp, K., Mansuy, I.M., 2014. 
Epigenetics of memory and plasticity. Prog. Mol. Biol. Transl. Sci. 
122, 305–40. doi:10.1016/B978-0-12-420170-5.00011-8 
Wolf, S.S., 2009. The protein arginine methyltransferase family: an 
update about function, new perspectives and the physiological role 
in humans. Cell. Mol. Life Sci. 66, 2109–21. doi:10.1007/s00018-
009-0010-x 
Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B.M., 
Montminy, M., Evans, R.M., 2001. A transcriptional switch 
mediated by cofactor methylation. Science 294, 2507–11. 
doi:10.1126/science.1065961 
Yadav, N., Lee, J., Kim, J., Shen, J., Hu, M.C.-T., Aldaz, C.M., Bedford, 
M.T., 2003. Specific protein methylation defects and gene 
expression perturbations in coactivator-associated arginine 
 152 
methyltransferase 1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 
100, 6464–8. doi:10.1073/pnas.1232272100 
Yang, Y., Bedford, M.T., 2013. Protein arginine methyltransferases and 
cancer. Nat. Rev. Cancer 13, 37–50. doi:10.1038/nrc3409 
Yang, Y., Lu, Y., Espejo, A., Wu, J., Xu, W., Liang, S., Bedford, M.T., 
2010. TDRD3 is an effector molecule for arginine-methylated 
histone marks. Mol. Cell 40, 1016–23. 
doi:10.1016/j.molcel.2010.11.024 
Ye, Q., Miao, Q.-L., 2013. Experience-dependent development of 
perineuronal nets and chondroitin sulfate proteoglycan receptors in 
mouse visual cortex. Matrix Biol. 32, 352–63. 
doi:10.1016/j.matbio.2013.04.001 
Young, N.M., Williams, R.E., 1985. Assignment of lectins specific for D-
galactose or N-acetyl-D-galactosamine to two groups, based on 
their circular dichroism. Can. J. Biochem. Cell Biol. 63, 268–71. 
doi:10.1139/o85-039 
Yu, Z., Chen, T., Hébert, J., Li, E., Richard, S., 2009. A mouse PRMT1 
null allele defines an essential role for arginine methylation in 
genome maintenance and cell proliferation. Mol. Cell. Biol. 29, 
2982–96. doi:10.1128/MCB.00042-09 
Zhou, X.H., Brakebusch, C., Matthies, H., Oohashi, T., Hirsch, E., 
Moser, M., Krug, M., Seidenbecher, C.I., Boeckers, T.M., Rauch, 
U., Buettner, R., Gundelfinger, E.D., Fässler, R., 2001. Neurocan 
is dispensable for brain development. Mol. Cell. Biol. 21, 5970–8. 
  153 
Zuo, Y., Lin, A., Chang, P., Gan, W.-B., 2005a. Development of long-
term dendritic spine stability in diverse regions of cerebral cortex. 
Neuron 46, 181–9. doi:10.1016/j.neuron.2005.04.001 
Zuo, Y., Yang, G., Kwon, E., Gan, W.-B., 2005b. Long-term sensory 
deprivation prevents dendritic spine loss in primary somatosensory 
cortex. Nature 436, 261–5. doi:10.1038/nature03715 
Zurita-Lopez, C.I., Sandberg, T., Kelly, R., Clarke, S.G., 2012. Human 
protein arginine methyltransferase 7 (PRMT7) is a type III enzyme 
forming ω-NG-monomethylated arginine residues. J. Biol. Chem. 
287, 7859–70. doi:10.1074/jbc.M111.336271 
 
 
